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RESUMEN / SUMMARY 
El desarrollo de la línea germinal comienza en la especie humana 
durante el desarrollo embrionario con la aparición de las células germinales 
primordiales (CGP) desde el epiblasto proximal en la semana 2 a 3 de 
gestación. Las CGP migran a las crestas gonadales y cambian su perfil de 
expresión genético y epigenético desde un patrón somático predefinido a 
un patrón germinal. Durante el proceso de maduración germinal que 
depende del sexo del embrión, la adquisición del patrón gamético permite 
que células germinales puedan entrar en meiosis, un proceso crucial por el 
cual los gametos reducen a la mitad la carga cromosómica para, tras la 
fecundación, dar lugar a un nuevo individuo diploide. 
Sin embargo, debido a las dificultades metodológicas, éticas, morales 
y legales que implica su estudio durante el desarrollo embrionario humano 
todo nuestro conocimiento acerca del desarrollo de la línea germinal en 
mamíferos procede de la extrapolación del modelo murino. 
 Por lo tanto, la generación de modelos in vitro para la derivación de 
células germinales humanas es de gran utilidad para estudiar tanto su 
desarrollo, como su biología y comportamiento. Varios estudios indican que 
tanto las células madre embrionarias humanas como las células madre 
pluripotentes inducidas humanas son capaces de mostrar un fenotipo 
similar al de una célula germinal tras su diferenciación llegando a mostrar 
marcadores meióticos y postmeióticos. Es más, recientemente se ha 
demostrado que células germinales inducidas in vitro a partir de hiPSC son 
 
 
capaces de recolonizar el nicho de las células madre espermatogoniales  en 
ensayos de xenotransplante en ratones inmunodeprimidos. 
Por otra parte, la reprogramación directa de un tipo celular 
diferenciado a otro mediante la sobreexpresión de factores de transcripción 
específicos, permite plantearse la hipótesis de la reprogramación directa de 
células somáticas adultas hacia células germinales. 
HIPÓTESIS Y OBJETIVOS:  
La hipótesis de trabajo es investigar la conversión directa de células 
somáticas adultas a células con fenotipo germinal inducidas in vitro 
mediante sobreexpresión de un conjunto de genes implicados en las 
distintas fases del desarrollo de las células germinales. 
El objetivo principal es la obtención in vitro de células germinales 
inducidas mediante sobreexpresión ectópica de un conjunto de genes 
descritos como clave durante el desarrollo de la línea germinal. 
En base a lo anteriormente descrito, los objetivos específicos son:  
1. Identificación, aislamiento y clonación en vectores lentivirales de genes 
humanos clave en el desarrollo de la línea germinal. 
2. Optimización de las condiciones de cultivo para mejorar el 
mantenimiento de las células somáticas adultas humanas reprogramadas. 
3. Cribado de los factores de reprogramación para encontrar la 
combinación más eficiente en términos de inducción y avance de la meiosis. 
 
 
4. Caracterización a nivel transcriptómico y epigenético de las células 
germinales inducidas in vitro. 
5. Análisis de la progresión meiótica y ploidía de dichas las células 
germinales inducidas in vitro. 
6. Análisis de la funcionalidad las células germinales inducidas in vitro en 
modelos de xenotranplante. 
METODOLOGÍA Y DISEÑO EXPERIMENTAL:  
Se han seleccionado y clonado en vectores lentivirales los siguientes 
genes relacionados con diferentes fases del desarrollo de la línea germinal:-  
Genes inductores de la formación de células germinales 
1) PRDM1: Factor de transcripción encargado de silenciar el programa 
somático en las CGP.  
2) PRDM14: Interactúa con PRDM1 en su función y participa en la inducción 
del proceso de reprogramación epigenética de la línea germinal in vivo. 
3) NANOS3: Relacionado con la supervivencia y el mantenimiento en estado 
quiescente de las células germinales mediante represión transduccional de 
ARNs mensajeros. 
4) LIN28A: Proteína de unión al ARN encargada de silenciar varios micro 
ARNs y relacionada con la especificación de las CGP mediante la regulación 
de PRDM1. 
 
 
5) NANOG: Factor de transcripción relacionado con la pluripotencia y 
proliferación de las CGP. 
Genes necesarios para la maduración y supervivencia de las células 
germinales: 
6) DAZ2: Proteína de unión al ARN codificada en el cromosoma Y, participa 
de forma esencial para que se desarrolle correctamente la 
espermatogénesis. Su pérdida de función produce el Síndrome de sólo 
células de Sertoli. 
7) DAZL: Proteína de unión al ARN descrita como esencial para la correcta 
maduración de las células germinales. Su pérdida de función produce 
esterilidad en ambos sexos. 
8) BOLL: Proteína de unión al ARN de la misma familia que DAZ2 y DAZL,  su 
pérdida de función produce fallos en la meiosis. 
9) VASA: Proteína de unión al ARN implicada en la meiosis y maduración 
germinal mediante su función como regulador de los ARNs asociados a 
PIWI. Su pérdida de función produce esterilidad en ratones macho. 
10) STRA8: Proteína implicada en la inducción de la meiosis en respuesta al 
ácido retinoico. 
Genes implicados en la meiosis: 
11) DMC1: Recombinasa que se encarga de la reparación de roturas 
programadas en el ADN durante la recombinación de los cromosomas 
homólogos en la profase I de la meiosis. 
 
 
12) SYCP3: Componente estructural esencial del complejo sinaptonémico 
durante la profase I de la meiosis. 
Una vez clonados, fueron transfectados en dos tipos celulares 
humanos primarios XY: fibroblastos de prepucio humano (hFSK de sus siglas 
en inglés) y células madre mesenquimales (hMSC, de sus siglas en inglés). 
Los días 7, 14 y 21 post-transfección, los cultivos celulares fueron 
analizados mediante su caracterización transcriptómica, e 
inmunofenotipado. Además, en el día 14, se analizó su estatus epigenético  
mediante secuenciación por bisulfito de dos genes improntados, su 
progresión meiótica y ploidía. Igualmente, 14 días después de su 
transfección las células germinales inducidas fueron introducidas en  el 
testículo del ratón para el ensayo de xenotransplante.  
La metodología seguida se detalla a continuación: 
- Caracterización transcriptómica mediante array de expresión y qRT-PCR, 
análisis epigenético del estado de metilación por secuenciación por 
bisulfito, inmunofenotipado por inmunofluorescencia. 
- Determinación del estado meiótico mediante inmunofluorescencia para 
SYCP3. Determinación de la haploidía mediante separación celular activada 
por fluorescencia (FACS) basada en intensidad de yoduro de propidio 
seguido de FISH para los cromosomas 18, X, Y y recomprobado con sondas 
para los cromosomas 10, 12 y 3. 
- Para el ensayo de xenotransplante, las células transfectadas se inyectaron 
en el conducto eferente de ratones NUDE (Crl:NU-Foxn1nu) previamente 
 
 
esterilizados con busulfán, según el protocolo descrito en la literatura 
(Ogawa et al. 1997). Dos meses tras el xenotransplante, se analizaron los 
testículos de los ratones para determinar su localización y progresión.  
CONCLUSIONES:  
La sobreexpresión ectópica de un conjunto de genes reguladores del 
desarrollo de la línea germinal, en dos líneas celulares humanas masculinas 
(hFSK y hMSC) induce la aparición de una población heterogénea de células 
con fenotipo similar al germinal. 
Estas células germinales inducidas muestran un perfil de expresión y 
metilación compatible con el de células germinales en diferentes estadios 
de maduración. 
Algunas de estas células germinales inducidas se pueden 
correlacionar con un estado similar al de espermatogonia dado que son 
capaces de avanzar en la meiosis e incluso terminarla, dando lugar a células 
haploides, tras ser expuestas a ácido retinoico. 
La combinación más efectiva de factores para conseguir un fenotipo 
meiótico se disminuyó de las 12 originales a 6 incluyendo PRDM1 y 
PRDM14, proteínas que actúan como factores de transcripción; junto con 
LIN28A, DAZL y VASA, que son proteínas de unión a ARN; y SYCP3, una 
proteína estructural del complejo sinaptonémico. 
Al ser xenotransplantadas, algunas de las células germinales 
inducidas muestran características similares a las de células madre 
 
 
espermatogoniales, al demostrar su capacidad para colonizar la lámina 
basal de los túbulos seminíferos, probando su funcionalidad in vivo. 
Por lo tanto, se propone que este estudio sea considerado como un 
modelo piloto para el estudio in vitro del desarrollo de la línea germinal en 
humanos.  
 
 
 
 
 
  
 
 
LIST OF ABBREVIATIONS
293-T - 293-T packaging cell line 
5caC - 5-carboxylcytosine 
5fC - 5-formylcytosine  
5hmC - 5-hydroxymehylcytosine  
ABP – androgen binding protein 
AMH - anti-müllerian hormone 
AP - alkaline phosphatase 
BER - base excision repair 
bFGF - basic fibroblast growth factor  
Bi-seq - bisulfite sequencing 
bp - base pairs 
BS - busulfan 
BSA - bovine serum albumin 
C - cytosine 
cDNA - copy deoxyribonucleic acid  
CGI - CpG Islands 
CpG – cytosine- guanine dinucleotides 
DAPI - 4',6-diamidino-2-phenylindole 
DAZ - deleted in azoospermia 
ddATP - 2',3'-dideoxyadenosine-5'-
triphosphate 
ddCTP - 2',3'-dideoxycytidine-5'-
triphosphate 
ddGTP - 2',3'-dideoxyguanosine-5'-
triphosphate 
ddNTP - dideoxynucleotide 
ddTTP - 2',3'-dideoxythymidine-5'-
triphosphate 
D-MEM/F12 - Dulbecco's modified 
Eagle's medium/ nutrient F-12 ham  
DMR - differentially demethylated region 
DNA: deoxyribonucleic acid 
E - embryonic day 
EB - embryoid body 
EGF - epidermal growth factor 
EmGFP - emerald green fluorescent 
protein 
endo-siRNA - small interfering 
endogenous RNA 
EP - elongated spermatid 
Epi – epiblast 
EpiSC – Epiblastic stem cells 
EpiLC - epiblast-like cell 
ESC - embryonic stem cell 
ExE - extraembryonic ectoderm  
FACS - fluorescence activated cell-sorting  
FBS - fetal bovine serum 
FDR - false discovery rate 
FISH - fluorescent in situ hybridization 
FSH - follicle-stimulating hormone 
G - guanine 
GC-M - germ-cell media for induced 
germ-cell survival 
gDNA - genomic deoxyribonucleic acid 
GDNF - glial cell line-derived 
neurotrophic factor 
GFP - green fluorescent protein 
ɤH2AX - Phosphorylation form of H2A.X 
GnRH - gonadotropin-releasing hormone  
GO – gene ontology 
H1 – histone 1 
H1LS - histone-1-like protein in 
spermatids 
H1T2 - histone 1 variant T2 
H2A - histone 2A 
H2A.X – histone 2A variant X 
H2A/H4R3me2s - histone 2A and histone 
4 arginine 3 symmetric dimethylation. 
H2B – histone 2B 
H2BK5ac – histone 2B lysine 5 
acetylation 
H3.3 – histone 3 variant 3 
H3K20me - histone 3 lysine 20 
methylation 
H3K27ac - histone 3 lysine 27 acetylation 
H3K27me3 - histone 3 lysine 27 
trimethylation 
H3K36me - histone 3 lysine 36 
methylation 
H3K4ac - histone 3 lysine acetylation 
H3K4me - histone 3 lysine 4 methylation 
H3K6ac - histone 3 lysine 6 acetylation 
H3K6me3 - histone 3 lysine 6 
trimethylation 
H3K79ac - histone 3 lysine 79 acetylation 
H3K79me3 - histone 3 lysine 79 
trimethylation 
H3K9ac - histone 3 lysine 9 acetylation 
H3K9me - histone 3 lysine 9 methylation 
H4 – histone 4 
H4K20me – histone 4 lysine 20 
methylation 
  
 
H4R3me2s - histone 4 arginine-3 
symmetric dimethylation 
hESC - human embryonic stem cell 
hFSK - human foreskin fibroblast 
hiPSC - human induced pluripotent stem 
cell 
hMSC: human mesenchymal stem cell 
i12F – induced with twelve factors  
i6F – induced with six factors  
IAP - intracisternal A particle 
ICR - imprinting control regions 
ICSI - intra-cytoplasmic sperm injection 
IF - immunofluorescence 
iGC - induced germ cell-like cell 
iPSC - induced pluripotent stem cell  
KSR - knock-out serum replacement 
LH - luteinizing hormone  
LIF - leukaemia inhibitory factor 
LINE - long interspersed nuclear element 
ƛMAX Exc – maximum excitation wave 
length 
ƛMAX Em - maximum emission wave length 
MACS - magnetic activated cell-sorting 
MD - Müllerian paramesonephric duct  
mESC - mouse ESC 
miPSCs - murine induced pluripotent 
cells  
miRISC - miRNA-induced silencing 
complex 
miRNA - microRNA  
mRNA - messenger RNA  
MSCI - meiotic sex chromosome 
inactivation 
MSUC - meiotic silencing of unpaired 
chromatin 
ORF – open reading frames 
OSKM - OCT4, SOX2, KFL4, and cMYC 
reprogramming factors (also known as 
Yamanaka’s factors) 
OSKMV- OCT4, SOX2, KFL4, cMYC, and 
VASA reprogramming factors 
PBS - phosphate-buffered serum 
PCA – principal component analysis 
PCR - polymerase chain reaction 
PFA - paraformaldehyde 
PGC - primordial germ cell 
PGCLC - PGC-like cell 
PI - propidium iodide  
piRNA - protein interacting RNA 
PMSF - phenylmethylsulfonyl fluoride  
PR - positive regulatory 
PSC - pluripotent stem cell 
p-value - probability value 
qRT-PCR – quantitative real-time PCR 
RA - retinoic acid 
RNA - ribonucleic acid 
rpm - rotations per minute 
RS - round spermatid  
SAC - spindle assembly checkpoint 
SCF – stem cell factor 
SEM – standard error of mean 
siRNA - small interfering RNA 
Spc I - primary spermatocyte 
Spc II - secondary spermatocyte  
Spg - spermatogonium 
SSC - spermatogonial stem cell 
T - thymidine 
U - uracil 
UTR - untranslated region 
WD - Wolffian mesonephric duct  
 
LIST OF GENES 
All the genes listed here refer to human annotated genes, although in many cases the text 
refers to the murine homologue when the gene names are the same. The species name is 
indicated only when the gene refers to other animal models. 
ACR – acrosin 
AID – activation–induced cytidine 
deaminase, coded by AICDA gene 
AKT – v–akt murine thymoma viral 
oncogene homolog 1 
ALK3 – bone morphogenetic protein 
receptor, type IA, coded by BMPR1A 
gene 
APOBEC – apolipoprotein B mRNA 
editing enzyme, catalytic polypetides  
  
 
Argonaute proteins – they are the 
catalytic components of the RNA–
induced silencing complex (RISC). Eight 
members of this family have been 
identified in humans, being classified in 
two subfamilies: PIWI (PIWIL1, PIWIL2, 
PIWIL3, and PIWIL4), and eIF2C/AGO 
(hAGO1, hAGO2, hAGO3, and hAGO4). 
BAX – BCL2-associated X protein 
BLIMP1 – PR domain containing 1, with 
ZNF domain (also known as PRDM1), B–
lymphocyte induced maturation protein 
1 
BMP – bone morphogenetic proteins 
BMP2 – bone morphogenetic protein 2 
BMP4 – bone morphogenetic protein 4 
BMP8b – bone morphogenetic protein  
BMPRII – bone morphogenetic protein 
receptor, type II (serine/threonine 
kinase) 
BOLL – boule-like RNA-binding protein 
(also known as BOULE) 
BOULE – boule-like RNA-binding protein 
(also known as BOLL) 
BUB – budding uninhibited by 
benzimidazole 
BUB1 – BUB1 mitotic checkpoint 
serine/threonine kinase 
BUB3 – BUB3 mitotic checkpoint protein 
BUBRI – BUB1 mitotic checkpoint 
serine/threonine kinase B, coded by 
BUB1B gene 
CD117 – tyrosine–protein kinase 
receptor (also known as SCFR or c–KIT) 
CD49f – integrin alpha 6, coded by ITGA6 
gene (also known as 6-integrin) 
cd9 – CD9 molecule 
CD90 – Thy-1 cell surface antigen (also 
known as Thy-1) 
Cerberus-like – cerberus 1 homolog 
(Xenopus laevis) in M. musculus. The 
human homologue is called DAN domain 
family member 5, BMP antagonist 
c-KIT – tyrosine-protein kinase receptor 
(also known as CD117 or SCFR) 
c-Kit-ligand – KIT ligand, coded by KITLG 
gene (also known as stem cell factor, 
SCF) 
cMYC – v-myc avian myelocytomatosis 
viral oncogene homolog 
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1.1 THE GERM LINE IN MAMMALS 
In sexually reproducing organisms germ cells allow the life-cycle to continue 
through generations. Specifically, in mammals, the germ line is clearly 
separated from somatic lineages during early embryonic development. In 
fact, according to the murine model, the germ line in mammals is formed at 
gastrulation from a small number of founder cells called primordial germ 
cells (PGCs) which escape their somatic fate to acquire a germinal role in 
order to complete meiosis and form mature haploid gametes. Thus, these 
are the only two cell types (i.e. oocytes and sperm cells) able to generate a 
complete organism after fecundation. 
1.1.1 GERM LINE DEVELOPMENT 
The whole process of germ line development takes place sequentially 
during early embryo development when PGCs change their gene expression 
pattern and undergo an epigenetic reprogramming process in which they 
proliferate and migrate from the posterior hindgut to the forming gonad. 
Next, germ cells continue their development by differentiation, according 
to the embryonic sex, into oocytes or sperm cells, a process that finishes at 
puberty when they complete their maturation. The germ-line 
developmental process involves global epigenetic reprogramming 
mechanisms that `turn off’ the somatic program and `switch on’ the germ 
line program to acquire pluripotent properties, `erasing’ the epigenetic 
memory that would otherwise drive them towards a somatic fate. This 
process, which also entails chromatin remodeling, is essential for the zygote 
to establish totipotency and is widely regulated at both the genetic and 
epigenetic levels. 
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1.1.1.1 SPECIFICATION AND MIGRATION 
In mice, PGCs can first be identified at embryonic day 6.25 (E6.25), when 
some cells in the proximal epiblast start to express Prdm1 (Ohinata et al., 
2005) which is induced by the BMP4 and BMP8b secreted by 
extraembryonic ectoderm (Fig.1.1A). 
Prdm1 suppresses the somatic gene expression program, allowing the 
expression of germ-cell specific markers STELLA (coded by the Dppa3 gene) 
and Nanos3 as well as the pluripotency markers Sox2, Oct4, and Nanog 
(Saga, 2008, Suzuki et al., 2008). Prdm1 expression is enhanced by LIN28A, a 
microRNA-binding protein that binds the microRNA Let7 (West et al., 2009), 
preventing binding to Prdm1 messenger RNA (mRNA). Prdm14 (which is 
also activated by BMP) acts synergistically with Prdm1 by inducing the re-
acquisition of pluripotency and by initiating epigenetic reprogramming 
(Kurimoto et al., 2008) and together with Nanog maintains pluripotency 
networks (Ma et al., 2011, Mitsui et al., 2003). In mice at E7.5 alkaline 
phosphatase (AP) positive PGCs are located in the posterior area of the 
primitive ridge, in the base of the allantoides (Culty, 2009). They start 
expressing Fragilis (also known as Ifitm3) and Stella (Saitou et al., 2002) and 
maintain Oct4, Nanog, and AP expression. In humans, the specification 
process occurs at two to three weeks of development (Ginsburg et al., 
1990, Mitsui et al., 2003).  
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After specification (E8.5), PGCs migrate and proliferate through the 
subjacent endoderm toward the gonadal ridges (Lawson and Hage, 1994, 
Godin et al., 1990) located next to the primitive hindgut. They pass through 
the mesoderm (E9.5) and start to bilaterally migrate towards the gonadal 
ridges, contributing to gonadal formation (E10.5-11.5; Fig. 1.1B), which in 
humans corresponds to gestation weeks four to five (Bendel-Stenzel et al., 
1998, Richardson and Lehmann, 2010). Their survival and migration are 
maintained by the apoptotic suppression role of Nanos3 (Suzuki et al., 
2008). At the gonadal ridge PGCs proliferate and form gonocytes (E11.0-
11.5), characterized by their rounded morphology and low nucleus to 
cytoplasm ratio (Donovan et al., 1986). Form this point, germ cells change 
their genetic expression program and epigenetic profiles, starting to 
express key genes for survival and maturation like DAZL and VASA 
(Castrillon et al., 2000a, Noce et al., 2001, Tanaka et al., 2000). Other genes 
from the DAZ (deleted in azoospermia) family, such as DAZ2 or BOULE (also 
 
 
FIG. 1.1. Specification and migration in mouse PGCs. Modified from (Saitou et al., 2012) A) 
Specification and migration of the developmental embryo. PGC precursors at embryonic day 
6.5(E6.5) and PGCs in embryos from E6.5 to E12.5 are shown in green, and the direction of 
their migration is indicated by green arrows; B) Detailed view of PGC migration at E9.5-
E10.5. The direction of migration is indicated by green arrows; Al, allantoides; AVE, anterior 
visceral endoderm; DE, distal endoderm; DVE, distal visceral endoderm; EM, embryonic 
mesoderm; Epi, epiblast; ExE, extraembryonic ectoderm; ExM, extraembryonic mesoderm; 
Sm, somite; VE, visceral endoderm. 
A B
Direct reprogramming of human somatic cells to meiotic germ-like cells 
- 10 - 
 
known as BOLL) in humans, have also been demonstrated to be necessary 
for the proper development of the germ line. In mouse, Daz is a master 
regulator of spermatogenesis, while Dazl seems to be critical for proper 
entry into meiosis (Ruggiu et al., 1997). 
1.1.1.2 SEX DETERMINATION, MEIOTIC ENTRY, AND MATURATION 
Germ cell sex determination depends on SRY gene expression, which is 
codified by chromosome Y (Byskov, 1986). In males, SRY activates SOX9 
expression which induces gonadal cells to differentiate into Sertoli cells. In 
turn Sertoli cells induce the bi-potential gonad to differentiate by causing 
the degeneration of Müllerian ducts as response to anti-müllerian hormone 
(Sinclair et al., 1990, McLaren, 1988, Koopman et al., 1990, Burgoyne, 
1988). At the same time, the Sertoli cells recruit cells from the 
mesonephros and coelomic epithelium to form the testicular cords (Kanai 
et al., 2005, Barsoum and Yao, 2006). In the absence of SRY and/or SOX9, 
i.e. in females, the Müllerian ducts give rise to the female gonad while the 
Wolf ducts degenerate (Fig. 1.2A). 
After their sexual specification, male and female germ cells follow different 
maturation patterns. During embryonic development, in the female gonad 
germ cells enter meiosis and stop at prophase I, at E13.5 in mouse and 
week 12 in humans, and only continue after activation of the hypothalamic-
pituitary axis at puberty (Monk, 1981, Monk and McLaren, 1981, Gondos et 
al., 1986). However, in males the germ cells (now called gonocytes) 
continue dividing by mitosis until they reach the pre-spermatogonia stage, 
at which point mitosis stops and meiosis is not initiated until puberty 
1. Introduction 
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FIG. 1.2. Sexual determination. A) Gonad sexual differentiation. In males, SRY expression 
induces SOX9 which, via AMH, causes MD degeneration. In females, WD degenerates. B)  PGC 
sexual determination by niche induction. RA production induces entry into meiosis via STRA8 
in females, with oocytes arresting in meiosis I. In males, Sertoli cells metabolize RA, preventing 
entry into meiosis until puberty, when spermatogenesis initiates. MD, Müllerian 
paramesonephric duct; WD, Wolffian mesonephric duct; AMH, anti-müllerian hormone; RA, 
retinoic acid. 
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(McLaren, 1984, Goto et al., 1999).  
The induction of meiosis is similar in both sexes: retinoic acid (RA) secreted 
by the mesonephros during PGC migration plays a critical role. In the ovary 
RA induces meiosis by promoting Stra8 gene expression (Bowles et al., 
2006), whereas SRY induces RA degradation through Cytochrome P450 
CYP26B1 expression in Sertoli cells (Fig. 1.2B). Thus, RA degradation 
prevents gonocytes from entering meiosis until puberty when hormonal 
changes cause CYP26B1 downregulation, preventing Sertoli cells from 
metabolizing RA (Koubova et al., 2006). 
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Meiosis is a unique and crucial process in sexual reproduction. It comprises 
a reductive cellular division in which four haploid cells are formed from one 
diploid cell. The first meiotic division (meiosis I) is preceded by one round of 
DNA replication and begins with a prophase divided into four stages 
(leptotene, zygotene, pachytene, diplotene). Then, two cells are formed 
with one copy of each pair of homologous chromosomes. At the second 
meiotic division (meiosis II) there is no DNA duplication, and sister 
chromatids separate to form four haploid cells (FIG. 1.3). 
 
FIG. 1.3. Female and male meiosis. A) At oogenesis, meiotic divisions are asymmetric, with 
three final polar bodies and one haploid oocyte. Meiosis only completes upon fecundation. B) 
In spermatogenesis, from a diploid spermatogonium four haploid spermatocytes are 
produced. These spermatocytes continue their maturation by a process called spermiogenesis. 
C) Prophase I stages. The axial element of the synaptonemal complex SYCP3 throughout 
prophase I is shown in red. 
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Meiosis allows genetic recombination to occur in order to create new 
genetic variants which can be inherited by the next generation. This 
happens when recombination events occur in the prophase of meiosis I. 
Homologous chromosomes become paired, thus allowing exchange of 
genetic material via non-sister homologous chromatids at recombination 
spots or synapses (Fig.1. 3C). These loci are formed by the synaptonemal 
complex comprising the highly phylogenetically and evolutionarily 
conserved SYCP1, SYCP2, and SYCP3 proteins. Recombinases such as DMC1 
repair the DNA double strand breaks formed during recombination events 
(Yoshida et al., 1998); all these processes are highly controlled because 
recombination mistakes would otherwise cause  meiotic arrest (Pittman et 
al., 1998).  
As meiosis moves forward, germ cells maturate acquiring the rest of their 
features. Should be noted that whilst oocytes finalize meiosis at 
fecundation (Fig. 1.3A) spermatozoa continue their maturation after 
finishing meiosis in a process called spermiogenesis. Their nuclei 
condensate, they lose all their cytoplasm and acquire motility (Fig. 1.3B). 
1.1.2 CONTROL OF GENE EXPRESSION DURING GERM LINE DEVELOPMENT 
Germ line development is controlled by a unique three-step genetic 
expression program: Firstly, somatic genetic program suppression is 
required, then the acquisition of pluripotency, and finally reprogramming to 
a unique and non-restrictive epigenome (Leitch and Smith, 2013, Saitou, 
2009). During these early stages, changes are similar in female and male 
germ cells. PGCs lose the vast majority of methylation marks and chromatin 
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modifications associated with somatic gene downregulation and 
pluripotency factors activation. Hence germ cells are able to initiate zygote 
formation and post-fecundation development. As gametogenesis goes 
forward, pluripotency gene expression decreases and the germ cell-specific 
expression program activates. This process is highly controlled at both the 
genetic and epigenetic levels, where germ line specific RNA-regulating 
proteins also have a specific role which is essential for completing meiosis 
and giving rise to a new generation. 
1.1.2.1 BMP SIGNALING  
PGC specification occurs very early in embryo development; in mouse it is 
initiated by a BMP4/8b signal from the extraembryonic ectoderm which 
activates PRDM1 (Fig. 1.4). Anteroposterior axis signals from the anterior 
visceral endoderm (AVE; i.e. LEFTY1 vs. NODAL, DKK vs. WNT3, or 
CERBEROUS-LIKE vs. BMP) define a germ line fate to proximal epiblast. At 
around E5.5 epiblast cells become competent to respond to BMP4 signaling 
through NODAL and WNT3. At this moment, NODAL signaling, mediated by 
SMAD2/FOXH1, specifies distal visceral endoderm cells to send anti-
posteriorization signals. Concomitantly, signals from the extraembryonic 
ectoderm (ExE), including BMP8b, prevent differentiation of proximal to 
distal visceral-endoderm, thus limiting anti-posteriorization events. At 
about E6.0-E6.5, distal visceral-endoderm moves anteriorly to form anterior 
visceral endoderm and the subpopulation of epiblast cells that receives the 
highest amount of BMP4 signaling becomes specified to PGCs and starts to 
express Prdm1 and Prdm14 (Saitou, 2009). BMP4 induces Prdm1 and 
Prdm14 expression in a dose-specific manner through the Alk3 complex and 
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BMP type II receptors (mainly BmprII) via SMAD1 and SMAD5 in the 
epiblast. BMP2 produced by visceral endoderm, acts in a similar way on 
PRDM1, but is not as efficient as BMP4. BMP8b controls anteroposterior 
development, preventing inhibitory signals against germ line specification 
from the AVE. Thus, three BMP signals act in a different but cooperative 
way to ensure sufficient exposure to epiblast BMP-SMAD signaling to 
specify a germ lineage fate (Saitou, 2009, Saitou et al., 2002). 
1.1.2.2 THE ROLE OF PRDM1 AND PRDM14 DURING SPECIFICATION 
The transcriptional repressor PRDM1 is considered to be the master 
regulator of germ line specification in mice. Prdm1 expression starts at 
E6.25 (Ohinata et al., 2005) in a group of 40 cells located in the posterior 
epiblast by AVE agonist signaling. PRDM1 is essential for suppressing the 
somatic program and creating the epigenetic status necessary for PGC-
related gene expression (Fig. 1.4). PRDM1 represses almost all of the 
downregulated genes in PGCs and activates some of the upregulated ones 
(Lehmann, 2012). It also associates with PRMT5, an arginine methyl 
transferase, through its positive regulatory (PR) domain to control the 
symmetrical dimethylation of H2A and H4 at arginine 3 (H2A/H4R3me2s) 
which generates a signal to inhibit the somatic program. After E11.5 this 
signal is lost as PGCs become epigenetically reprogrammed (Ancelin et al., 
2006).  
After repression of the somatic-program PRDM1 together with PRDM14 
promote epigenetic reprogramming so that a pluripotency status can be 
reacquired (Fig. 1.4). Prdm14 is expressed in the morula and the inner cell 
Direct reprogramming of human somatic cells to meiotic germ-like cells 
- 16 - 
 
 
FIG. 1.4. Murine PGC specification pathway. Signaling by BMPs activates PRDM1 and 
PRDM14 expression through SMAD. In the absence of LIN28A, the mature form of 
microRNA Let7 (miR-let7) blocks PRDM1 translation. LIN28A binds these pri-miRNAs/ 
pre-miRNA hairpin loops, preventing their processing, hence enabling PRDM1 
translation. PRDM1, through PRMT5/7 and TFAP2C, acts synergistically with PRDM14 by 
downregulating differentiation and upregulating specific germ line gene expression. 
Modified from (Saitou and Yamaji, 2010). 
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mass cells, but it disappears during development and is expressed again in 
PGCs only between E6.5 and E13.5-E14.5, unlike Prdm1 which can be 
expressed in other cell types (Saitou and Yamaji, 2010). Initially, Prdm14 
expression is independent of PRDM1, but its maintenance strictly depends 
on PRDM1 (Kurimoto et al., 2008, Saitou and Yamaji, 2010). 
Both PRDM1 and PRDM14 repress de novo DNA-methylases Dnmt3a and 
Dnmt3b, as well as Uhrf, another component of the DNA-methylation 
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maintenance-machinery. PRDM14 is essential for epigenetic 
reprogramming due to its ability to reactivate Sox2 expression and repress 
the histone-methyl-transferase Glp. This repression directly affects DNA-
methylation machinery by two mechanisms (dependent and independent) 
to other chromatin modifications, mainly histone 3 lysine 9 dimethylation, 
(3K9me2; Hackett et al., 2012). 
Tcfap2C (or AP2ɣ) is another critical element which is downstream to 
PRDM1 (Fig. 1.4); its expression starts at E7.5 after PGC specification and is 
maintained during gonocyte migration until they reach the gonadal ridge 
when its expression stops at E13.5. TCFAP2C prevents mesodermal 
differentiation and enhances the germ cell program (Weber et al., 2010). 
Because PGCs emerge in the context of mesodermal induction, TCFAP2C 
repression is critical. 
1.1.2.3 POST-TRANSCRIPTIONAL REGULATION BY RNA-BINDING PROTEINS  
Germ line RNA-binding proteins prevent somatic differentiation and control 
many cellular functions, such as germ cell specification, sexual identity, 
proliferation, survival, migration, and regulation of transposable elements. 
These proteins are associated in large RNA-protein complexes called P-
bodies (or nuage). The RNA-binding protein group, including VASA, NANOS, 
PUMILIO, DND1, DAZL, PIWI, and TUDOR, is highly conserved and present in 
different stages of germ line development (Lehmann, 2012). 
LIN28A is a RNA-binding protein that acts as an upstream regulator of 
PRDM1 (West et al., 2009) by inhibiting Let7 family microRNA maturation 
(Fig. 1.4), whereas Let7 is a microRNA that binds to the 5’-untranslated 
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FIG.1.5. Gene expression changes during germ line development. A) Germ line related gene 
expression; B) male gametogenesis control by RNA-binding proteins; C) male gametogenesis 
control by piRNA.  
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region (5’UTR) sequence of Prdm1 mRNA, blocking its translation and 
preventing germ line development (West et al., 2009). By inhibiting Let7 
maturation and thus activating Prdm1, LIN28A is involved in PGC 
specification (Fig. 1.5B). Indeed, LIN28A, together with OCT4, SOX2, and 
NANOG are sufficient to reprogram human fibroblasts into induced 
pluripotent stem cells (iPSCs; Saitou and Yamaji, 2010), and seems to be 
involved in the main core of the pluripotency network. 
Genes from the DAZ family form another group of RNA-binding proteins 
involved in germ line development (Ruggiu et al., 1997) which are 
expressed in migrating PGCs until the spermatocyte I stage in males (Fig.  
1.5B).  
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In humans this family is composed of the autosomal genes BOULE and 
DAZL, and the DAZ gene cluster, encoded by the Y chromosome. In mouse, 
Daz acts as a master regulator of spermatogenesis, whilst Dazl is critical for 
meiosis: in knock-out mouse models apoptosis increases at the beginning of 
meiosis. (Ruggiu et al., 1997). Loss of BOULE gene function results in 
azoospermia with primary defects at the meiotic transition(Kee et al., 
2006). 
VASA is an important RNA-binding protein required for germ cell 
maturation and their proper entry into meiosis. Similar to Daz family genes, 
it is highly conserved in mammals and is located in perinuclear, electron-
dense structures known as germplasm which are enriched in RNA and other 
RNA-binding proteins (Castrillon et al., 2000b). In humans and mice it is 
codified by the DDX4 gene, a member of the DEAD-box family, and 
translates an ATP-dependent RNA-helicase with several functions in germ 
cell lineages, including proliferation, differentiation, and transposable 
element silencing (Lehmann, 2012). It is expressed specifically by germ cells 
(Fig. 1.5B) when they arrive to the genital ridge and its expression continues 
until peri-meiotic  stages (Lasko and Ashburner, 1988). Interestingly, mouse 
knock-out models for mouse vasa homolog (Mvh) show male infertility, but 
in Drosophila the phenotype is the opposite, causing female sterility 
(Tanaka et al., 2000).  
In contrast, Piwi, Tudor, and Argonaute form part of the PIWI interacting 
RNA (piRNA) family and control transposable element expression. piRNAs 
are small non-coding RNAs defined by their ability to bind Argonaute family 
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BOX 1. SMALL NON-CODING RNA BIOGENESIS 
Small non-coding RNAs are single stranded 
RNAs that specifically bind to a target 3’UTR mRNA 
sequence, inhibiting their translation or inducing 
their degradation. There are three main types in 
mammals: microRNAs (miRNAs), small interfering 
endogenous RNAs (endo-siRNAs) and PIWI-
interacting RNAs (Suh and Blelloch, 2011). 
miRNAs are transcribed by RNA-
polymerase II and are recognized by the RNase 
DROSHA, which cuts them into hairpin loops (Han 
et al., 2009) which are recognized by DICER, a 
cytoplasmic endonuclease that produces the 
double stranded mature miRNA.  siRNAs are 
derived from large double-stranded RNAs and are 
directly processed by DICER to produce multiple 
copies (Fabian et al., 2010). miRNAs and siRNAs act 
similarly: they bind to the miRNA-induced silencing 
complex (miRISC) where proteins such as 
Argonaute bind to mediate post-transcriptional 
regulation of target mRNA by sequence 
complementarity (Suh and Blelloch, 2011). 
piRNAs do not require DICER for their 
processing. They are generated from large single 
strand precursors manly codified by intergenic 
repetitive sequences (Aravin et al., 2008, Suh and 
Blelloch, 2011). According to the ping-pong model, 
Mili cuts  
primary piRNAs to define a 5’end that will be 
recognized by Miwi2. Then, Miwi2 cuts the other 
precursor strand, generating a new 5’end to bind 
Mili, leading to an amplification loop (Suh and 
Blelloch, 2011). Most of the details of this model 
are not well understood. The ping-pong cycle only 
explains repetitive sequence-derived piRNA 
biogenesis, while there is a second class of piRNA, 
derived from intergenic sequences and associated 
with late spermatogenesis that is not yet 
understood. 
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members (including Miwi/Piwil1, Miwi2/Piwil4, and Mili/Piwil2 in mouse; 
Box 1; Suh and Blelloch, 2011, Aravin et al., 2008).  
During spermatogenesis two types of piRNA are expressed (Fig.  1.5C). The 
first, with a repetitive nature, are expressed before pachytene in prophase 
I, while the second is non-repetitive and its expression is upregulated after 
zygotene in prophase I. They both interact with Mili (the murine homolog 
for HILI in humans) but the first type does so in conjunction with Miwi2 (the 
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murine homolog for HIWI2 in humans) while the second type interacts with 
Miwi (the murine homolog for HIWI in humans). Deletions in Mili and/or 
Miwi2 lead to arrest in meiosis I whilst mice defective for Miwi suffer arrest 
in meiosis II at the round spermatid stage (Kuramochi-Miyagawa et al., 
2010, Carmell et al., 2007). There are also some data indicating that VASA is 
necessary for proper piRNA ping-pong amplifying-cycles because Mvh 
knock-out mice have the same phenotype as Miwi, Mili, and Miwi2 knock-
out mice (Kuramochi-Miyagawa et al., 2010, Medrano et al., 2013). 
piRNAs act to promote the de novo methylation of transposons and other 
genomic repetitive sequences, thus promoting their silencing and, as a 
consequence, genomic stability during meiosis (Suh and Blelloch, 2011, 
Fabian et al., 2010, Aravin et al., 2008). This function is particularly relevant 
in germ cell lineages in order to prevent somatic differentiation and to 
protect the future generation’s genome throughout the cell cycle. 
Nevertheless the mechanism by which piRNA acts on the DNA methylation 
machinery remains unknown (Lehmann, 2012). 
1.1.2.4 DETERMINANTS OF GERM CELL PROLIFERATION AND SURVIVAL 
Specified PGCs start to express AP, STELLA (Dppa3) and to downregulate 
Hox genes (i.e. Hoxa1, Hoxa2, Hoxa3, Hoxb1, Hoxb2, Hoxd1 and Hoxd9), as 
well as other mesodermal-program genes (i.e. Snai1, Tbx3, Tbx6, Mesp1, 
etc.; Kurimoto et al., 2008). Hence, PGC precursors that previously had a 
somatic fate, lose their mesodermal features to recover their pluripotency 
potential and activate transcriptional regulators which are specific for germ 
line lineages (Fig. 1.5A). They upregulate genes required for germ line 
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specification, i.e. Prdm1, Dppa3, Ifitm3, Dnd1, and Mvh, and characteristic 
of pluripotency, i.e. Sox2 and Nanog (Kurimoto et al., 2008, Saitou et al., 
2012). 
During PGC migration and proliferation, the transmembrane receptor c-Kit 
and its ligand stem cell factor (SCF) regulate their proliferation and survival, 
probably via AKT/mTOR/BAX. At later stages (E9.5) OCT4 and NANOG are 
also critical for PGC survival (Fig. 1.5A; Arnold and Robertson, 2009). PGCs 
express relatively high levels of c-KIT (Donovan et al., 1986) which plays a 
dual role in male fertility control: firstly, it is expressed and is functional in 
postnatal spermatogonia, and secondly, TR-KIT, an intra-cellular protein 
encoded by an internal promoter, accumulates during spermatogenesis. At 
the beginning of meiosis, c-KIT expression ceases but TR-KIT maintains its 
levels until postmeiotic stages. The SCF receptor (c-Kit-ligand) also plays a 
very important role in regulating PGC proliferation, survival, and migration. 
PGC differentiation into gonocytes induces marker changes: SSEA1 and 
OCT4, together with c-KIT and AP activity, continues but reduces as 
gonocyte β1- and α6-integrin expression levels increase; c-KIT expression 
later returns in spermatogonia. 
1.1.3 EPIGENETIC CHANGES DURING GAMETOGENESIS  
Just after specification, PGCs have a stable epigenetic status, involving DNA 
methylation and X chromosome inactivation in females, which establishes 
an epigenetic barrier for the acquisition of totipotency. When PGCs enter 
the gonadal ridges they undergo global epigenetic methylation mark 
erasure (in two well-defined waves of demethylation) and chromatin is 
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remodeled, a process that ends at around E13.5 reaching a basal (the most 
naïve possible in mammals) epigenetic status. This is a different 
reprogramming process to that which occurs during early embryo 
development where imprinted genes and other loci stay methylated and 
polycomb-based chromatin modifications remain. PGCs undergo such 
profound reprogramming events because they must overcome multiple 
epigenomic barriers, mainly due to the inductive mechanism of germ line 
specification in somatic-fate cells instead of an inherited germplasm, as in 
Drosophila (Hackett et al., 2012). 
1.1.3.1 METHYLOME REPROGRAMMING  
The methylome is defined as the set of covalent modifications (formed by 
the addition of methyl groups to DNA at position 5 of the cytosine [C] 
pyrimidine ring) in a certain cell at a given time (Box 2). DNA methylation 
occurs mainly in the C located in Cytosine-Guanine (CpG) dinucleotides and 
are usually grouped into CpG islands (CGIs). These CpG dinucleotides are 
found in only approximately 1% of mammal genomes, generally at 
promoter regions, 5’UTRs, and first exons, and are involved in 
transcriptional regulatory functions (Portela and Esteller, 2010). An increase 
of methylation is usually associated with transcriptional repression and CGIs 
in the promoter regions of each particular cell lineage acquire a tissue-
specific methylation pattern throughout development, a process which is 
usually associated with transcriptional repression and an increase in 
methylation.; however, many important DNA methylation marks are also 
located in repetitive genomic regions, i.e. transposable elements, which can 
involve up to 45% of the genome. These sequences propagate by randomly 
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BOX 2. DNA METHYLATION, CONCEPTS, AND ASSOCIATED FUNCTIONS (Part one) 
5mC, 5hmC, 5fC, 5caC: the methyl group 
from 5mC undergoes TET protein-mediated 
oxidation, forming 5-hydroxymehylcytosine (5hmC), 
5-formylcytosine (5fC), and 5-carboxylcytosine 
(5caC). 5hmC is considered to be the signal that 
starts the active erasure of methylation marks.  
CpG Islands (CGIs), are regions of more than 
200 bp (300-3000 bp) with a C+G content of at least 
55% and a statistically predicted CpG ratio of, at 
least, 0.6%. They are usually located in 5’UTR 
regions, promoters, and the first exon. Methylation 
is generally associated with transcriptional 
inactivation, unless these regions are located in gene 
bodies, where methylation acts as a transcriptional 
activator because it prevents the start of spurious 
transcription (Berdasco and Esteller, 2010). 
Differentially Methylated Regions (DMRs), 
are regions with a different methylation status 
between tissues, cells, individuals, etc.; Imprinting 
regions are genomic loci that represent a different 
methylation status depending on the parental origin 
of the chromosome (maternal or paternal); 
imprinting control regions (ICRs) are formed when 
imprinting  
 
 
regions control more than one gene (Berdasco 
and Esteller, 2010) 
Methods of studying the methylome: 
methylation-sensitive enzyme digestion, is 
based on the use of restriction enzymes which 
target sequences sensitive to methylation; 
methylated/ hydroxymethylated DNA 
immunoprecipitation (MeDIP/hMeDIP) is used 
where fragmented genomic DNA is enriched for 
5mC or 5hmC by immunoprecipitation; in 
bisulfite sequencing (Bi-seq), genomic DNA is 
treated with sodium bisulfite salt to transform 
Cs, but not 5mC/5hmCs, to uracil (U); treated 
DNA is sequenced and compared to a reference 
sequence. If C is maintained, this specific locus 
was initially methylated and vice versa. This 
method allows for single nucleotide resolution 
and with sufficient deep reading it enables 
absolute quantification of methylation levels. It 
is the most widely used method, but it does not 
distinguish between 5mC and 5hmC, thus levels 
of 5hmC in the genome may be 
underestimated by this technique (Saitou et al., 
2012). 
 
 
inserting new copies of themselves, hence their methylation acts to 
maintain chromosomal integrity (Berdasco and Esteller, 2010). Throughout 
the mammalian life cycle there are two epigenetic reprogramming events 
that involve massive DNA demethylation: The first in the zygote, just after 
fertilization, in order to erase the epigenetic signature inherited from 
gametes (except imprinting marks) and to reacquire totipotency; the 
second during PGC development, to restore the developmental potency 
and to erase imprinting marks. This erasure of parental imprinting marks is 
essential for the proper development of the next generation, establishing 
new marks according to the somatic sex of the embryo.  
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BOX 2. DNA METHYLATION, CONCEPTS, AND ASSOCIATED FUNCTIONS (Part two) 
DNMT (DNA-5-cytosine-methyl-
transferase) enzyme family catalyzes the transfer 
of methyl groups from S-adenosyl-methyonine to 
DNA. In mammals there are five DNMT family 
members: DNMT1, DNMT2, DNMT3a, DNMT3b, 
and DNMT3L, but only DNMT1, 3a, and 3b have 
methyltransferase activity. DNMT1 is considered 
to be the maintenance methylase because it 
copies the methylation mark from the template 
strand during DNA replication. DNMT3a and 3b 
are de novo methylases and are considered to be 
responsible for establishing methylation patterns 
during development. DNMT3L recruits DNMT3a 
and 3b when non-methylated H3K4 nucleosomes  
are recognized and is required for maintaining 
maternal imprinting marks (Saitou et al., 2012). 
TET (ten-eleven translocation) proteins, 
including TET1, TET2, and TET3, catalyse the 
oxidation of 5-methycytosine to 5-
hydroxymehylcytosine (5hmC), 5-formylcytosine 
(5fC) and 5-carboxylcytosine (5caC).  
AID (activation-induced deaminase) and 
APOBEC (apolipoprotein B mRNA editing enzyme, 
catalytic polypeptides), are cytidine deaminases that 
transform C to U; BER (base excision repair) is 
involved in the DNA repair pathway, and eliminates 
miss-paired bases by cutting the 5’end of the 
phosphodiester link of the abasic site which is then 
completed by a DNA polymerase (Saitou et al., 
2012). 
 
- Methylation mark erasure 
Classically, it was considered that this second reprogramming process 
begins at PGC specification and gonadal entry at E10.5, with demethylation 
occurring in imprinting regions and other differentially demethylated 
regions (DMR) at E11.0-E12.5 (Seisenberger et al., 2013).  
However, new results indicate that the reprogramming process initiates 
much earlier than previously supposed, at E8.0-E8.5. According to the most 
recent studies, PGC demethylation takes place in two phases (Fig. 1.6A):  
the first being an early phase, during migration, where some specific 
regions are maintained actively methylated; and the second after gonadal 
ridge colonization, affecting sequences with epigenetic memory (e.g. 
imprinting regions, X chromosome CGIs, and CGIs in germ cell-related 
promoters), although, there are other regions such as intracisternal A 
particles (IAPs) that are not affected by this epigenetic erasure.  
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FIG. 1.6. Epigenetic changes during gametogenesis. A) Methylome reprogramming; B) 
Chromatin changes.  
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In fact, another recent study demonstrated that PGC demethylation, 
including erasure of imprinting marks, seems to involve conversion of 5-
methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) via TET 
methylcytosine dioxygenase 1 and 2 (TET1/ TET2; Seisenberger et al., 2012, 
Hackett et al., 2013). Between E9.5 and E10.5, as 5mC is lost, PGCs 
asynchronously gain 5hmC which is then progressively lost at a rate specific 
to each locus. This fact agrees with the increase in TET1 and TET2 
expression observed between E10.5-E11.5, suggesting that there is a strict 
temporal order of 5mC erasure. Additionally, methylation may be passively 
lost, meaning that 5mC, as well as its derivatives (5hmC, 5fC, and 5caC; Fig. 
1.7A; Box 2) would be lost over rounds of cellular divisions giving rise to a 
hypomethylated status at E13.5 (Seisenberger et al., 2012).   
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At this moment, downregulation of the de novo demethylases Dnmt3a and 
Dnmt3b, and Uhrf1 cofactor, the methylation maintenance system in PGCs, 
prevents remethylation. This, together with the progressive loss of 5hmC 
widely enhances the epigenetic erasure associated with cell division. 
Furthermore, demethylation depends on the AID/APOBEC system (Popp et 
al., 2010) to convert 5mC into thymidine (T). This system, followed by the 
base excision repair (BER) system (Hackett et al., 2012), may act as an 
auxiliary active demethylation mechanism in PGCs (Hackett et al., 2013).  
In conclusion, global demethylation in PGCs is consistent with a passive 
erasure mechanism, which may be supplemented by active methylation 
maintenance at some specific loci (Fig. 1.7B), which disappears after they 
arrive to the gonads (Seisenberger et al., 2012, Seisenberger et al., 2013). 
Genomic regions that escape from demethylation (i.e. long interspersed 
nuclear elements, LINEs; or IAPs) retain 5mC marks, suggesting the 
existence of specific systems to prevent both 5hmC conversion and direct 
5mC erasure (Seki et al., 2005). 
Thus while 5mC loss in zygotes depends on the conversion of 5mC in to 
5hmC by TET3 in the paternal genome or the passive direct depletion of 
5mC in the maternal genome, both mechanisms (TET1/2 and passive 
demethylation) cooperate in PGCs (Hackett et al., 2013). However, the vast 
majority of these studies were all based on methylome studies after 
bisulfite conversion which does not allow 5mC and 5hmC to be 
distinguished, meaning that the role of 5hmC plays in PGC development 
may remain underestimated.  
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 - Acquisition of the gametic methylation pattern: 
After PGC demethylation, the genome must remethylate de novo in order 
to reach the sex-specific methylation profile of mature gametes. Again, our 
current knowledge of this process is extrapolated from imprinting regions 
and retrotransposons. De novo methylation in male PGCs occurs several 
days after the end of erasure, between E14.5-E16.5, and continues until the 
spermatogonial stages, while in female PGCs, the methylation pattern is 
established in the growing oocyte after birth. This de novo methylation 
results in the mature methylation pattern characteristic of gametes, with 
 
FIG. 1.7. Epigenetic erasure mechanisms and their intermediates. A) The process of 5mC 
oxidation by TET and the possible cellular mechanisms involved. B) Differences between 
active and passive demethylation processes (replication-independent and dependent, 
respectively). 
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their respective somatic sex imprinting marks (Seisenberger et al., 2012) 
and requires the activity of DNMT3a, DNMT3b, and DNMT3L to establish 
these de novo marks. For some maternal imprinting marks, DNMT3L is 
recruited to non-methylated histone 3 lysine 4 (H3K4) tails to allow 
DNMT3a and DNMT3b to bind these sequences. Therefore, the mechanism 
by which imprinting marks are reacquired is different from the transposable 
elements mechanism mediated by piRNAs. At the end of the process, in 
males, spermatozoa are highly methylated (around 80%) whist in females, 
oocytes are about 30% methylated (Seisenberger et al., 2012). 
1.1.3.2 CHROMATIN REPROGRAMMING AND MEIOTIC CONTROL.  
Chromatin structure changes which control the transcriptional status of 
DNA (Box 3), are initiated directly by PRDM1 by binding through its PR 
domain with PRMT5, an arginine methyltransferase, to increase 
H2A/H4R3me2s levels. This mark is involved in the somatic-to-germ-cell 
fate transition (Ancelin et al., 2006) and it initiates chromatin 
rearrangements (Fig. 1.6B).  
These changes are similar in both sexes and occur in concert with the 
suppression of the somatic program. From day E7.5 repressive 
modifications are detected in PGCs: specifically, there is a gradual loss of 
H3K9me2 and an increase in histone 3 lysine 27 trimethylation (H3K27me3) 
between E8.5-E9.0 to E12.5. This epigenetic transition coincides with loss of 
lysine methyltransferase Glp (Seki et al., 2005) expression. Additionally, 
unlike H3K9me2, global H3K9me3 levels are maintained in migrating PGCs 
(Hackett et al., 2012). Nevertheless, only the X chromosome from female 
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BOX 3. CHROMATIN STRUCTURE AND HISTONE MODIFICATIONS 
Chromatin structure controls the 
transcriptional status of DNA. Nucleosomes, 
formed by the histone core H2A, H2B, H3, and H4 
and the linker histone H1, are the structures 
responsible for the extent of chromatin packing. 
All the histones can undergo post-translational 
modifications associated with gene expression; 
the different combinations of all these marks 
determine a permissive or non-permissive 
transcriptional status.  
In general, acetylation, methylation, 
phosphorylation, and ubiquitination are related 
with transcriptional activation, whilst methylation, 
sumoylation, and proline isomerization are 
associated to repression. Compacted 
heterochromatin is transcriptionally inactive, and 
has low levels of acetylation, especially on H3K9, 
and high levels of H3K9me2/me3, H3K27me, and 
H4K20me, which are all marks which are 
considered to be transcriptional repressors. In 
euchromatin there are high levels of acetylation 
and it is enriched in H3K9me3/ac, H3K4me3/ac, 
H3K36me3/ac, and H3K79me/ac marks. 
Transcriptionally active genes are, in turn, 
enriched in H3K4me3, H3K27ac, H2BK5ac, and 
H4K20me1 marks at promoter regions, and 
H3K79me1 and H4K20me1 on gene bodies. The 
different levels of histone modifications can be 
predictive of the gene expression status, but it 
depends on the context. For example, H3K36me 
and H3K9me have a positive effect on coding 
regions but a negative one on promoter regions 
(Kouzarides, 2007). 
 
 
PGCs show an extended decline in H3K27me3 levels which is directly 
related to the beginning of X chromosome reactivation, hence there is an 
established chromatin status which characterizes  pluripotency (Hackett et 
al., 2012).  
In the second step, methylome erasure starts the chromatin remodelling 
process at around E11.5 when PGCs colonize the gonadal ridges. The main 
nuclear architecture reorganizations detected at this time imply that there 
are histone modification changes which allow exchange of these histone 
variants. This includes transient reorganization of H1, H3K27me3, and 
H3K9me3, and stable reorganization of histone 3 lysine 9 acetylation 
(H3K9ac) and H2A/H4R3me2s (Hackett et al., 2012). Hence, when PGCs are 
colonizing the genital ridges, methylation marks on histone 3 lysine 4 
(H3K4me) and H3K9ac increase, associating these two marks with a 
transcriptionally permissive state (Seki et al., 2005).   
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Proper epigenetic reprogramming of germ cells is crucial for proper 
progression through meiosis, but there are also some histone modifications 
that occur during meiosis. H3K4 mono-, di- and trimethylation levels, as 
well as H3K9me2, are globally changed during prophase I;  the relevance of 
these epigenetic modifications remains unknown, but many of the factors 
involved in histone methylation are essential, especially for male germ cell 
development (Kota and Feil, 2010). 
During meiosis, recombination events occur preferentially at specific 
regions called recombination hotspots. They are sequence-specific and 
need a concrete chromatin configuration: starting recombination sites are 
enriched in H3K4me3 and H3K9ac (Kota and Feil, 2010). It is thought that 
epigenetic erasure is necessary to promote the formation of chiasmata at 
these hotspots during meiosis because they enable PRDM9, a lysine 
methyltransferase, to recognize H3K4me3, a signal for recombination to 
take place (Hackett et al., 2012).  
Other chromosome regions that do not recombine during meiosis are 
transcriptionally silenced via a mechanism called meiotic silencing of 
unpaired chromatin (MSUC) which prevents non-homologous 
recombination. In mammals, the best studied example is the condensation 
and inactivation-silencing of the sexual chromosomes during male meiosis, 
which can be distinguished as sexual bodies. This process is called meiotic 
sex chromosome inactivation (MSCI) and involves H3 to H3.3 exchange, as 
well as the accumulation of phosphorylated H2A.X (Kelly and Aramayo, 
2007, Kota and Feil, 2010). 
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This extensive and organized epigenetic reprogramming is required for the 
subsequent acquisition of totipotency in mature gametes, to rearrange 
imprinting marks and to produce gametes with the suitable epigenome to 
enable the proper development of a new individual (Seki et al., 2005). 
1.2. MALE GAMETOGENESIS 
Gamete maturation is different depending on the sex of the embryo. In 
females, germ cells go into meiotic arrest until puberty when hormonal 
cycles start. Hormonal signaling stimulates meiosis to progress, but from all 
the follicles that are stimulated in each cycle, only one will ovulate 
producing a metaphase II oocyte that will finalize meiosis, which can only 
occur after fertilization (McLaren, 1995). In males, germ cells instead 
remain in mitotic arrest, and when puberty arrives, germ cells re-start their 
cellular divisions and differentiate continuously in order to start meiosis 
and give rise to mature spermatozoa.  
1.2.1 THE SPERMATOGONIAL STEM CELL MICROENVIRONMENT.  
Spermatogenesis occurs in the lumen of the seminiferous tubules, 
mediated by and surrounded by Sertoli cells that act as germ-cell support 
cells. These cells are located from the basal lamina of the tubule to the 
lumen and their function is to nurture and to support developing germ cells 
(Fig. 1.8). Immature Sertoli cells are present from birth and proliferate until 
puberty when they start to differentiate into mature Sertoli cells. They are 
joined together by tight junctions and form the blood-testis barrier that 
divides the seminiferous tubule into two compartments: the basal (pre-
meiotic) and the adluminal compartments (Dufour et al., 2005). Leydig cells, 
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together with macrophages, lymphocytes, blood vessels, etc. comprise the 
interstitial space located between these seminiferous tubules (Lehmann, 
2012).  
The basal compartment controls and delimitates spermatogonial stem cell 
(SSC) differentiation. SSCs are the cell subpopulation that lead to male germ 
cell propagation throughout the whole adult life (Kanatsu-Shinohara et al., 
2008) so they are considered the germ line stem cells in the male germ line 
(Kyurkchiev et al., 2012). In humans, SSCs are present at the basal 
membrane of seminiferous tubules (Fig. 1.8) from the moment of birth in 
prepuberal tissue; while in mice the gonocyte-to-spermatogonia transition 
takes place 1-4 days postpartum (de Rooij, 2009). Once sexual maturity is 
 
FIG. 1.8. Stages of spermatogenesis.  SSCs, spermatogonial stem cells; Spg, spermatogonium;  
Spc I, primary spermatocyte;  Spc II, secondary spermatocyte;  RS, round spermatid;  EP, 
elongated spermatid. 
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reached spermatogonia start to asymmetrically divide to give rise to 
mitotically active spermatogonia, which can advance into spermatogenesis, 
whilst also self-renewing to maintain adult testicular stem cells (Kolasa et 
al., 2012, Waheeb and Hofmann, 2011, Phillips et al., 2010, Hermann et al., 
2010).  
The SSC niche is the microenvironment which regulates stem cell fate by 
maintaining the balance between self-renewal and differentiation and is 
maintained by Sertoli cells and the basal lamina of the seminiferous tubule 
to which they are bound. Sertoli cells produce large amounts of the growth 
factors required for the maintenance of the SSC subpopulation. Among 
them, the production of glial cell line-derived neurotrophic factor (GDNF) is 
particularly important, because it promotes SSC self-renewal in vitro and in 
vivo to initiate an intracellular response when bound to its receptor, GFRA1, 
which is present in spermatogonia. Other relevant factors involved in 
maintaining the cells in an undifferentiated state are basic fibroblast growth 
factor (bFGF) and epidermal growth factor (EGF), which are also secreted by 
Sertoli cells (Simon et al., 2010, Kanatsu-Shinohara et al., 2008, Dores et al., 
2012). 
1.2.1.1 SPERMATOGONIAL STEM CELL CULTURE 
There are different techniques that enable the identification and 
purification of SSCs (Goossens et al., 2013, Wyns et al., 2010), including 
several membrane markers which are characteristic of spermatogonia. 
Among them there are 6-integrin (CD49f) and 1-integrin, two laminin 
receptors (Conrad et al., 2008), CD9, a basal membrane cell attachment 
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marker (Kanatsu-Shinohara et al., 2004), Thy-1 (CD90), a immunoglobulin-
protein family member which is overexpressed in neonatal mouse and 
primate testis, including in humans (Kubota et al., 2003, Ryu et al., 2004, 
Hermann et al., 2010), PLZF (also known as ZBTB16) which is SSC-specific 
(Buaas et al., 2004), GFRA1, a GDNF receptor (Hofmann et al., 2005, von 
Schonfeldt et al., 2004), and NOTCH1 (von Schonfeldt et al., 2004). Use of 
such markers enables cellular subpopulations to be identified and 
separated by fluorescence activated cell-sorting (FACS) or magnetic 
activated cell-sorting (MACS).  
SSC culture is challenging, in particular, blocking differentiation, 
maintenance of long-term survival, and promotion of proliferation (Geens 
et al., 2008). This is accomplished by culturing them in conditioned media 
supplemented with GDNF, EGF, bFGF, and leukemia inhibitory factor (LIF; 
Kanatsu-Shinohara et al., 2003, Guan et al., 2009), or SCF (Oatley and 
Brinster, 2006), to simulate the natural physiological niche and the signals 
sent by Sertoli and Leydig cells. Serum-free and feeder cell monolayer co-
culture systems have also been developed, demonstrating that SSCs can 
proliferate under these conditions (Kanatsu-Shinohara et al., 2004, Kanatsu-
Shinohara et al., 2005). Co-culture with somatic cells, in particular with 
Sertoli cells, seems to be necessary to differentiate SSC towards male 
haploid gametes. This technique has already demonstrated promising 
results in humans, where SSCs isolated from human biopsies and co-
cultured with Sertoli cells, have shown expression of markers for meiotic 
progression and haploid cell formation (Riboldi et al., 2012). 
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1.2.1.2 GERM CELL TRANSPLANTS 
Transplantation of SSCs into mice is an assay which defines the functional 
activity of this cellular subpopulation (Geens et al., 2008, Brinster and 
Avarbock, 1994, Brinster and Zimmermann, 1994). In the murine model, 
donor SSCs are injected into the seminiferous tubules of sterilized mice, 
either through deferent ducts, rete testis, or the seminiferous tubules 
themselves (Ogawa et al., 1997), and colonize the niche, in some cases even 
regenerating active spermatogenesis (Avarbock et al., 1996) to produce 
healthy and fertile offspring (Wu et al., 2012, Schlatt et al., 2003). Similar 
results have been produced with SSC xenotransplants from other animal 
models, including primates, by transplanting not only purified SSCs, but also 
a pool of gamete cells at different stages of spermatogenesis (Schlatt et al., 
2002, Hermann et al., 2007, Hermann et al., 2012, Wu et al., 2012). 
Although there are evolutionary differences between species, these can be 
overcome so that complete spermatogenesis can be obtained from rat-to-
mouse or human-to-non-human primate tubule transplantation. However, 
human germ cell transplantation into mouse tubules has been shown to be 
limited to the formation of pro-spermatogonia, spermatogonia, or very 
early meiotic derivatives (Nagano et al., 2008). 
1.2.2 THE STAGES OF SPERMATOGENESIS 
Spermatogenesis is the process in which diploid spermatogonia terminally 
differentiate into mature, mobile, and haploid spermatozoa (Fig. 1.8). It can 
be divided in three stages: the proliferative phase, meiosis, and 
spermiogenesis (McLaren, 1984, Hess and Renato de Franca, 2008). 
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1.2.2.1 THE PROLIFERATIVE PHASE 
Spermatogonia attached to the basal lamina divide by mitosis. A small 
subpopulation constitutes the SSC pool while the rest are their progeny. In 
prepuberal children, the germ cell population is exclusively constituted by 
SSCs, whereas in an adult testis only 1% of spermatogonia are SSCs (de 
Rooij, 2009). Hence, maturating spermatogonia divide by mitosis following 
waves of maturation from puberty onwards which continues throughout 
adult life under hormonal control.  
The hypothalamus secretes gonadotropin-releasing hormone (GnRH) which 
acts on the pituitary gland, triggering the release of luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH). LH causes Leydig cells to 
secrete testosterone which stimulates Sertoli cells to promote and regulate 
spermatogenesis, and limits GnRH and LH production at the pituitary level 
in a negative feedback loop. FSH, together with testosterone, induces 
Sertoli cells to transport nutrients to the inner part of the tubule to activate 
spermatogenesis, as well as androgen binding protein (ABP) synthesis; ABP 
is necessary for maintaining testosterone levels in the seminiferous 
epithelium. Sertoli cells also produce inhibin in response to FSH, which 
inhibits FSH and GnRH production at the pituitary level (de Kretser et al., 
1998, Phillips et al., 2010). 
From this point, spermatogonia are able to differentiate into primary 
spermatocytes, diploid cells with 23 pairs of homologous chromosomes, 
each one with two sister chromatids (2n, 2c) ready to start meiosis.  
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1.2.2.2 MEIOSIS 
Primary spermatocytes break through the blood-testis barrier to the 
adluminal compartment where they initiate meiosis. Meiosis consists of 
two cellular divisions (meiosis I/ meiosis II) with similar stages to mitosis 
(prophase, metaphase, anaphase, and telophase) but these are preceded 
by only one DNA replication. At meiosis I, primary spermatocytes duplicate 
their DNA content (2n, 4c) before prophase I, which is divided into five well-
differentiated stages (Handel and Schimenti, 2010, Medrano et al., 2013):  
1) Leptotene: homologous chromosomes are aligned but not yet paired. 
Each pair of sister chromatids, bound by cohesins, start to form a 
chromosomal scaffold called the synaptonemal complex, formed by 
cohesins REC8, STAG3, and SMC1B, and axial elements SYCP3 and SYCP2.  
2) Zygotene: topoisomerase SPO11 mediates programmed double-strand 
DNA breaks that allow recombination repair machinery to recognize them. 
Phosphorylation of H2A.X to form ɤH2A.X is necessary in order to recruit 
the recombinase-related RECA, DMC1, and RAD51 proteins, among others, 
to repair breaks by homologous recombination. At this stage, chromosome 
pairing is completed and axial elements become lateral elements in the 
synaptonemal complex along the strands of the DNA which are being 
zipped. 
3) Pachytene: chromosomal synapsis is completed by the structural 
function of SYCP1 and the central elements SYCE1 and SYCE2. Bivalents 
(crossovers) appear at the specific recombination sites between 
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homologous chromosomes. MLH1 and MLH3 mediate DNA break mismatch 
repair by homologous recombination.    
4) Diplotene: the synaptonemal complex disappears, the chromosomes 
undergo desynapsis and the bivalents start to condensate. At this stage the 
recombination sites can be observed by the formation of chiasmata (the 
point where two homologous non-sister chromatids exchange genetic 
material).  
5) Diakinesis: chromosomes complete condensation, but the sister 
chromatids remain bound by cohesins.  
The process goes through metaphase I, anaphase I, and telophase I, when 
primary spermatocytes (spermatocyte I) divide into two secondary 
spermatocytes (spermatocyte II). Spermatocyte II cells are haploid 
(homologous chromosomes are segregated) with 23 chromosomes, each 
one with two sister chromatids (1n, 2c). Meiosis II is a cellular division 
similar to mitosis but without a previous DNA replication. At the end, 
spermatocyte II cells divide into two haploid spermatids with 23 
chromosomes, each one with one sister chromatid (1n, 1c). 
Meiosis has several checkpoints, most of them also present in mitosis, 
which are concentrated along the different stages of prophase I to avoid 
synapsis or recombination mistakes (e.g. the pachytene checkpoint). One of 
the most important is the spindle assembly checkpoint (SAC), at anaphase I. 
This SAC is formed by MADI and MADII proteins; the BUB proteins BUBI, 
BUB3, and BUBRI; and MPSI. It is a mechanism that detects unattached 
tubules or the loss of tension in the kinetochores of chromosomes during 
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metaphase in order to ensure correct chromosome segregation (Medrano 
et al., 2013, Handel and Schimenti, 2010). 
1.2.2.3 SPERMIOGENESIS 
Following meiosis II, male germ cells undergo morphological differentiation 
from spermatid to mature spermatozoa. This process is called 
spermiogenesis and is characterized by: i) nuclear condensation, in which 
histones are exchanged for protamines (Gaucher et al., 2010); ii) acrosome 
formation from the Golgi apparatus; iii) flagellum creation from the 
centrosome (Handel and Schimenti, 2010, Phillips et al., 2010) $(Fig. 1.8). 
Throughout this process, spermatids change from a round to an elongated 
morphology, as the chromatin compacts; when spermiogenesis ends 
spermatozoa are released into the lumen of the seminiferous tubule.  
Histone-to-protamine exchange is one of the most studied chromatin 
remodelling processes in which nucleosome histones are substituted by 
small basic proteins called transition nuclear proteins 1/2 (TNP1/TNP2) 
$(Okada et al., 2007). Moreover, the vast majority of described histone H1, 
H2A, and H2B variants are present in the testis, and in vitro studies 
demonstrate that these nucleosomes bind to the DNA in a less stable way.  
The presence of histone variants would explain why TNPs only help 
protamine exchange: they are not essential for this process but they help to 
avoid aberrant packaging events (Gaucher et al., 2010). This process is also 
helped by covalent histone modifications, such as H4 lysine acetylation or 
histone ubiquitination, in order to facilitate their degradation, and allowing 
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BOX 4. BIVALENT DOMAINS 
Bivalent domains are chromatin 
domains with histone modification marks from 
both transcriptional activators and repressors. 
For example, in pluripotent cells, H3K4me3 and 
H3K27me3 co-exist even though the H3K4me is 
associated with transcriptional activation and 
the H3K27me mark is associated with 
transcriptional repression. The result is a low 
basal expression level of transcription factors 
that are controlled by these domains.  
As pluripotent cells differentiate bivalent domains 
tend to maintain only one of these marks but never 
both. Thanks to this importance of the ‘stemness-
maintenance’ mechanism, pluripotent cells can 
activate gene transcription during development in a 
controlled and quick manner, an ability that is lost 
during differentiation (Portela and Esteller, 2010, 
Kouzarides, 2007). 
 
the chromatin to become more accessible (Hazzouri et al., 2000, Awe and 
Renkawitz-Pohl, 2010). 
In a second step, TNPs are exchanged by protamines, which are essential 
for postmeiotic development in mammals. Besides compacting the 
spermatozoon genome, histone exchange by protamines helps to protect 
the genome against mutagen-induced damage (Rathke et al., 2010). 
However, certain regions of the genome retain their histones. These regions 
include the loci of key developmental genes, imprinted genes, microRNA, 
and homeotic genes. These histones are enriched in H3K4me3 and 
H3K27me3 chromatin modifications with the opposite ‘meanings’ (Box 4) 
but which co-exist in bivalent domains (Farthing et al., 2008).  
1.3 IN VITRO GAMETE GENERATION 
According to the World Health Organization (WHO), infertility affects up to 
14% of reproductive-aged couples. This percentage is increasing in 
developed countries mainly due to a delay in the age of maternity and an 
increase in harmful habits.  
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In fact, according to the 2005 American National Survey on Family Growth, 
there was a 20% increase in couples with fertility problems between 1995 
and 2002 (Stephen and Chandra, 2006). Gamete donation may be a 
solution when these infertility problems are caused by poor gamete quality 
or an absence of gametes. Considering only the male factor, sperm counts 
in more than 100 worldwide studies demonstrated a progressive decline in 
the quality of sperm from between 1930-1940 to 2012 (Sharpe, 2012). 
Moreover, standardized and prospective studies with men aged between 
18-25 years from seven different European countries confirm that, although 
the mean of spermatozoa concentration is between 45-65 million/mL, the 
proportion of men with less than 20 million/mL is close to 20% (Jorgensen 
et al., 2006). Furthermore, low gamete counts are usually associated with 
poor gamete quality, i.e. low mobility and/or abnormal sperm morphology. 
Hence, a higher number of young men can be classified as sub-fertile 
(Sharpe, 2012) 
Despite the variety of results from different tracking reports, low gamete 
quality seems to be one of the most important causes of infertility. In 2000, 
32% of assisted reproduction cycles carried out in 49 countries involved 
egg-donation (Adamson et al., 2006), and the US Department of Health and 
Human Services established that, in 2004, 12.5% of these cases were 
accounted for in the USA alone (Wright et al., 2007). Moreover, the Sixth 
Report on the European Results of Assisted Reproductive Techniques, 
published by the European Society of Human Reproduction and Embryology 
(ESHRE) in 2006 as a part of the European IVF-Monitoring Program 
(Andersen et al., 2006) indicated that the proportion of cycles with 
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ovodonation increased to 22.4% in 2002. Although the clinical results were 
excellent (recording a 34.9% clinical pregnancy rate) gamete donation is 
associated with a number of ethical, legal, and personal difficulties, and so, 
there is a growing interest in the study of germ line development (Medrano 
et al., 2013). 
Most of our knowledge about germ line development in mammals comes 
from extrapolation from the murine model. However, due to moral, ethical, 
and legal difficulties regarding the use of tissues from early human 
embryological stages (from gestational week 2-3 where most of the key 
events take place) still very little is known about this process in humans 
(Marques-Mari et al., 2009). In fact, although pre-implantation embryo 
development, including gastrulation, is similar between mice and humans, 
there are some relevant differences. In mouse, cells from the proximal 
epiblast remain in direct contact with ExE from E5.0 to E6.5, and ExE-cell 
BMP4 signaling causes the germ cell fate to be adopted. In humans, before 
gastrulation at around day 8 of development, some pluripotent cells from 
the epiblast form the amnioblast, resulting in the formation of a new cavity 
between the amnioblast and epiblast:  the amniotic cavity. Therefore from 
this point amnioblastic cells are in direct contact with cytotrophoblastic 
cells; in the second week of development most epiblastic cells are already 
separated from the trophoblastic layer by the amnioblastic layer and the 
amniotic cavity (Fig. 1.9).  
To date, there is no information about what part of the epiblast acquires 
the germinal fate or where the induction signal comes from. At the end of 
week three PGCs are detectable for the first time by their AP activity at the 
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FIG.1.9. Human post-implantation embryo development. At day 8, the human embryo 
consists of syncytiotrophoblast (not shown), cytotrophoblast (CT, purple), epiblast (Epi, 
blue), and hypoblast (Hypo, yellow). In contrast to the mouse embryo, these epiblast cells 
have an almost formed amnioblast (Am), and the amniotic cavity appears between the Epi 
and Am. At day 12, before gastrulation starts, epiblast cells are not in direct contact with CT. 
En: Extraembryonic Endoderm; SpM: Extraembryonic Splanchnopleuric mesoderm; SoM: 
Extraembryonic Somatopleuric mesoderm. From (Saitou and Yamaji, 2010) 
wall of the yolk sac, at the base of allantoides, and the future umbilical cord 
(Saitou and Yamaji, 2010).  
Given that studying the cell fate specification mechanisms in human 
embryos is so complicated, to better specify these mechanisms the 
knowledge derived of mouse models must be supplemented information 
obtained from other animal models with post-implantation embryo 
development closer to humans (e.g. rabbit, pig, etc.) $(Saitou and Yamaji, 
2010). Human embryonic stem cells (hESCs) and human induced 
pluripotent stem cells (hiPSCs) have also been used to demonstrate that a 
germ-cell-like state can be induced in vitro (Clark et al., 2004, Kee et al., 
2006, Park et al., 2009, Panula et al., 2011, Medrano et al., 2011, Bucay et 
al., 2009 , Tilgner et al., 2008, Durruthy Durruthy et al., 2014). As both 
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embryonic stem cells (ESCs) and iPSCs (in general, pluripotent stem cells, 
PSC) are capable of differentiating not only into the three germinal layers 
but also into germ cells, they can also be used as a model to understand the 
genetic and epigenetic basis of germ cell specification and development in 
humans, hence the recent increasing interest in in vitro gamete derivation 
research (Medrano et al., 2013). 
1.3.1 GERM CELL DERIVATION FROM PLURIPOTENT STEM CELLS 
In 2003 Schöler’s group first demonstrated that mouse ESCs (mESCs) 
expressing green fluorescent protein (GFP) under the control of a distal 
Oct4 promoter spontaneously differentiated towards germ-line cell lineages 
(Hubner et al., 2003). After differentiation, these GFP-positive cells were 
selected and were maintained in culture, spontaneously differentiating, 
until some structures similar to follicles appeared in which oocyte-like cells 
(OLCs) were observed. OLCs were parthenogenetically activated and 
formed pseudo-blastocysts. This breakthrough study opened up the 
possibility of obtaining germ cells in vitro for study. In the same year, and 
following a similar approach, another group reported the differentiation of 
sperm-like cells (SLCs) from mESCs. In this study, they used the Mvh 
promoter associated with GFP as a reporter; they differentiated tri-
dimensional mESC aggregates using BMP4 and engrafted GFP-positive cells 
into testis. These cells participated in spermatogenesis in vivo, although the 
authors did not specify if any offspring were obtained (Toyooka et al., 
2003).  
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One year later, Daley’s group proved the apparent functionality of in vitro 
derived gametes: mESCs differentiated to embryoid bodies (EBs) 
spontaneously formed SSEA1+ and OCT4+, putative germ cells. These cells 
were isolated and cultured with RA to induce their entry into meiosis, and 
they showed an Igfr2r and H19 imprinting pattern which correlated with 
spermatozoa. Most importantly, these cells were able to form blastocysts 
after injection into oocytes by intra-cytoplasmic sperm injection (ICSI) 
(Geijsen et al., 2004). 
Similar results from hESCs were later obtained by Reijo-Pera’s group by 
spontaneous EB differentiation, which is a reference model for germ cell in 
vitro differentiation. They established that undifferentiated hESCs already 
express some germ-cell-related markers, such as c-KIT and DAZL, but not 
other later markers such as VASA or SYCP3 and proposed that hESCs consist 
of a heterogeneous population in which some cells are predisposed 
towards germ-cell-fate differentiation (Clark et al., 2004). Many other 
studies have demonstrated the formation of germ cells in vitro using 
different strategies. The main approaches were based on purification of 
spontaneously-derived germ-line cells, and gonadal tissue co-cultures (Park 
et al., 2009 ), as well as cell culture media growth factor supplementation 
(Kee et al., 2006). 
- Meiotic progression and the role of RNA-binding proteins  
Despite these findings, proper meiotic progression of germ cell derived 
cells, either from mESCs or hESCs was still a challenge. Studies 
demonstrated aneuploidies in mESC-derived oocytes because, despite 
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detecting SYCP3 expression, other elements also required for meiotic 
progression, such as SYCP1, SYCP2, REC8, STAG3, or SMC1-b, were not 
expressed (Novak et al., 2006). Other groups achieved complete meiosis in 
purified spontaneously-differentiated in vitro-derived germ cells. They 
cultured these cells with a mixture of growth factors in the absence of 
genetic manipulation (Eguizabal et al., 2011). However, following this work, 
other authors described how ectopic expression of genes belonging to the 
DAZ family (DAZ2, DAZL, BOULE) enables a proper meiotic progression in 
both hESCs and hiPSCs (Panula et al., 2011, Kee et al., 2009). These papers 
describe how overexpression of a pool of RNA-binding proteins with a 
highly conserved structure can result in proper meiotic progression in the 
absence of a gonadal niche. They also demonstrated the crucial role those 
factors play in transcriptional regulation throughout germ line 
development. Following this idea, ectopic expression of VASA, another 
RNA-binding protein which is highly conserved in mammals, has shown a 
similar effect on the induction of meiosis (Medrano et al., 2011).  
In fact, the same group went further to explore, for the first time, the role 
of one of these RNA-binding proteins on the in vivo differentiation of 
human-derived germ cells. They derived these cells using an integration-
free hiPSC line via RNA-based reprogramming using only Yamanaka’s 
factors (OCT4, SOX2, KFL4, and cMYC; OSKM) or by combining them with 
VASA RNA (OSKMV). They transplanted undifferentiated hiPSCs into the 
inner part of the seminiferous tubules of sterilized immunodeficient mice to 
test their in vivo differentiation capacity. OSKMV-hiPSCs showed the 
greatest capacity to differentiate in vivo into SYCP3-expressing germ-cell-
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like, whereas only OSKM-hiPSCs that remained outside the seminiferous 
tubules proliferated and formed small tumours similar to the teratomas 
formed in ESC characterization assays. These results, apart from being the 
first ones reporting the in vivo differentiation of human-derived germ cells, 
highlight the role of VASA, an RNA-binding protein, in proper meiotic entry 
and the control of the pluripotency-state (Durruthy Durruthy et al., 2014). 
- Production of living offspring from in vitro-derived germ cells 
Despite these promising results demonstrating the ability of ESCs and iPSCs 
to generate germ cells in vitro, and this first approximation of in vivo 
functionality of in vitro derived germ cells, there are few groups that have 
been able to obtain living offspring from these induced germ cells. The first 
such report used SSC lines derived from mESCs. Reporter genes under the 
control of Stra8 and Prmt1 were used to purify SSCs and after purification 
the culture media was supplemented with RA to induce meiosis. In vitro 
sperm-like cells appeared and when they transplanted these cells into a 
host-mouse testis they formed haploid sperm with limited motility; 
functionality was demonstrated by producing living offspring after ICSI. 
However, the pups showed phenotypic alterations such as growth 
retardation and aberrant imprinting patterns that led to premature death 
(Nayernia et al., 2006). 
Saitou’s group produced another strategy for obtaining in vitro germ cells 
capable of producing fertile offspring: they differentiated mESCs and 
murine induced pluripotent cells (miPSCs) into epiblast-like cells (EpiLCs), 
representing a cellular state very close to epiblast cells before gastrulation 
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but different from epiblastic stem cells (EpiSCs). They generated PGC-like 
cells (PGCLCs) which expressed β3-integrin and SSEA1 from these EpiLCs, 
and differentiated these by adding BMP4 to the culture media. The PGCLCs 
obtained by this technique showed imprinting patterns according to their 
somatic sex and when transplanted into host mice, they went through both 
complete spermatogenesis (Hayashi et al., 2011) and oogenesis and 
produced fertile offspring after ICSI (Hayashi et al., 2012). Moreover, this 
group recently showed how a similar PGCLC-phenotype could also be 
obtained only by overexpressing Prdm1, Prdm14, and TFAP2C genes which 
act downstream of the BMP4 signaling pathway, although in this case in the 
absence of BMP4 as an inductor. Importantly, these PGCLCs are able to 
complete spermatogenesis when injected into host mice leading to the 
production of fertile offspring by ICSI (Nakaki et al., 2013). 
1.3.3 DIRECT REPROGRAMMING 
One of the main applications of ESCs and iPSCs is to direct their 
differentiation towards almost any cell type. However, the advent of iPSC 
reprogramming technologies represented a paradigm shift in our 
understanding of how transcription factors can affect the phenotypic 
plasticity of differentiated somatic cells to reprogram them. Hence, by 
deepening in our understanding of transcription factors, it has been shown 
that cellular identity can be directly changed following a methodology 
similar to that used to reprogram iPSCs. To date, several cell types have 
been obtained by direct reprogramming of differentiated somatic cells, 
without first reverting to pluripotent state, including direct conversion of 
fibroblasts to cardiomyocytes (Ieda et al., 2010), blood precursors (Szabo et 
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al., 2010), neurons (Kim et al., 2011, Vierbuchen et al., 2010), and even 
Sertoli cells (Buganim et al., 2012), exocrine pancreas cells to insulin 
producing β-cells (Zhou et al., 2008), or astrocytes to neurons (Corti et al., 
2012). However, there are no reports showing that germ cell like cells have 
been directly obtained from somatic cells. Even so, in the light of previous 
studies, it is known that differentiated cells maintain a high level of 
phenotypic plasticity and cell fates can be changed with proper 
manipulation. This has many potential applications, from pharmacological/ 
toxicological screening to illness modelling (Ladewig et al., 2013).  
Nonetheless, there are many challenges in the reprogramming field. The 
role of the epigenome remains undefined, and the question of whether it 
functions equally-well when reprogrammed also remains. Research into 
post-transcriptional and pre-translational control, involving miRNAs and 
RNA-binding proteins, is also gaining momentum. Given the evidence 
currently available regarding the possibility of deriving germ cells in vitro, it 
seems that direct reprogramming or induction of germ cell formation from 
adult somatic cells may be a feasible strategy that would create a more 
realistic in vitro model of human germ line development allowing the role 
of cells which are extremely difficult to study in vivo to be explored in vitro.  
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Germ cell-like cells have been derived in vitro from pluripotent stem cells, 
both ESCs and iPSCs. Following a similar approach to iPSC reprogramming, 
adult cell types have been directly induced to convert into other 
differentiated cell types.  
Based on these findings the working hypothesis of this doctoral thesis is 
that human somatic cells can be directly reprogrammed in vitro into 
induced germ-like cells using a pool of key germ cell-related factors. 
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3.1 GENERAL OBJECTIVE 
To obtain induced germ cell-like cells (iGCs) in vitro from human somatic 
cells by genetic overexpression of key germ cell-related factors. 
 
3.2 SPECIFIC OBJECTIVES 
1. To identify, isolate, and clone into lentiviral vectors the key human 
germ cell developmental genes. 
2. To optimize culture conditions in order to maintain putative derived 
iGCs in vitro. 
3. To screen the cocktail of reprogramming factors to identify the most 
efficient combination of genes for inducing a meiotic phenotype. 
4. To characterize the iGCs obtained at the transcriptomic and epigenetic 
level. 
5. To analyze the meiotic progression and ploidy of these iGCs. 
6. To test the in vivo functionality of these iGCs by their ability to colonize 
the spermatogenic niche in busulfan-sterilized mice. 
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Based on the literature, together with previous reports from our group, 
twelve germ cell-related genes were selected and cloned into lentiviral 
vectors and overexpressed in two commercially available human male (XY) 
somatic primary cell types: human foreskin fibroblasts (hFSKs) and human 
mesenchymal stem cells (hMSCs).  
Reprogrammed cells were analyzed on days 7, 14, and 21 after transduction 
so as to establish a time-course pattern during the process of direct 
reprogramming towards a germ-cell-like fate. Transcriptomic 
characterization by expression arrays and real-time polymerase chain 
reaction (qRT-PCR), as well as phenotyping by immunofluorescence were 
performed at all of these time points. Moreover, epigenetic 
characterization by bisulfite sequencing, meiotic progression, ploidy assays, 
and xenotransplantation assays were performed on day 14 after 
transduction (Fig. 4.1). 
 
FIG. 4.1 Experimental design. Human somatic cells were transduced with germ cell-related 
genes and cultured under a specific germ cell medium. The reprogrammed cells where 
analyzed on days 7, 14 and 21 after transduction. A thorough explanation is included in the 
main text. FISH: fluorescent in situ hybridization; IF: immunofluorescence; KSR, Knock-out 
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5.1. GENE SELECTION, ISOLATION, AND CLONING 
5.1.1 GENE SELECTION 
According to current knowledge and our group’s previous results, 12 genes 
were chosen for ectopic overexpression in human somatic cells. These 
genes are all involved in different stages of in vivo and in vitro germ cell 
differentiation and development and are listed below: 
- Genes related with germ-cell induction  
 PRDM1 (BLIMP1): A transcription factor involved in PGC specification 
and somatic-program silencing (Kurimoto et al., 2008, Saitou, 2009, 
Vincent et al., 2005). 
 PRDM14: Interacts with PRDM1 and has an important role in inducing 
epigenetic reprogramming during in vivo PGC development (Kurimoto et 
al., 2008).  
 NANOS3: Related to germ cell survival and quiescent state maintenance 
by repressing mRNA translation (Suzuki et al., 2008). 
 LIN28: An RNA-binding protein which is involved in microRNA silencing 
for PGC specification by regulating PRDM1 (West et al., 2009).  
 NANOG: A transcription factor involved in PGC pluripotency and 
proliferation (Mitsui et al., 2003). 
- Genes related with PGC survival and maturation  
 DAZ2: Is encoded by the Y chromosome and is an RNA-binding protein 
essential for proper spermatogenesis. In vivo, DAZ2 deficiency causes 
Sertoli-only syndrome (Farthing et al., 2008).  
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 DAZL: Is an RNA-binding protein involved in germ cell maturation. Loss 
of its function causes sterility in both sexes (Gill et al., 2011, Medrano et 
al., 2011, Ruggiu et al., 1997, Kee et al., 2009).  
 BOLL: Is an RNA-binding protein, from the same family as DAZ2 and 
DAZL. Loss of its function causes meiotic errors (Kee et al., 2009).  
 VASA: An RNA-binding protein involved in germ cell maturation and 
meiosis via its piRNA-regulating function. Loss of function is a cause of 
male sterility in mice and female sterility in Drosophila (Castrillon et al., 
2000b, Fujiwara et al., 1994, Medrano et al., 2011, Tanaka et al., 2000).  
 STRA8: Is involved in inducing meiosis by RA signaling (Guan et al., 2009, 
Bowles et al., 2006). 
- Genes involved in meiosis 
 DMC1: Is a DNA-recombinase that acts during homologous chromosome 
recombination at prophase I of meiosis by repairing double strand 
breaks (Pittman et al., 1998, Yoshida et al., 1998).  
 SYCP3: Is a structural component of the synaptonemal complex during 
prophase I of meiosis (Reynolds et al., 2007, Costa et al., 2005). 
5.1.2 GENE ISOLATION AND CLONING 
5.1.2.1 ISOLATION 
The open reading frame (ORF) sequences of the different genes of interest 
(GenBank accession numbers are shown in Table 5.1) were isolated from 
human testis copy DNA (cDNA) which was obtained by reverse transcription 
of human adult testis total RNA (Clontech). These isolated polymerase chain 
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reaction (PCR) products were cloned into the pLenti7.3-V5 lentiviral 
backbone (Invitrogen) using the Gateway system (Invitrogen). Primers were 
designed using the Primer3 tool (http://frodo.wi.mit.edu/primer3/) in order 
to specifically hybridize on the start and stop transcription sites of each 
mRNA (Fig. 5.1). 
Retrotranscription was performed as follows: RNA was quantified using a 
NanoDrop spectrophotometer (ND-1000 Spectrophotometer, Thermo 
Scientific) and about 500 ng of total RNA from each sample was converted 
into cDNA with oligo-dTs for reverse transcription using the Advantage® RT-
for-PCR kit (Clontech) following the manufacturer’s instructions.   
 
FIG. 5.1 General strategy for gene isolation and PCR amplification. TSS, transcription start 
site; CDS, coding DNA sequence. 
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cDNA amplification was performed by PCR using the thermostable proof-
reading polymerase Pfx50-DNA (#12355012, Invitrogen). The primer 
sequences used to isolate the ORFs are shown in Table 5.1. 
TABLE 5.1. GenBank accession numbers and primer sequences for cloned genes; according 
to the Gateway technology manufacturer’s instructions 5’ forward primers all include a CACC 
sequence.  
GENE GenBank  
accession no.  
Primer sequence 5’3’ Length (bp) 
PRDM1 NM_182907.2 F: CACCATGGAAAAGATCTATTCCA 2080 
R: TTAAGGATCCATTGGTTCAACTG  
PRDM14 NM_024504.3 F: CACCATGGCTCTACCCCG  1720 
R: CTAGTAGTCTTCATGAAACTTCA  
LIN28 NM_024674.4 F: CACCATGGGCTCCGTGT 634 
R: TCAATTCTGTGCCTCCGGGA 
NANOS3 NM_001098622.2 F: CACCATGGGGACCTTTGACC 583 
R: CTAGGTGGAGATGGAGGGAGAG 
NANOG NM_024865.2 F: CACCATGGGTGTGGATCCAG 922 
R: TCACACGTGTTCAGGTTGCATG 
DAZ2 NM_020363.3 F: CACCATGTCTGCTGCAAATCCT 1692 
R: CTCTTCTCTGACTATTTA 
DAZL NM_001351.3 F: CACCATGGCTACTGCAAATCC 892 
R: TCAAACAGATTTAAGCATTGCC  
BOULE NM_197970.2 F: CACCATGGAAACCGAGTCC 892 
R: TTAATAATGAATGCTCCACACTG  
VASA NM_024415.2  F: CACCATGGGAGATGAAGATTG  2179 
R: TTGGCTTTAATGCCATGACTC 
STRA8 NM_182489.1 F: CACCATGGGGAAGATTGATGT 997 
R: TTACAAATGTTCATCGTCAAAGG  
SYCP3 NM_001177949.1  F: CACCATGGTGTCCTCCGGA  715 
R: TCAGAATAACATGGATTGAAGAG  
DMC1 NM_007068.2 F: CACCATGGAGGAGGATCAAGT 1027 
R: CTACTCCTTGGCATCCCCAAT  
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Briefly, the PCR conditions were the following: Pfx50-DNA polymerase 10x 
Buffer with MgSO4 (1x); dNTP mix (200 μM); primers (1.0 µM), template 
DNA at less than 0.5 μg/50 μL, and Pfu-DNA polymerase (2-3 U/μL) at a 
concentration of less than 1.25 U/50μL. In general the PCR programs were 
as shown in Table 5.2. The PCR product was isolated using a QIAquick gel 
extraction kit (#28704, Qiagen). 
TABLE 5.2. PCR cycles for Pfx50-DNA polymerase extension. 
Step  Temperature  Time  Number of Cycles 
Initial Denaturation  95° C  1-2 minutes 1 cycle 
Denaturation  95° C  0.5-1 minute 25-35 cycles 
Annealing 42–65° C  30 seconds  
Extension 72–74° C  2-4 minutes 
Final Extension  72–74° C  5 minutes  1 cycle 
Soak  4° C  Indefinite  1 cycle 
 
5.1.2.2 pENTRTMTOPO® VECTOR CLONING 
Briefly, the Gateway system (Invitrogen) is a two-step cloning system in 
which the isolated PCR product is first cloned into a pENTRTM/D-TOPO® 
system entry vector (#K2400-20, Live Technologies) and is then sub-cloned 
into an expression vector with a lentiviral backbone. The PCR products are 
directionally cloned with the pENTRTM/D-TOPO® system by adding four 
specific bases to the forward primer (CACC) and the covalently bound 
Topoisomerase I from Vaccinia virus allows these PCR products to be cloned 
in the right direction. The pENTRTM/D-TOPO® map is shown in Appendix 1. 
Cloning reactions were performed following the manufacturer’s 
instructions. E. coli Transforming One Shot TOP10® (Invitrogen, Carlsbad, 
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CA, #C4040-10, Life Technologies) were transformed by heat shock and the 
transformed clones were selected by conferred kanamycin resistance. 
Transformed clones were analyzed using restriction enzymes to ensure 
proper cloning of the insert. The plasmids were isolated using the PureLink® 
HQ Mini Plasmid Purification Kit (#K2100-01, Life Technologies). Moreover, 
pENTRTM/D-TOPO® has attL1/attL2 sequences which enables specific site 
recombination with the destination/ expression vectors (pLENTI7.3/V5-
DEST).  
5.1.2.3 DESTINATION VECTOR CLONING 
The destination pLenti7.3/V5-DEST vector (#V534-06, Life Technologies) 
includes the attR1/attR2 sites which are complementary to the attL1/attL2 
sequences; this facilitates the proper insertion of the gene of interest from 
the pENTRTM/D-TOPO® into the target. This plasmid has a V5-epitope tag at 
the 3’ end of the insertion site, so the resulting recombinant protein has a 
V5-fusion tag at the C-terminal end, and in addition, it also contains the 
emerald green fluorescent protein (EmGFP) under control of the SV40 
promoter as a reporter (Appendix 1). The recombination reactions were 
performed according to the manufacturer’s instructions. Transformed 
clones were selected by conferral of ampicillin resistance and plasmids 
were purified as previously described. Recombinant plasmids were 
sequenced using primers provided by the manufacturer:  
forward primer 5′–CGCAAATGGGCGGTAGGCGTG–3′ (CMV);  
reverse primer 5′–ACCGAGGAGAGGGTTAGGGAT–3 (V5 C-term).  
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Finally, the clones were amplified and purified with a QIAGEN Plasmid Maxi 
Prep kit (#12965, QIAGEN). 
5.2 REPROGRAMMING FACTOR OVEREXPRESSION AND CELL CULTURE 
OPTIMIZATION 
5.2.1 SOMATIC PRIMARY CULTURES 
The following cell lines were cultured in vitro: 
- Human foreskin fibroblasts (hFSKs; 46, XY) from the American Type Culture 
Collection (Manassas, VA; Ref. ATTC #CRL-2429). 
- Human mesenchymal cells (hMSCs) from bone marrow (46, XY; PT-2501, 
Lonza). 
- Patient-derived primary Sertoli cells (Riboldi et al., 2012) 
- The 293-T packaging cell line (293-T) from the American Type Culture 
Collection (Manassas, VA; Ref. ATCC # CRL-11268). 
5.2.2 LENTIVIRAL TRANSDUCTION 
Once the lentiviral expression constructs containing the inserts were 
obtained they were ectopically overexpressed following a conventional 
protocol for lentiviral transduction. Briefly, three plasmids were co-
transfected onto 293-T cells to produce lentiviral supernatants:  
- Plasmid 1, containing the HIV-gag polymerase (retro-transcriptase) and 
accessory proteins Tat and Rev (pCMVdeltaR8.91, derived from 
pCMVR8.931). 
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- Plasmid 2, containing the envelope glycoprotein VSV-G (pMD.G) for 
pseudotyped lentiviral particle production. 
- Plasmid 3, destination/expression lentiviral vector pLenti7.3/V5-DEST with 
the cloned gene.  
These plasmids were obtained using a QIAGEN Plasmid Maxi Prep kit 
(#12965, QIAGEN). Their respective maps are shown and described in 
Appendix 1.  
High-titre lentiviral supernatants were generated in the 293-T packaging 
cell line by transitory co-transfection with the three plasmids at 0.5 µg/mL 
with Fugene HD (Roche Diagnostics, Indianapolis, IN; Ref. n. 4709705001) at 
5 µg/mL in OPTI-Mem low protein cell culture medium (Invitrogen; Ref. n. 
31985-047). Co-transfection media were incubated for 6-8h at 37˚ C in a 
humidified atmosphere with 5% CO2. This medium was then replaced with 
D-MEM (Sigma, Ref. n. D6421) supplemented with 10% fetal bovine serum 
(FBS; Life Technologies) without antibiotics. Viral supernatants were 
collected and filtered after 72 h. 
Infection was performed by adding the lentiviral supernatant to hFSK and 
hMSC primary cultures for 8-12 h at 37˚ C in a humidified atmosphere with 
5% CO2 in the presence of 10 µg/mL of polybrene (Sigma-Aldrich, St Louis, 
MO; Ref. n. TR1003G) when they were at 60% confluence. After infection 
these lentiviral supernatants were removed and replaced with conventional 
culture media. Seventy-two hours after transduction the cells were checked 
for EmGFP fluorescence as a lentiviral vector expression reporter. 
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5.2.3 CULTURE CONDITIONS 
All cells were cultured at 37° C in an incubator with a thermostat, with 
saturated humidity and 5% flow-regulated CO2. Cell manipulation was 
carried out in laminar flow hood under sterile conditions. The culture media 
were as follows: 
- Conventional culture media: Dulbecco's modified Eagle's medium/ 
nutrient F-12 ham (D-MEM/F12; GIBCO, Invitrogen) supplemented with 
10% FBS and 2 mM Glutamine, 0.1 mM MEM non-essential amino acids 
(both Life Technologies), and 1% penicillin/streptomycin (Life Technologies) 
- Induced germ-cell survival/germ-cell media (GC-M): DMEM/F12 with 20% 
knock-out serum replacement (KSR; GIBCO, Invitrogen), 2 mM glutamine 
(Life Technologies), and 0.1 mM non-essential amino acids (Labclinics, PAA), 
supplemented with 1000 U/ml human recombinant LIF (Sigma), 20 ng/mL 
human recombinant GDNF (Peprotech), 5 µM Forskolin (Sigma), 10 ng/ml 
bFGF (Invitrogen), 0.1 mM 2-mercaptoethanol (Millipore), 5 ng/mL SCF 
(Peprotech), and 2 µM RA (Sigma). 
- Co-culture with Sertoli cells: twenty-four hours before seeding the 
reprogrammed cells, Sertoli cells were plated on a collagen matrix (#C6745, 
Sigma) at a density of 104 cells/cm2 and cultured under standard conditions. 
3-days post-transduction, reprogrammed cells were harvested and seeded 
on this Sertoli cell monolayer. The co-culture was maintained with GC-M 
until day 14 when they were harvested for further analysis. 
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5.3 CHARACTERIZATION OF GERM CELLS INDUCED IN VITRO  
5.3.1 TRANSCRIPTOMIC CHARACTERIZATION 
Total RNA was prepared using the RNeasy Mini Kit (Qiagen) following the 
manufacturer’s instructions. RNA quantification and purity were 
determined using a NanoDrop spectrophotometer. The integrity of the RNA 
samples (RNA quality control procedure) was assessed with a 2100 
Bioanalyzer (Agilent Technologies, Madrid, Spain) by running an aliquot of 
the RNA samples in the RNA 6000 Nano LabChip (Agilent Technologies, 
Madrid, Spain). The Bioanalyzer-2100 software determines a parameter 
indicative of RNA integrity called an RNA integrity number (RIN), which is 
calculated using ribosomal RNA ratios; values higher than 7 confirm high 
quality RNA. Transcriptomic characterization was performed either by an 
expression array or qRT-PCR.  
5.3.1.1 EXPRESSION ARRAY 
All samples were hybridized onto the Whole Human Genome Oligo 
Microarray (Agilent Technologies) that encompasses more than 44,000 
human DNA probes. The sample preparation and hybridization protocols 
were adapted from the Agilent Technical Manual. Briefly: 
1) Microarray hybridization: First-strand cDNA was transcribed from 100 ng 
of total RNA using the T7-Oligo(dT) promoter primer. Samples were 
transcribed in vitro and Cyanine-3 (Cy-3) labelled (Quick- AMP labelling kit, 
Agilent Technologies). Fragmented copy RNA (cRNA) samples (1.65 µg) 
were hybridized onto chips by incubating them for 16 h at 65° C with 
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constant rotation. The microarrays were then washed in two one-min steps 
in two washing buffers (Agilent Technologies, Madrid, Spain). Hybridized 
microarrays were scanned in an Axon 4100A scanner (Molecular Devices, 
Sunnyvale, CA, USA), and data were extracted with the GenePix Pro 6.0 
software (Molecular Devices, Sunnyvale, CA, USA).   
2) Data processing and analysis: The GenePix Pro 6.0 software was used for 
array image analysis and to calculate the spot intensity measurements, 
which are considered to be raw data. Spot intensities (medians) without 
background subtraction were transformed to the log2 scale using R 
software (R Development Core Team, 2004) and libraries from the 
Bioconductor database (www.bioconductor.org). Before quantile 
normalization, the data were initially represented on a box plot so that the 
distribution could be analyzed and any abnormal microarray data could be 
subtracted. Replicates by gene symbol were merged and the data were 
filtered in order to delete unknown sequences or probes without a gene 
description. The web-based Babelomics tool 
(http://babelomics.bioinfo.cipf.es) was used on the resulting data matrix to 
merge the replicates from each probe by mean and for principal 
component analysis (PCA). Next, samples treated with i12F/i6F versus 
MOCK controls were statistically analyzed using the Rank Products module 
in MeV software for statistical analysis (www.tm4.org). A false discovery 
rate (FDR) correction of less than 5% was used. The DAVID web-based tool 
(http://david.abcc.ncifcrf.gov) was used to predict the biological processes 
affected. Microarray results were validated by performing qPCR for two of 
the most interesting upregulated genes. 
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5.3.1.2 QUANTITATIVE REAL-TIME PCR 
RNA quantification was measured using a NanoDrop spectrophotometer. 
Next, 500 ng of total RNA was converted into cDNA with oligo-dTs using the 
Advantage® RT-for-PCR kit (Clontech) following the manufacturer´s 
instructions. 
Subsequently, 2 µl of cDNA were qRT-PCR amplified with SYBR®Green 
(Invitrogen). Transcription levels were determined by using a LightCycler 
480 (Roche) in triplicate reactions and normalized to the average of the 
housekeeping gene RPL19 using the 2-ΔΔCt method. The primers used to 
detect gene expression are described in Appendix 2 and were designed with 
the Primer3 tool (http://frodo.wi.mit.edu/primer3/). 
5.3.2 EPIGENETIC CHARACTERIZATION BY BISULFITE SEQUENCING 
Epigenetic characterization was performed by bisulfite sequencing (bi-seq), 
a technique which is based on bisulfite-converted genomic DNA (gDNA). 
Treating gDNA, previously extracted with the QIAamp DNA MiniTM kit 
(Qiagen), with bisulfite converts C into U residues. Hence, bisulfite 
treatment changes the genomic sequence depending on the methylation 
status of individual Cs; by comparing the post-treated sequence to a 
reference sequence, the initial C methylation status can therefore be 
determined (Fig. 5.2). 
Genomic DNA was extracted with the QIAamp DNA Mini kit (Qiagen) and 
100 ng of gDNA was processed using the EpiTect Bisulfite Kit (Qiagen) 
according to the manufacturer’s instructions. 1 µL of bisulfite-treated gDNA 
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was PCR-amplified in the presence of 5 mM MgCl2, 0.2 mM dNTPs, 10 pmol 
of each primer, and 1 U Platinum Taq polymerase (Invitrogen). PCR 
amplifications for H19 and PEG1/MEST1 were initiated at 94˚ C for 3 min 
followed by 45 cycles of 94˚ C for 30 sec; 58˚ C for 30 sec; and 72˚ C for 30 
sec. Primer sequences are included in Appendix 2. The resulting PCR 
products were gel-extracted using a QIAquick gel extraction kitTM (Qiagen) 
and cloned into the pCR®2.1-TOPO® VECTOR using the TOPO-TA cloning® 
kit (Ref. 45-0641, Invitrogen). At least 20 clones were sequenced for 
analysis, and CpG methylation analysis was performed using BiQ Analyzer 
software (Max Planck Institut Informatik). 
 
FIG. 5.2 gDNA bisulfite conversion. A) Biochemical bisulfite conversion reaction; B) General 
methylation-status discrimination strategy; C) Interpretation of results after bisulfite 
treatment. Ref. Seq., Reference sequence used to compare with the Bs-converted seq., the 
sequenced bisulfite-converted DNA. 
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5.3.3 MEIOTIC PROGRESSION ANALYSIS 
In order to assess the meiotic status and progression of treated cells, two 
different assays were performed. SYCP3 staining on meiotic spreads allows 
meiotic cells to be identified and to subsequently determine how advanced 
through meiosis they are, while ploidy analysis by fluorescence in situ 
hybridization (FISH) enables us to determine if reprogrammed cells have 
completed meiosis, forming haploid cells. 
5.3.3.1 SYCP3 STAINING 
Meiotic spreads were performed as previously described (Kee et al., 2006, 
Panula et al., 2011, Medrano et al., 2011). Briefly, cells were collected and 
resuspended in hypoextraction buffer (30 mM Tris, 50 mM sucrose, 17 mM 
citric acid, 0.5 mM dithiothreitol [DTT], 0.5 mM phenylmethylsulfonyl 
fluoride [PMSF] all from Sigma Aldrich, and 5 mM 
ethylenediaminetetraacetic acid [EDTA] from Invitrogen, at pH 8.2-8.4). The 
solution was incubated for 30 min at room temperature and then put onto 
slides which had previously been fixed with 1% paraformaldehyde (PFA). 
Slides with the cellular solution were incubated overnight in a humid 
chamber at room temperature. Then, the cells were permeabilized for 2 
min with 0.04% Photoflo (KODAK) followed by incubation with blocking 
solution for 60 min with 4% donkey serum in 1 % bovine serum albumin 
(BSA) and 0.1% Triton X100 in phosphate-buffered serum (PBS). Human 
anti-CREST antibody (Fisher Scientific) was used at a 1:1,000 dilution and 
incubated overnight at 37˚ C in a humid chamber. Rabbit polyclonal anti-
SYCP3 primary antibody (Novus Biologicals) was used at a 1:100 dilution 
5. Methods 
- 79 - 
 
and incubated for 3 h at 37˚ C in a humid chamber. The slides were washed 
with blocking solution and the secondary donkey anti-human 4',6-
diamidino-2-phenylindole (DAPI)-conjugated antibody (Jackson 
Immunoresearch) was applied at a 1:100 dilution and incubated overnight 
at 37˚ C in a humid chamber. The following day the slides were washed as 
described above and incubated with a donkey anti-rabbit 
tetramethylrhodamine (TRITC)-conjugated antibody (Abcam) at a 1:200 
dilution for 1 h at 37˚ C in a humid chamber. Prolong Gold anti-fade reagent 
(Life Technologies, ref. P36935) was applied. Finally, the cells were counted 
under a fluorescence microscope. SYCP1 co-staining with SYCP3 was also 
performed following a similar protocol. 
5.3.3.2 PLOIDY ANALYSIS: DNA-SORTER AND FLUORESCENCE IN SITU 
HYBRIDIZATION 
Ploidy analysis was performed following different strategies: i) in the total 
population; ii) in the putative haploid population, which had previously 
been purified by a DNA-content cell sorter; iii) in manually selected clumps. 
- DNA-content fluorescent-activated cell-sorting (FACS): cells were 
harvested into a single cell suspension and then fixed with 70% ethanol 
over night at - 20° C. The cells were then washed and incubated in a 
solution containing 0.2 mg/ml RNase A and 0.02 mg/ml propidium iodide 
(PI, Invitrogen) in Hank’s balance salt solution (HBSS, Invitrogen) for 30 min 
at 37° C. Cells were sorted according to their DNA content by a MoFlo® 
(Modular Flow Cytometer; Beckman Coulter, Dako, Denmark, 
http://www.dako.com) jet-in-air high-speed sorter.  
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- Fluorescence in situ hibridization (FISH): Cells were harvested into a single 
cell suspension (total population or manually selected clumps) or sorted cell 
populations were collected and post-fixed with Carnoy’s fixative (1:3 acetic 
acid:methanol) for 5 min and then air dried. The slides were dehydrated in 
a sequence of 70%, 80%, and then 100% ethanol and air dried. FISH probes 
for chromosomes 18 (D18Z1,Kreatech, KI-20018-B) , and X and Y (SE-X 
[DXZ1]/SE-Y [DYZ3], Kreatech, KBI-20030) were denatured on slides at 73° C 
for 5 min and then hybridized at 37° C overnight. The slides were then 
washed with 50% formamide, 2X saline sodium citrate at 43° C for 5 min 
each. ProLong Gold anti-fade reagent with DAPI was applied to the slides 
and the cells were counted under a fluorescence microscope. 
5.3.4 IMMUNOFLUORESCENCE 
Cultured cells were fixed with 4% PFA for 15 min at room temperature and 
then washed twice with PBS. They were then permeabilized with 1% 
TritonX100 in PBS for 15 min at room temperature, blocked with 0.5% 
Tween20, 1% BSA, and 4% secondary-antibody host-serum. Primary 
antibodies were incubated over night at 4˚ C, while secondary antibodies 
were incubated for 2-3 h at room temperature in the dark. A detailed 
description of the antibodies used is included in Table 5.3. ProLong Gold 
anti-fade reagent with DAPI was applied to the slides and the cells were 
counted under a fluorescence microscope. 
For 5hmC immunostaining, a chromatin-opening step was performed 
before permeabilizing: cells were incubated with 4M HCl for 15 min and 
neutralized with 100 mM Tris-HCl at pH 8.5 for 30 min at room 
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temperature. Blocking was performed overnight at 4˚ C and primary 
antibodies were incubated for 4 h at room temperature. 
Table 5.3 Primary antibodies used. 
ANTIGEN PRIMARY ANTIBODY REF COMPANY 
CREST Human anti-centromere protein 15-234 Fisher 
SYCP3 SCP-3 Purified rabbit antisera NB 300-232 Nobus 
SYCP1 Goat anti SCP-1 sc-23600 Santa Cruz  
5hmC Rabbit anti-5-
hydroxymethylcytosine 
39791 Active Motif 
Alkaline 
Phosphatase (AP) 
Mouse monoclonal anti-TRA2-
54 
MAB4354 Millipore 
PLZF Mouse monoclonal anti-PLZF MAB2944 R&D 
HIWI Rabbit anti-HIWI 710208 Novex-life 
technologies 
ACRO Goat anti-acrosin sc-46284 Santa Cruz  
Human VASA 
(hVASA) 
Goat anti-VASA AF-2030 R&D 
NuMA Rabbit anti-Human NuMA Ab36999 ABCAM 
V5-epitope Mouse monoclonal anti-V5 r960-25 Invitrogen  
 
5.4 XENOTRANSPLANT ASSAYS 
In order to test the in vivo functionality of the germ cells induced in vitro, a 
xenotransplant assay was performed (Fig. 5.3). Briefly, transduced cells 
were injected into the efferent duct of previously busulfan-sterilized nude 
mice to test if they were able to recolonize the SSC niche. 
5.4.1 MOUSE STRAIN SELECTION 
For this assay 4-6-week-old nude (Crl:NU-Foxn1nu) male mice were chosen 
This strain is appropriate for these xenotransplant assays because they are 
immunodeficient and so no immuno-cross-reactivity is expected with the 
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FIG. 5.3 General overview of xenotransplant assay. GFP; green fluorescent protein, hFSK; 
human foreskin fibroblast, IP; intraperitoneal. 
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human transplanted cells. 
This animal model assay was approved by the ethical committee (Comité de 
Ética y Bienestar Animal, Universidad de Valencia, Ref, A1332863413145). 
Since all these animals are immunodeficient, all the procedures and animal 
manipulations were performed under sterile conditions. 
5.4.2 BUSULFAN STERILIZATIONSTERILISATION 
Busulfan is a DNA-alkylating agent (Fig. 5.4) that can eliminate germ cells 
and breaks cell-to-cell junctions between Sertoli cells. These effects allow 
the colonization of transplanted cells in the basal lamina from seminiferous 
tubules. The mice were sterilized by an intraperitoneal (IP) injection of 
busulfan (30-35 mg/kg) dissolved in dimethyl sulfoxide (DMSO) and after 4-
6 weeks when endogenous spermatogenesis is suppressed, the mice were 
xenotransplanted. 
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Mice were kept under sterile conditions in a specific pathogen free area in 
the Animal Facility at the Faculty of Pharmacy (University of Valencia) until 
the xenotransplant surgery was carried out. 
5.4.3 PREPARATION OF DONOR CELLS 
hFSK cells were harvested 14 days post-transfection and prepared for 
xenotransplant. Cell harvesting was synchronized to correspond with week 
4 after busulfan sterilization of the recipient mice. 
The EmGFP reporter gene, under the control of a constitutive promotor 
contained in our lentiviral backbones, was used to track cells after 
transplantation. This backbone also incorporates a short V5-epitope at the 
C-terminal of the recombinant protein that can act as a marker of cells that 
have been properly transduced. Even so, another non-viral marker was 
chosen: the CellVue® Claret far red fluorescent from a cell linker Kit (Sigma-
Aldrich, ref. MIDCLARET/ 24849-1). This far red fluorescent molecule (ƛMAX 
Exc = 655 nm; ƛMAX Em = 675 nm) binds to the aliphatic tails of phospholipids 
and inserts into cellular lipid bilayers (Fig. 5.5) allowing cell tracking over 
cell divisions.  
Harvested cells were incubated with CellVue® Claret far red according to 
the manufacturer’s instructions: briefly, 107cells/mL were incubated at a 
 
FIG. 5.4 The chemical structure of Busulfan. 
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final concentration of 2 µM CellVue® Claret Far Red for 4 min at room 
temperature in the dark. The cells were washed twice with 10% BSA in PBS 
and then washed with GC-M.  
Finally, the cells were concentrated to 1-3x105 cells/µL in GC-M and kept on 
ice. Just before xenotransplant 10% (v/v) trypan blue dye and 1 mg/mL 
DNase I were added to ensure that the injected cells could be properly 
visualized while being injected into the seminiferous tubules and to prevent 
the formation of cellular aggregations.  
5.4.4 XENOTRANSPLANTATION 
Four weeks after busulfan sterilization (approximately 2.5-3-month-old 
mice) xenotransplant surgery was performed (Fig. 5.6). Mice were 
anesthetized using 5% isofluorane and the abdominal area was prepared by 
applying povidone-iodine. The recipient testes were exteriorized through a 
0.75 cm mid-ventral abdominal incision.  
 
FIG. 5.5 CellVue® Claret Far Red Fluorescent Cell Linker. A. Fluorescence absorption and 
emission spectra. B. Membrane-labeling insertions.  
A B
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FIG. 5.6 Mice xenotransplant. A. Surgery set-up overview; B. Mouse preparation and testis 
manipulation; C. Seminiferous tubules at the start of donor cell injection; D, Appearance of 
the xenografted testis after injection. 1: Inhalational anaesthesia; 2: Dissecting scope; 3: 
micromanipulator; 4: FemtoJet microinjector; 5: Injection pipette; 6: pre-cut “V” paper pad; 
7: exteriorised testicle; 8: sponge; 9: tip of injection pipette inserted into the efferent duct. 
1
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The first testis to be injected (right) was pulled out through the incision 
using the testis fat pad and placed on the pre-cut ‘V’ paper pads to secure it 
in position. The membrane connecting the testis to the epididymis was 
gently pulled apart and fat cleared to expose the efferent duct. Using 
sponges, the testis was positioned upright to align a long straight stretch of 
efferent duct with the injection pipette (bevelled micropipettes with a 75 
µm inner diameter). The pipette was filled with 8-10 µl of cell preparation 
and, with the help of a micromanipulation unit (Leica), was inserted into the 
efferent duct so that its tip was positioned in the rete testis.  
Cell injections were performed with a FemtoJet microinjector (Eppendorf). 
After the injection was completed on the first side, the sponges were 
removed and the testis was returned to the abdominal cavity. The same 
steps were repeated on the other testis, and finally the incision was 
sutured. All these steps were performed under a dissecting scope with a flat 
base and tilting binocular eyepiece tube (Nikon). 
5.4.5 XENOTRANSPLANTED TISSUE ANALYSIS 
Two months post-surgery the mice were sacrificed by cervical dislocation 
and the testes were removed and analyzed for the formation of colonies of 
iGCs by flow cytometry and confocal immunofluorescence using 
cryosections.  
- Flow cytometry protocol: Half of each xenotransplanted testis was 
mechanically minced and enzymatically disaggregated (2 mg/mL 
collagenase IA [Worthington, ref. LS004176] was added for 15 min at 37˚ C 
and then centrifuged at 200 rpm,  followed by two decantation steps and 
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trypsinization using 0.25% trypsin [Life technologies] for 10 min at 37˚ C). 
Then, 10 mg/mL DNase I (Sigma-Aldrich, ref. D4513) was added to the 
single cell suspension and immediately followed by lysis buffer to eliminate 
erythrocytes (dilution 1:10 from red blood cell Lysis Buffer 10X, BioLegend, 
ref. 420301). The single-cell suspension was filtered (with a 50 µm diameter 
filter from Partec CellTrics®, ref. 04-004-2327) and then counted. 
Conventional cell suspension immunofluorescence was then performed: 
Briefly, cells were fixed with 1% PFA for 15 min at room temperature, 
washed, and then resuspended in Perm/Wash Buffer 1X (dilution 1:10 from 
BD Perm/WASH™ Buffer; BD, ref. 554723). Primary antibodies (Table 5.3) 
were incubated at a 1:100 dilution for 1-2 h on ice and following washing, 
the secondary antibodies were incubated consecutively for 1 h on ice in the 
dark. Cells were analyzed with a 4-laser LSRFortessa BECTON DIKINSON 
flow cytometer for antibody expression and the presence of the CellVue® 
Claret Far Red signal. 
- Tissue cryosections: The other part of each xenotransplanted testis was 
cryopreserved in O.C.T.TM compound (Tissue Tek, ref. 4583); 8 µm 
cryosections were made using a Leica CM1950 Cryostat, and conventional 
immunofluorescence was carried out: Briefly, tissue sections were fixed 
with 4% PFA for 10 min at room temperature. After washing, the slides 
were permeabilized with 1% TritonX100 in PBS for 20 min at room 
temperature, and blocked with 4% donkey serum (Sigma-Aldrich, ref 
D9663), 3% BSA, and 0.1% Tween20. Primary antibodies were incubated at 
a 1:200 dilution overnight at 4˚ C and consecutive secondary antibodies 
were incubated for 1-2 h at room temperature in the dark. Finally the slides 
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were mounted with Prolong Gold anti-fade reagent with DAPI. Sections 
were analyzed by confocal microscopy (Olympus FV1000), for the presence 
of different primary antibodies and for the CellVue® Claret Far Red signal. 
NuMA+/VASA+/CellVue+ triple positive cells located on the basal layer of 
tubules were counted for 15 serial cryosections per transplanted testis 
leaving a distance of 80 µm between them. The average number of triple 
positive cells found by two independent researchers was divided by the 
number of injected cells in each testis and multiplied by 105 to obtain the 
colonization efficiency per 105 injected cells. 
5.5 STATISTICAL EVALUATION OF THE RESULTS 
For each experiment at least three independent samples (n = 3) were used. 
The different values are represented as the mean plus or minus (±) the 
standard error of mean (SEM).  
Statistical significance was calculated with the SPSS statistical package (SPSS 
Inc.). Statistical analysis of the RT-qPCR results as well as meiosis and FISH 
counts was performed with one-way ANOVA and t-student pair-wise 
comparisons. Statistical significance was accepted for P-values less than 
0.05. The only exception was data from the expression arrays: an 
explanation is included for these experiments in their respective results 
sections. 
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6.1 HUMAN FORESKIN FIBROBLAST REPROGRAMMING USING TWELVE 
GERM LINE FACTORS INDUCES THE FORMATION OF PUTATIVE GERM CELL-
LIKE CELLS 
6.1.1 ECTOPIC EXPRESSION OF TRANSDUCED GENES 
As previously explained, based on the literature, a cocktail of twelve 
candidate genes was chosen because of their role in mammalian germ line 
development: PRDM1 (Vincent et al., 2005), PRDM14  (Kurimoto et al., 
2008), LIN28A (West et al., 2009), NANOG (Mitsui et al., 2003), NANOS3 
(Suzuki et al., 2008), DAZ2, BOULE, DAZL (Ruggiu et al., 1997), VASA (also 
known as DDX4) $(Fujiwara et al., 1994), STRA8 (Bowles et al., 2006), DMC1 
(Yoshida et al., 1998), and SYCP3 (Costa et al., 2005). These genes were 
isolated by PCR and their ORFs were cloned into a lentiviral expression 
backbone containing a CMV promoter and tagged with a GFP reporter. The 
lentiviral vector also included a V5 epitope at the C-terminal end of the 
cloned protein (Appendix 1). The lentiviral particles carrying the transgenes 
of interest were used in a mixture of equal proportions of the twelve 
factors (i12F) to transduce a human somatic primary culture of foreskin 
fibroblasts (hFSKs; 46, XY). The empty lentiviral backbone (MOCK) was also 
included as an independent negative control condition. To check the 
lentiviral infection efficiency GFP fluorescence emission was used as a 
reporter (Fig. 6.1A-B). As shown by qRT-PCR, transduced hFSK primary 
cultures overexpressed all the transgenes, although at different levels (Fig. 
6.1C). PRDM1 and NANOG transgene expression levels were constantly 
lower than the others because the infection efficiency was not as high as 
that of the other lentiviral particles. In the case of PRDM1, the lower rate of 
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overexpression (compared with the levels reached by the other factors) is 
explained by the relatively high basal levels of PRDM1 in hFSK cells. Even 
though levels of ectopic NANOG overexpression were not as high as the 
other factors, there was a 60 fold-change compared with MOCK controls 
meaning that their levels were sufficient enough to obtain the expected 
phenotype. 
6.1.2 REPROGRAMMED CELL MORPHOLOGICAL CHANGES S AND THE 
ESTABLISHMENT OF CELL CULTURE CONDITIONS 
Initially, human primary cultures were transduced with the previously 
mentioned twelve factors and were cultured in standard medium consisting 
of DMEM/F12 with 20% of FBS. A morphological change was observed from 
day 7 post-transduction, when some small clumps of compacted, small, 
 
FIG. 6.1 Green fluorescence protein (GFP) and reprogramming factor expression in i12F-
treated hFSKs. A) Bright-field microscopy; B) Dark-field microscopy; C) qRT-PCR transgene 
overexpression. Values are indicated as the fold-change vs. the MOCK-treated negative 
controls. 
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round cells began to appear. After few days, these clumps disappeared, an 
indication that perhaps the culture conditions were not optimal for their 
survival (Fig. 6.2A).  
In order to improve the survival of these cell clumps, and based on previous 
reports on the derivation of germ cells from testicular biopsies, a specific 
cell culture media (Germ Cell Media; GC-M) was designed with the purpose 
of promoting putative germ cell survival. This GC-M consisted of 
DMEM/F12 supplemented with 20% KSR, 20 ng/mL GDNF, 10 ng/mL bFGF, 
1000 U/mL LIF, 5 ng/mL SCF, and 2 μM RA (Conrad et al., 2008, Kossack et 
 
FIG. 6.2 A) Morphological change were only maintained under GC-M culture conditions. B) 
i12F-treated cell clusters were alkaline phosphatase positive. Scale bar represents 10μm. 
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al., 2009, Golestaneh et al., 2009). Under these cell culture conditions an 
increase in spontaneous cell clump formation was observed (Fig. 6.2A). 
Moreover, these cell clumps could be maintained in culture for up to 50 
days and were also positive for AP (Fig 6.2B). These results suggested that 
these clumps had a putative induced germ cell like cell (iGC) identity that 
could only be maintained in GC-M supplemented with growth factors. 
6.2 TWELVE FACTOR-REPROGRAMMED CELLS HAVE A GERM LINE-LIKE 
TRANSCRIPTOMIC AND EPIGENETIC PROFILE 
6.2.1 TRANSCRIPTOMIC ANALYSIS BY EXPRESSION ARRAY AND 
QUANTITATIVE REAL-TIME PCR 
Expression arrays were performed using RNA samples to determine the 
global expression profile of i12F-transduced cultures. Treated cultures from 
different independent experiments clearly clustered in a defined group (Fig. 
6.3A) and from these 21 genes that were significantly differentially 
upregulated compared to MOCK controls were identified, indicating that 
the gene expression profile of the transduced culture cells had switched. 
Gene ontology (GO) analysis of these genes indicated that they were 
implicated in germ cell-related processes (Fig. 6.3B-C) such as meiosis (P < 
0.001), spermatogenesis (P < 0.001) or germ cell development (P < 0.001), 
among others, with a predicted activation of translation regulation activity 
(fold enrichment) of 63.95 (P < 0.001). 
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FIG. 6.3. A) Hierarchical clustering of significantly upregulated genes in i12F-transduced 
samples vs. MOCK controls. B) Percentages of fold-enrichment in GO terms. C) Details of the 
enrichment in GO terms related to ‘germ line development’. (*) sexual reproduction (1%), 
multicellular organism reproduction (1%), reproductive processes in a multicellular organism 
(1%), reproductive developmental process (2%), gamete generation (1%). 
Germ line 
development
46%
Epithelial cell differentiation 13%
Fluid transport 7%
Regulation of neuronal 
synaptic plasticity 6%
Defense response 4%
Myeloid leukocyte
differentiation 3%
Cell motion 3%
Negative regulation of cell
development 3%
Chemotaxis 3%
Inflamatory response 3%
Leukocyte differentiation 2%
Cellular hormone metabolic process 2%
Meiotic cell cycle 3%
Meiosis 3%
M phase of meiotic cell cycle 3%
Others related to Reproductive
developmental process (*)
Male meiosis I 18%
Spermatogenesis 2%
Male gamete generation 2%
Ovulation cycle process 4%
Female gonad development 4%
Ovulation cycle 4%
Ovarian follicle development 6%
Development of primary female sexual characteristics 4%
Female sex differentiation 4%
Positive regulation of 
translational initiation 33%
Regulation of cell
proliferation 1%
Rhythmic process 3%
A
B
C
Direct reprogramming of human somatic cells to meiotic germ-like cells 
 
- 96 - 
 
Following this, expression analysis by qRT-PCR was performed on days 7, 
14, and 21 resulting in a significant increase in expression of several germ 
line specific markers when compared with MOCK controls. Indeed, 
spermatogonial markers such as PIWIL2 (HILI) and the GDNF receptor type 
1α (GFRA1) , as well as meiotic and post-meiotic markers including Acrosin 
(ACR), Transition Protein 2 (TNP2), and Protamin 1 (PRM1), were among the 
germ line markers that were upregulated after i12F-transduction  indicating 
the presence of a heterogeneous germ cell-like population at different 
developmental stages within the reprogrammed cultures.  
Moreover, the expression of the markers HILI, TNP2, PRM1 and ACR, but 
not GFRA1, was relatively enriched in the manually isolated iGC clumps 
when compared with the total population, indicating the likelihood that 
more developmentally advanced germ cell-like cells were localized within 
the iGC clumps (Fig 6.4A-E). It is worth noting that germ line-related marker 
expression changed with the time, showing a temporal germ line-like 
expression pattern with an increase in the expression of later-stage markers 
concurrently with a decrease of the earliest ones. For example, GFRA1 
expression decreased over time in culture (Fig. 6.4A) while TNP2 was 
overexpressed not only in the total population but especially in the 
manually selected clumps (Fig. 6.4C). Hence, these germ line marker 
expression temporal dynamics indicate that the i12F-reprogrammed cells 
were a heterogeneous germ cell-like cell population that recapitulate the in 
vivo germ cell developmental program in vitro. 
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6.2.2 H19 AND PEG1 IMPRINTING CONTROL REGION BISULFITE 
SEQUENCING 
To determine whether i12F-treated cells were able to recapitulate the in 
vivo germ line cell developmental epigenetic reprogramming in vitro, the 
 
FIG. 6.4. Germ line marker expression. A) qRT-PCR expression analysis of the germ line 
markers GFRA1; B) PIWIL2; C) TNP2; D) PRM1; E) ACR on days 7, 14 and 21 post-
transduction; F) Representative scheme of the in vivo expression of these different markers. 
Values are indicated as fold change vs. MOCK controls mean ± SEM; (*) = significant vs. 
MOCK controls; (^) = significant vs. total population. (*/^ = P-value < 0.05; **/^^ = P-value < 
0.001). 
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methylation status of the parentally imprinted H19 and PEG1/MEST loci 
promoters were analyzed by bi-seq. As expected for a somatic cell type, 
MOCK controls showed approximately 50% CpG methylation for both loci. 
However, in 14-day post-12F-transduction cultures methylation was 
decreased in the paternally imprinted (and thus sperm-methylated) H19 
locus  to approximately 21% CpG methylation in the whole cell cultures and  
35.15% in manually selected clumps (Fig. 6.5A) compared to the MOCK 
control. On the other hand the maternally imprinted (and thus sperm de-
methylated) PEG1/MEST locus showed only a small increase (54.7%) in CpG 
methylation compared with the MOCK cells which was enhanced to 65.4% 
in the manually selected clumps (Fig. 6.5B). 
The bi-seq analysis is based on bisulfite modification of genomic DNA. The 
main handicap of this method is that it cannot distinguish between 5mC 
and 5hmC so the percentages of methylation analyzed may be biased: some 
of the 5mCs detected may in fact correspond to 5hmCs. 5hmC has been 
described as a pre-erasure marker for CpGs that are about to be actively de-
methylated by the TET family demethylases (Tahiliani et al., 2009). 
Interestingly, a relative 5hmC enrichment was observed in the iGC clumps 
two weeks post-transduction (Fig. 6.5E) which correlates with enriched 
TET1 and TET2 (but not TET3) expression (Fig. 6.5D), as well as the lack of 
significant DNMT1, DNMT3A, or DNMT3B expression changes in these 
clumps compared to controls (Fig. 6.5F). 
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FIG. 6.5. Methylation status of two imprinted genes, H19 (A) and PEG1/MEST (B) by bi-seq 
analysis; C) Percentages of methylation. D) qRT-PCR for TET and DNMT DNA-methylation 
modifications (F); E) 5hmC immunofluorescence for i12F-hFSK treated cells. Data is 
presented as the normalised mean fold change ± the SEM. (*) represents significant 
differences (P < 0.05) compared to controls; (+) represents significant differences (P < 0.05) 
between the i12F cells alone and the isolated i12F-clumps. 
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FIG. 6.6 Immunostaining analyses of reprogrammed fibroblasts at 14 and 21 days post-
transduction for the germ line markers alkaline phosphatase (AP) $(A), PLZF (B), HIWI (C), 
and ACR (D). The periphery of iGC clumps in i12F/16F conditions is highlighted by dashed 
lines. Scale bar represents 10µm. Larger images are provided on the CD-version 
accompanying this thesis. 
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6.2.3 PHENOTYPIC CHARACTERIZATION OF i12F CLUMPS   
Since our previous morphological, transcriptomic, and methylation results 
suggested that i12F clumps are a differentiated cell subpopulation, 
phenotypic characterization was carried out to better discriminate the 
differences between these putative subpopulations. Further 
immunostaining analysis allowed the expression of AP, PLZF, HIWI, and 
ACROSIN to be detected at the protein level at different time points (Fig. 
6.6). Interestingly, these markers were also relatively enriched, and were 
mainly localized in the iGC clumps, supporting previous observations and 
indicating relative germ cell enrichment in the clumps.  
6.3 TWELVE FACTOR-REPROGRAMMED CELLS CAN PROGRESS THROUGH 
MEIOSIS IN VITRO 
6.3.1 MEIOTIC SPREAD ANALYSIS BY SYCP3 STAINING 
Since i12F-reprogrammed cells showed post-meiotic marker expression 
their prophase I meiotic progression status was analyzed by  examining the 
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localization and distribution of one of the axial elements of the 
chromosomal scaffold  of the synaptonemal complex: SYCP3 (Kee et al., 
2009, Medrano et al., 2011, Panula et al., 2011). Synaptonemal complexes 
comprise the axial elements SYCP2 and SYCP3, among other proteins, and 
their formation starts at leptotene during prophase I. At this time SYCP3 
acquires a punctate conformation which changes to a more elongated one 
as chromosome pairing is completed through prophase I during zygotene, 
pachytene, and up to diplotene; at diplotene the synaptonemal complex 
disappears, the chromosomes undergo desynapsis and the bivalents 
condensate (Fig. 6.7A). 
This analysis was performed on day 14 post-transduction because 
represented the peak appearance of iGC clusters. Approximately 8.69% of 
the reprogrammed hFSK cells positively stained for SYCP3 (Fig. 6.7B) 
however, around 7.07% of the SYCP3 positive nuclei showed a staining 
pattern considered aberrant because they represented random protein 
aggregations (Fig. 6.7F). Thus, approximately 1.62% of reprogrammed cells 
showed a correct positive SYCP3 staining pattern, suggesting that these 
cells were involved in prophase I of meiosis. Approximately 35.8% of 
meiotic nuclei (0.58% of the total population) had an elongated SYCP3 
staining pattern corresponding to late zygotene and pachytene stages of 
prophase I, whereas the other 64.2% (1.04% of the total population) 
showed a punctate staining pattern corresponding to leptotene (Fig. 6.7C-
D). Completion of synapsis is mediated by SYCP1, a central element with a 
structural function in the synaptonemal complex, which binds to 
chromosomes in the late stages of prophase I. 
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FIG. 6.7 Meiotic progression of hFSKs 14 days post-transduction. A) Illustrative pictures of 
the SYCP3 staining pattern; B) Percentage of aberrant/dotted/elongated staining pattern 
found in each condition in hFSK cells; C) Representative images of SYCP3 staining pattern 
overlaid and merged with transduced-cell images; D) Percentage of dotted/elongated 
staining pattern found in each hFSK cell condition; E) Representative SYCP1 (green) and 
SYCP3 (red) co-immunostaining; F) Representative SYCP3 aberrant conformations. Scale bar 
represents 10μm. Data is presented as the mean ± the SEM. (*) represents significant 
differences (P < 0.05) compared to the control. 
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Since SYCP1 may act as a better chromosomal synapsis marker than SYCP3, 
co-immunostaining was performed in order to assess whether SYCP3 and 
SYCP1 co-localized. In the i12F-treated hFSK cells SYCP3 and SYCP1 only co-
localized in the more advanced stages of prophase I (Fig. 6.7E).  
With the aim of improving the culture media towards obtaining better 
meiotic efficiency rates, a different strategy was tested: in order to mimic in 
vivo spermatogenesis, three-day post-transduction i12F-hFSKs were co-
cultured with a Sertoli cell feeder monolayer in GC-M. These Sertoli cells 
were obtained from human patients with obstructive azoospermia who 
underwent testicular biopsies as a part of their clinical infertility treatment. 
Primary Sertoli cell cultures were transduced with a constitutively 
expressed red fluorescent protein (RFP) prior to the initiation of the co-
culture (Riboldi et al., 2012). However, no significant differences at the 
morphological level (Fig. 6.8A) or in meiotic progression (Fig. 6.8B-C) were 
detected 14 days post-transduction compared to the non-co-cultured 
condition. 
6.3.2 PLOIDY ANALYSIS BY FLUORESCENCE IN SITU HYBRIDIZATION 
In order to asses if i12F-treated cells were able to complete meiosis a ploidy 
analysis was performed. Since we expected a very low number of cells to 
finalize meiosis the candidate haploid cell population was enriched 
according to their DNA content.  
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For this purpose, i12F-reprogrammed cells were treated with PI and the 
putative haploid (1N) population was sorted by FACS according to their DNA 
content. FISH with probes for the centromeres of chromosomes 18, X, and Y 
was then performed on the total cell population, the manually selected 
clumps, and the FACS sorted (putative haploid) population (Fig 6.9B). Using 
this method, between 1 and 2% of putative haploid cells from i12F-
transduced cell cultures were isolated, which correlates with the 
percentage of meiotic cells found by SYCP3 staining (Fig 6.9D). The 
percentage of haploid cells in the unsorted i12F-transduced hFSK was 
 
FIG. 6.8 A) Representative pictures of transduced cells (labelled with GFP) co-cultured with 
primary Sertoli cells (labelled with red fluorescent protein; RFP). Asterisk indicates green iGC 
clumps surrounded by red Sertoli cells. Scale bar represents 10μm; B) Percentage of 
aberrant/dotted/elongated staining pattern found in each condition in hFSK cells; C) 
Percentage of dotted/elongated staining pattern found in each condition in hFSK cells; Data 
is presented as the mean ± the SEM. (*) represents significant differences (P < 0.05) 
compared to the control. CC, co-culture with Sertoli cells. 
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1.57%, whereas there was a haploid cell enrichment of up to 4% in the 
sorted cell population (Fig 6.9D). Because the iGC clumps showed higher 
expression of post-meiotic markers, FISH analysis was performed in order 
to elucidate where these haploid cells were located, showing that there 
were 2.56% within the iGC clumps compared to 1.57% in the total cell 
population (Fig. 6.9D). 
These results were validated by repeating the FISH analysis with 
centromeric probes for chromosomes 10 (aqua), 12 (green), and 3 (red) in 
the same nuclei whilst concomitantly determining their ploidy (Fig 6.9C), 
demonstrating haploidy for at least five of the 23 chromosome pairs. 
Since the putative haploid cell population within the i12F-treted cells may 
have been enriched by this DNA-content FACS protocol, the DNA-
methylation status for the H19 and PEG1/MEST loci was also analyzed in 
this putative haploid population by bi-seq. Interestingly, the 1N sorted 
population showed similar patterns to the manually selected clumps, with a 
CpG methylation reduction at the H19 locus (30.74% and 35.13% 
methylation respectively in manually selected clumps vs. 50.49% 
methylation compared to the somatic cell control). There were no 
significant CpG methylation changes at the PEG1/MEST locus (49.03%) 
compared to the somatic control (55.67%) although there was a slight 
decrease compared to CpG methylation in manually selected clumps 
(65.4%; Fig. 6.6A-C).   
All these results (i.e., germ cell marker expression by qRT-PCR and immuno-
phenotyping, meiotic progression by FISH, and methylation levels by bi-seq) 
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FIG. 6.9 Ploidy analyses in hFSKs 14 days post-transduction. A) Illustrative FACS plots of the 
cell cycle in cells stained with propidium iodide (PI); B) Representative FISH results for 
probes against chromosomes 18 (aqua), X (green), and Y (red) in putative 1N sorted cells and 
(C) re-hybridization with probes for chromosomes 10 (aqua), 12 (green), and 3 (red). Scale 
bar represents 10μm. (D) Percentage of haploid cells found in each treatment based on the 
analysis of these three probes in hFSK cells. Data is presented as the mean ± SEM. (*) 
represents significant differences (P < 0.05) compared to the MOCK and MOCK 1N sorted 
controls. 
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support the concept that a more developmentally advanced reprogrammed 
cell population resided in these clumps. Differences in the percentages of 
haploid cells and methylation levels between manually selected clumps and 
DNA-content sorted cells can be explained by the experimental subjectivity 
of the manual clump selection. 
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Finally, a combination of SYCP3 staining and FISH was used to identify the 
intermediate meiotic stages of prophase I from leptotene to pachytene by 
using both SYCP3 staining and ploidy analysis by FISH with centromeric 
probes against chromosomes 18, X, and Y on the same nuclei (Fig. 6.10).  
Before prophase I, diploid cells duplicate their chromosomes (2n, 4c), 
showing normal diploidy by FISH. At leptotene homologous chromosomes 
start to condensate, so centromeric probes for somatic and sexual 
chromosomes are represented by only one mark; they show a diploid (18, 
18, X, Y) karyotype. At this stage, SYCP3 starts to become expressed with a 
punctate conformation along the chromosomes.  
As meiosis advances, chromosome pairing is completed and SYCP3 changes 
its lateral synaptonemal complex position to an axial one, acquiring an 
elongated conformation. Chromosome pairing means that the centromeric 
probes used show different mark combinations as they progress from a 
diploid to haploid status (from 18, 18, X, Y; 18, X, Y; 18, 18, X-Y; to 18, X-Y as 
an overlaying mark), together with the elongated SYCP3 conformation 
which is characteristic of late-zygotene and pachytene. Diplotene is a very 
fast stage, during which the synaptonemal complex disappears.  
At meiosis II, the resulting cells are haploid but have two sister chromatids 
(1n, 2c), which is represented by the 18, X-Y chromosomal probe 
conformation in the absence of SYCP3 staining. When meiosis is completely 
finished and the sister chromatids are segregated, haploid cells (1n, 1c) are 
formed, resulting in a chromosomal probe conformation of either 18, X or 
18, Y. All these possible combinations were found using both these 
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techniques consecutively on the same nuclei (Fig. 6.10). Hence, the 
detection of both SYCP3 staining and ploidy analysis for chromosomes 18, 
X, and Y made it possible to identify iGCs in different stages of meiotic 
progression.  
6.4 GERM CELL-RELATED GENE SCREENING REVEALS OPTIMAL 
COMBINATIONS THAT INDUCE MEIOTIC PROGRESSION AS THE MAIN 
READ-OUT 
With the i12F-reprogramming treatment we obtained a heterogeneous 
population with spermatogonial stem cell-characteristics at several levels 
(transcriptomic, epigenetic, and phenotypic) with the ability to initiate and 
progress through meiosis, acquiring an iGC status. The next objective was to 
find the minimal optimal combination of reprogramming factors which 
 
FIG. 6.10. SYCP3 and FISH detection on the same nuclei. The expected and observed staining 
correlates with the different stages of meiosis. SYCP3 (red), chromosomes 18 (blue probe), X 
(green probe), and Y (red probe). Scale bar represents 10μm. 
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would still produce similar results. To do this, different combinations within 
the pool of 12 factors were screened using the progression of meiotic 
spreads for each condition, as assessed by SYCP3 staining to measure the 
efficiency of germ cell reprogramming. 
Interestingly, several combinations of the twelve factors were able to 
induce meiosis, but most of these combinations gave rise to SYCP3 staining 
pattern aberrations (Fig. 6.11A). Some combinations were chosen as the 
most efficient compared to the i12F-reprogramming treatment, as 
measured by the percentages of elongated zygotene/pachytene SYCP3 
staining (Fig. 6.11B). In all these cases (highlighted with arrows in Fig. 6.11) 
the percentages of zygotene/pachytene were higher than those obtained 
with the i12F-treated cells (1.1; 0.7; 0.6; 0.7; and 0.7% in the total 
population respectively vs. 0.58% in the i12F treated cells). Among these 
combinations, members of the DAZL/VASA genes were always present. 
Interestingly the best results using the latest stages in meiotic progression 
were obtained when different combinations of PRDM1/PRDM14/LIN28A 
were present. None of these combinations alone were able to induce 
endogenous expression of SYCP3 indicating that overexpression of this gene 
was mandatory for reprogramming towards an iGC phenotype.  
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FIG. 6.11 Meiotic progression of different combinations of reprogramming factors 14 days 
post-transduction. A) Percentage of aberrant/punctate/elongated staining pattern and B) 
detailed percentage of punctate/elongated staining pattern found in each condition in hFSK 
cells 14 days post-transfection. Data are presented as mean; C) overexpressed factors 
included in each condition.  
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In order to determine the most effective combination, their ability to 
complete meiosis was interrogated by FISH for chromosomes 18, X, and Y, 
following the same strategy as with the i12F-treated cells. Their phenotypic 
characteristics and morphological changes were also analyzed by further 
immunostaining analysis to detect the expression of AP, PLZF, HIWI, and 
ACROSIN at the protein level on days 14 and 21 post-transduction.  
The percentages of haploid cells within the total population and the 
putative haploid cell-sorted population indicated that although all these 
combinations were able to complete meiosis, resulting in the production of 
haploid cells, there were some combinations which were more effective 
than others compared to the i12F-reprogramming treatment. According to 
the extent of meiotic progression, the conditions A, B, and C showed better 
results than i12F-treated cells (Fig. 6.12A). However, when analyzing the 
percentages of haploid cells in the putative 1N sorted population, in the 
manually selected clumps as well as the total population, the conditions B 
and C seemed to present higher rates of meiosis completion (Fig. 6.12B).  
In conclusion, condition C, with an average of 1.88% meiotic cells (30.85% 
of them showing an elongated SYCP3 pattern; Fig. 6.12A), 12.15% haploid 
cells within the sorted putative 1N cell population, and 5.86% haploid cell 
enrichment in iGC clumps (Fig. 6.12B) appeared to be the combination with 
the most consistent results. The relationship between meiotic progression 
and haploid cell formation, together with immunostaining for germ line-
related markers and morphological changes (Fig. 6.12C) points towards 
condition C as the most efficient combination which includes the fewest 
germ cell-related factors.  
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FIG. 6.12. A) Detail of the percentage of meiotic progression and B) ploidy analysis of hFSK 
cells with the five main combinations 14 days post-transduction; C) Immunostaining analysis 
of reprogrammed fibroblasts at 14 and 21 days post-transduction for the germ line markers 
AP, PLZF, HIWI, and ACR. The periphery of iGC clumps in i12F/16F conditions are highlighted 
by dashed lines. Scale bar represents 10µm. A larger image is provided on the CD-version of 
this thesis. Data are presented as mean ± SEM. 
 
PLZF MERGED
iS
C
P
3
A
B
C
D
E
DAPI
D14 D21
PLZF MERGEDDAPI
HIWI MERGEDDAPI HIWI MERGEDDAPI
iS
C
P
3
A
B
C
D
E
D14 D21
ACRO MERGED
iS
C
P
3
A
B
C
D
E
DAPI
D14
ACRO MERGEDDAPI
D21
AP MERGED
iS
C
P
3
A
B
C
D
E
DAPI
D14
AP MERGEDDAPI
D21
0.55
1.43 1.23 1.23
0.83 0.93 1.04
0.53
1.33
1.03
0.65
0.93 0.65 0.58
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
iSYCP3 A B C D E i12F
Leptotene Zygotene/Pachytene
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
M
O
CK
 1
N
M
O
CK
 T
O
TA
L
iS
YC
P3
 1
N
iS
YC
P3
 T
O
TA
L
A 
1N
A 
TO
TA
L
A 
CL
U
M
PS
B 
1N
B 
TO
TA
L
B 
CL
U
M
PS
C 
1N
C 
TO
TA
L
C 
CL
U
M
PS
D 
1N
D 
TO
TA
L
D 
CL
U
M
PS
E 
1N
E 
TO
TA
L
E 
CL
U
M
PS
i1
2F
 1
N
i1
2F
 T
O
TA
L
i1
2F
 C
LU
M
PS
A DAZL+VASA+STRA8+SYCP3
B DAZL+VASA+BOULE+SYCP3
C PRDM1+PRDM14+LIN28+DAZL+VASA+SYCP3
D PRDM1+PRDM14+LIN28+DAZL+VASA+STRA8+
SYCP3
E PRDM14+LIN28+NANOS3+VASA+SYCP3
A
B
c
6. Results  
- 113 - 
 
6.4.1 SIX FACTOR-TREATED CELLS BEHAVE LIKE TWELVE FACTOR-INDUCED 
GERM CELL LIKE CELLS AT THE TRANSCRIPTOMIC, EPIGENETIC, AND 
MEIOTIC LEVELS 
Because the most effective treatment was the combined ectopic expression 
of PRDM1, PRDM14, LIN28, DAZL, VASA, and SYCP3 (referred to above as 
“combination C”, from hereon in termed “i6F”), the next objective was to 
assess their transcriptomic, epigenetic, and phenotypic status following the 
same strategies as with the i12F-reprogrammed cells. Expression arrays 
showed that i6F reprogrammed cultures clustered into a well-defined 
group, and resulted in a list of 21 significantly up-regulated genes compared 
with MOCK control cells, indicating that a significant switch in their 
expression program had occurred (Fig 6.13A).  
Hierarchical clustering of statistically significant differentially expressed 
genes clustered i12F- and i6F-reprogrammed cultures as well as MOCK 
controls separately (Fig. 6.13B). A different condition (iSYCP3) according to 
the results extrapolated from the screening assay was added as a second 
negative control to exclude any collateral effects of SYCP3 overexpression  
which also clustered into another group (Fig. 6.13B). Similarly, PCA of these 
statistically significant genes clustered the i12F-and i6F-reprogrammed cells 
into defined groups which were different from those of the MOCK controls. 
(Fig. 6.13C).  
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Moreover, similar to i12F-treated cultures, cell transduction with the i6F 
pool and subsequent culture in GC-M induced the formation of iGC clumps 
and the qRT-PCR results showed that these were relatively enriched for the 
expression of PIWIL2, TNP2, and PRM1 on day 21 of culture, but not for 
GFRA1 or ACR. Interestingly, ACR was maximally expressed in the clumps on 
day 14 instead of day 21 (Fig. 6.14). 
 
 
 
FIG. 6.13. A) Hierarchical cluster representation of significantly upregulated genes in i6F 
samples vs. MOCK controls; B) Hierarchical clustering of the differentially expressed genes 
when MOCK, iSYCP3, i12F, and i6F samples were compared; C) Principal component analysis 
(PCA) of statistically significant differentially expressed genes. 
BA
C
MOCK
i12F
i6F
6. Results  
- 115 - 
 
DNA methylation-level analysis by bisulfite sequencing of i6F-
reprogrammed cells showed a decrease in methylation in the promotor 
region of the paternally imprinted gene H19 (33.21%), but a 
hypermethylated status for the maternally imprinted gene PEG1/MEST 
 
FIG. 6.14. Germ line marker expression. A) qRT-PCR expression analysis of the germ line 
markers GFRA1; B) PIWIL2; C) TNP2; D) PRM1; E) ACR on days 7, 14, and 21 post-
transduction; F) Representative scheme for the in vivo expression of the different markers. 
Values are indicated as fold change vs. MOCK controls; (*) = significant vs. MOCK controls; 
(^) = significant vs. total population. (*/^ = P-value < 0.05; **/^^ = P-value < 0.001). 
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(93.49%), indicating that i6F treated cells may have acquired an imprinting 
pattern corresponding to that of mature oocytes (Fig. 6. 15A-C). This 
hypomethylation trend was also reproduced in the pattern obtained for 
H19 methylation within the manually selected clumps (36.75%) and the 
putative haploid population sorted by FACS according to their DNA-content 
(17.89%; Fig. 6.15A, C) Interestingly, PEG1/MEST methylation levels within 
manually selected clumps (59.56%) and putative haploid population 
(52.85%) maintain similar levels to somatic controls (55.57%) while total 
population is highly hypermethylated (93.49%; Fig. 6.15B-C). Also, i6F-
transduced clumps were enriched in 5hmC (Fig. 6.15E) which is consistent 
with both the expression of TET1, TET2, and TET3 (Fig. 6.15D) and also with 
non-significant changes observed in DNMT expression levels when 
compared to controls (Fig. 6.15F).   
Therefore i6F-treated cells showed an epigenetic and transcriptomic profile 
similar to a spermatogonial stem cell and were able to initiate meiosis and 
even form haploid cells, albeit as a heterogeneous population (Fig. 6.16A-
D). Co-localization of SYCP1 with SYCP3 was also checked as previously 
described, confirming synaptic recombination (Fig. 6.16C). Interestingly, the 
iSYCP3 control showed the highest percentage of aberrant SYCP3 
conformation (Fig. 6.16B) probably because of the lack of the proper 
genetic background; moreover, the percentage of haploid cells resulting 
from the i6F-treatment was statistically significant compared to the iSYCP3 
control (Fig. 6.16F). 
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FIG. 6.15. Methylation status of two imprinted genes, H19 (A) and PEG1/MEST (B) by bi-seq 
analysis; C) Percentages of methylation. D) qRT-PCR for DNA-methylation TET or DNMT 
modifications (F); E) 5hmC immunofluorescence for i6F-hFSK treated cells. Data is presented 
as the normalized fold-change mean ± SEM. (*) represents significant differences (P < 0.05) 
compared to the controls; (+) represents significant differences (P < 0.05) between i6F whole 
cultures and i6F clumps. 
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FIG. 6.16. Meiotic progression and ploidy analysis of hFSKs 14 days post-transduction. A) 
Illustrative pictures of the SYCP3 staining pattern in transduced cells. SYCP3 (red); CREST 
(blue); B, D) Percentage of punctate/elongated staining pattern. Data is presented as the 
mean ± SEM. (*) represents significant differences (P < 0.05) between leptotene nuclei and 
controls. (+) represents significant differences (P < 0.05) between zygotene/pachytene nuclei 
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and controls. C) SYCP1 (green) and SYCP3 (red) co-localization. E) Representative FISH results 
for probes against chromosomes 18 (aqua), X (green), and Y (red) in putative 1n-sorted cells; 
F) Percentage of haploid cells found in each treatment based on the analysis of these three 
probes. Data are presented as the mean ± SEM. (*) represents significant differences (P < 
0.05) compared to MOCK 1N-sorted controls. (+) represents significant differences (P < 0.05) 
compared to iSYCP3 1N-sorted controls. Scale bar represents 10μm. 
 
As shown by IF analysis (Fig. 6.12C), the detection of characteristic markers 
for pre- and post-meiotic spermatogenic stages (i.e. AP, PLZF, HIWI, and 
ACR) confirmed that these markers were relatively enriched and were 
mainly localized in the iGC clumps (Fig. 6.12C). As expected, the iSYCP3 
negative control did not show any morphological changes or expressed any 
germ line markers at the transcriptomic (Fig. 6.14A-E) or protein level (Fig. 
6.12C). 
6.5 DIRECT GERM LINE REPROGRAMMING WITH TWELVE AND SIX 
FACTORS CAN BE REPRODUCED IN HUMAN MESENCHYMAL CELLS FROM 
BONE MARROW ORIGIN 
In order to determine the reproducibility of our findings, the same 
experimental design using the overexpression of both i12F and i6F gene 
sets was applied to a different somatic cell type. Commercial primary 
human male mesenchymal cells (hMSCs, 46, XY) from bone marrow origin 
were chosen for these experiments because previous reports indicated that 
these cells can spontaneously express germ line-related genes (Johnson et 
al., 2005). These hMSCs were transduced with the i12F or i6F gene cocktails 
and cultured in the same GC-M as for hFSKs; MOCK and iSYCP3 conditions 
were included as negative controls. Following the same hFSK experimental 
set up, the transcriptomic and phenotypic status of treated cells was 
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FIG. 6.17. Morphological changes in i12F- and i6F-treated hMSCs 14 days after transduction. 
Brightfield and darkfield images showing GFP fluorescence; Scale bar represents 10μm. 
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Bright Field GFP Bright Field GFP
hMSC i6FA B
interrogated, as well as their capacity to reach, enter, and progress through 
meiosis and to form haploid cells. In contrast with previous observations in 
hFSK reprogrammed cells, where most of the cells kept their fibroblastic 
morphology and some iGC clumps appeared, hMSCs were much more 
sensitive to the reprogramming process. During the first week of lentiviral 
transduction most of the cells de-attached from the culture plates and the 
only ones that remained attached had switched their morphology to form 
iGC clumps (Fig. 6.17).  
6.5.1 TRANSCRIPTOMICS OF MESENCHYMAL iGCs  
Fourteen days post-transduction, i12F- and i6F-treated hMSC cultures were 
analyzed by qRT-PCR to check germ line marker expression (Fig. 6.18A-E). 
They were enriched in pre- and post-meiotic markers which changed over 
time, following a germ line-like compatible pattern. Moreover, both i12F 
and i6F-transduced-hMSCs expressed AP, PLZF, PIWIL2/HIWI, and ACR germ 
line markers at the protein level at 14 days post-transduction as shown by 
immunostaining (Fig. 6.18G), indicating that, similar to hFSK-iGCs, these 
reprogrammed cell cultures contained different subpopulations at different 
stages of germ line maturation.  
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FIG. 6.18. Germ line marker expression. A) qRT-PCR expression analysis of the germ line 
markers GFRA1;  B) PIWIL2; C) TNP2; D) PRM1; E) ACR; in the different reprogramming 
conditions on days 7, 14, and 21 post-transduction. Values are indicated as mean fold 
change ± SEM vs. MOCK controls; (*) = significant vs. MOCK controls; (^) = significant vs. 
total population. (*/^ = P-value < 0.05; **/^^^ = P-value < 0.001). (+) represents significant 
differences (^ = P < 0.05) with iSYCP3 condition; F) Representative scheme of the in vivo 
expression of the different markers; G) Immunofluorescence of i12F and i6F-hMSC treated 
cells for different germ line markers. Larger images are provided on the CD-version. 
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Interestingly, the time-expression pattern was different between hMSC- 
and hFSK-iGCs. Later germ cell-markers (i.e. TNP2, PRM1, and ACR) were 
maximally expressed on day 21 in both i12F- and i6F-hFSK-iGCs (Fig. 6.5C-E; 
6.14C-E) whilst these same markers reached maximum expression levels on 
days 7 and 14 in hMSC-iGCs in both i12F and i6F conditions (Fig. 6.18C-E). 
Moreover, manually selected clumps of i12F- and i6F-transduced hFSKs 
presented a similar time-expression pattern to hMSC-iGCs. They showed 
higher expression levels of the later germ cell markers PRM1 and ACR on 
day 14 post-transduction instead of on day 21 (Fig. 6.5D-E; 6.14D-E) 
suggesting that hFSK-iGCs-clusters may be closer to hMSC-iGCs in terms of 
the timing of transcriptomic reprogramming because the reprogrammed 
population is enriched in these clusters. 
6.5.2 MESENCHYMAL iGCs PROGRESS THROUGH MEIOSIS AND FORM 
HAPLOID CELLS 
When hMSCs were subjected to reprogramming, approximately 10.3% and 
18.99% of mesenchymal transduced cells showed a positive SYCP3 staining 
profile for the i12F and i6F conditions respectively (Fig. 6.19A). Similar to 
the results with hFSKs, around 7.99% of i12F- and 16.97% of i6F-transduced 
SYCP3 positive nuclei showed an aberrant staining pattern representing 
protein aggregations (Fig. 6.19B). Thus, only 2.31% of i12F- and 2.02% of 
i6F-transduced hMSCs showed a correct positive SYCP3 staining pattern. 
The percentage of meiotic cells with an elongated SYCP3 pattern in the i12F 
cultures was 31.6% (0.73% of the total population), whereas 68.39% of cells 
(1.58% of the total population) showed a punctate staining pattern.  
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FIG. 6. 19 Meiotic progression and ploidy analysis 14 days post-transduction in 
reprogrammed hMSCs. A) Illustrative pictures of the SYCP3 staining pattern in transduced 
cells. SCP3 staining pattern (red) is co-localized with centromeres stained with CREST (blue); 
B) Percentage of aberrant/punctate/elongated staining pattern, and C) detailed percentage 
of punctate/elongated staining pattern found in each condition in hFSK cells. Data is 
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presented as the mean ± SEM. (*) represents significant differences (P < 0.05) between 
leptotene nuclei and controls. (+) represents significant differences (P < 0.05) between 
zygotene/pachytene nuclei and controls; C) Illustrative FACS plots of the cell cycle in cells 
stained with PI; D) Representative FISH results for probes against chromosomes 18 (aqua), X 
(green), and Y (red) in putative 1N sorted cells; E) Percentage of haploid cells found in each 
treatment based on the analysis of these three probes in hFSK cells. Data is presented as the 
mean ± SEM. (*) represents significant differences (P < 0.05) compared with the MOCK 1N 
sorted controls. (+) represents a significant difference (P < 0.05) compared with the iSCP3 1n 
sorted controls. Scale bar represents 10μm. 
 
In contrast, the percentage of meiotic cells with an elongated SYCP3 
pattern in the i6F mesenchymal cultures was 56.93% (1.15% of the total 
population), and 43.07% of cells (0.87% of the total population) showed a 
punctate staining pattern (Fig. 6.19C). Additionally, only around 1% within 
the unsorted populations in the i12F reprogrammed hMSCs were haploid, 
whereas the percentage rose to 1.11% in the i6F condition. Furthermore, 
we observed an enrichment of 17.87% in i12F and 20% in i6F cultures of 
haploid cells within the putative 1N sorted cell population (Fig. 6.19D-E). 
In order to improve hMSC culture conditions in terms of survival and 
meiotic progression efficiency, the same co-culture system strategy as for 
i12F-hFSK cultures, using RFP-Sertoli cells as feeders, was attempted. 
However, no significant differences were observed in the morphology of 
i12F-hMSC treated cells (Fig. 20A) or in the percentages of the meiotic cells, 
in any of the analyzed stages for SYCP3: leptotene, zygotene/pachytene, 
and aberrant conformations (Fig. 20B-C). 
 
6. Results  
- 125 - 
 
 
FIG. 6.20. A) Representative pictures of i12F-hMSC transduced cells (labeled with GFP) co-
cultured with Sertoli primary cells (labeled with RFP). Asterisks indicate green iGC clumps 
surrounded by red Sertoli cells. Scale bar represents 10μm; B) Percentage of 
aberrant/punctate/elongated staining pattern, and C) detailed percentage of 
punctate/elongated staining pattern found in each condition in hFSK cells. Data is presented 
as the mean ± SEM. 
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6.6 XENOTRANSPLANTATION DEMONSTRATES THAT iGCs ARE ABLE TO 
COLONIZE THE GERMINAL EPITHELIUM OF SEMINIFEROUS TUBULES  
Based on the previously described results indicating spontaneous meiotic 
induction and a suitable germ-cell like expression profile, we hypothesized 
that part of the reprogrammed iGCs would have a spermatogonia-like 
phenotype. Nevertheless, this is an in vitro model that needs a functional 
proof of concept to demonstrate its in vivo functionality. A key feature of 
germ cells is that they can contribute to the spermatogenesis of sterilized 
mice. As iGCs show spermatogonia-like features, they are also expected to 
be able to colonize the SSC physiological niche, i.e. the basal lamina of the 
seminiferous ducts (Brinster and Zimmermann, 1994). Therefore, a 
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xenograft assay was performed with the iGCs to test their functionality in 
vivo. This assay requires the use of immunosuppressed mice, such as the 
nude mouse strain, which must be chemically sterilized using busulfan prior 
to transplant (Ogawa et al., 1997) so that xenotransplanted cells are 
presented with an empty niche without the presence of competing cells 
such as the host’s own spermatogonial cells (see Fig. 5.3 in Methods for a 
general overview of the procedure).  
The busulfan dose-response effect on mouse spermatogenesis 12 weeks 
post-injection, the length of the complete experimental design, is shown in 
(Fig. 6.21). Different busulfan doses were tested in terms of survival and 
sterilization 12 weeks post-injection in this mouse strain (Fig. 6.21A). 
 
FIG. 6.21. The effects of busulfan dosage. A) dosage-mortality curve; B) histological effects of 
busulfan 12 weeks post-injection. Asterisks indicate seminiferous tubules with no evidence 
of spermatogenesis. 
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Busulfan showed a sterilizing effect on spermatogenesis, although 12 weeks 
after intraperitoneal injection (IP) the mice started to recover some 
spermatogenic capacity (Fig. 6.21B). As expected, the highest levels of 
spermatogenesis-recovery correlated with the lowest levels of busulfan 
dosage and vice versa: the highest levels of busulfan caused the highest 
rates of mortality (Fig. 6.21A. 
Therefore, based on the literature (Wang et al., 2010) and our preliminary 
data, a range of 30-35 mg/Kg of busulfan was used to chemically sterilize 
the animals. All the male mice used were sterilized by an IP injection of 30-
35mg/kg busulfan dissolved in DMSO at 4-6 weeks of age prior to 
xenotransplant (details shown in Table 6.1). Because this mouse strain is 
immunodeficient, no immuno-cross-reactivity due to the human origin of 
the transplanted iGCs was expected after the xenotransplantation. After 
four weeks, when endogenous spermatogenesis is suppressed, the mice 
were ready for xenotransplant. 
For this experiment, hFSKs were used as primary somatic cells and were 
transfected with MOCK, iSYCP3, i12F, and i6F lentiviral supernatants. 
Transduced hFSK cells were cultured in GC-M and harvested 14 days post-
infection, so as to correspond with the fourth week after the IP busulfan 
dose. Cells were harvested and incubated with CellVue® Claret Far Red 
Fluorescent Cell Linker Kit to verify the origin of the xenotransplanted cells 
in future analyses using two methods: V5-peptide (included in the lentiviral 
backbone; Appendix 1) immunoreactivity; and fluorescent emission (at ƛMAX 
Exc = 655 nm; ƛMAX Em= 675 nm) from CellVue® Claret Far Red Fluorescent Cell 
Linker (henceforth CellVue). 
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Table 6.1 Detailed data on the mice used. 
MICE PER 
CONDITION 
Busulfan dosage 
(mg/g) 
Final body 
weight (g) 
Median testis 
weight (mg) 
SD testis 
weight (mg) 
MOCK 1 40 31.8 33.2 0.50 
2 35 33.2 25.9 3.74 
3 30 37.2 * * 
4 30 37.7 82.2 10.18 
5 30 38.6 13.05 12.51 
Number of 
animals (N) 
5     
iSYCP3 1 40 31.8 34.2 0.50 
2 30 35.8 * * 
3 30 -- -- -- 
4 30 34.4 97.85 23.40 
5 35 37.2 81.6 0.56 
Number of 
animals (N) 
4     
i12F 1 40 40.8 43.6 10.11 
2 40 -- -- -- 
3 35 36.1 31.35 0.21 
4 35 38.2 69.8 12.44 
5 35 37.3 51.75 7.42 
6 35 37.7 46.8 1.69 
Number of 
animals (N) 
5     
i6F 1 40 40.8 57.9 10.11 
2 40 -- -- -- 
3 35 32.8 29.9 2.30 
4 35 35.5 36.5 0.00 
5 35 32.9 28.85 0.85 
6 30 35.4 54.85 5.05 
Number of 
animals (N) 
5     
CONTROL 1 30 35.3 32.9 2.75 
2 30 35.4 36.8 2.75 
Number of 
animals (N) 
2     
-- death after surgery 
* data not-collected 
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Once the cell solution was prepared, the xenotransplantation surgery was 
performed (details are provided in table 6.2) so that the in vitro-derived 
iGCs could be injected into the inner part (up to 70%) of the seminiferous 
tubules. 
Table 6.2 Number of injected testes. 
CONDITION Number of 
animals (N) 
Total testes 
injected (n) 
Negative 
controls 
MOCK 5 5 5 
iSYCP3 4 4 4 
i12F 5 6 4 
i6F 5 6 4 
CONTROL 2 0 2 
 
Two months after xenotransplantation, mice were sacrificed and the testes 
were removed to analyze whether the injected iGCs were able to colonize 
the SSC niche. The weight of the testes was similar between the different 
busulfan dosages (Fig. 6.22A-B) in MOCK, iSYCP3, i12F, and i6F treatments 
(Fig. 6.22C-D). 
Moreover, the relative normalized ratio of testis weight vs. their respective 
body weight compared to control non-sterilized mice was analyzed. In the 
case of mice transplanted with the negative control samples (i.e., MOCK, 
iSYCP3) the relative weight of the testes were lower than the non-sterilized 
controls, suggesting that the transplanted cells were not able to colonize 
the empty tubules. On the contrary, the ratios of the samples from mice 
transplanted with i12F- and i6F-iGCs were higher than the negative controls 
and, in i6F-iGCs transplanted samples, higher than the non-sterilized 
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FIG. 6. 22. Relationship between testicular weight (A) and normalized testicular weight (B) 
with busulfan dosage. Relationship between testicular weight (C) and normalized testicular 
weight (D) with busulfan dosage disaggregated by conditions. 
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controls (Fig. 6.23A). This ratio, together with the GFP emission detected 
inside the seminiferous tubules immediately before their analysis (Fig. 
6.23B) indicated iGC-colonization for both i12F- and i6F-iGCs. 
Xenotransplanted testes were divided into two parts: one was used for 
immuno-phenotyping by flow cytometry to confirm the presence of the 
xenotransplanted iGCs, and the other was immunohistologically analyzed to 
assess the localization of colonizing xenotransplanted iGCs.  
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FIG. 6.23. Average of normalized testis weight/body weight (mg/g) ratio compared to control 
samples (A); Illustrative picture of how i12F treatment shows GFP expression inside the 
tubules (B) White arrows indicate the highest intensity spots for GFP emission, which 
correlates with GFP emission from iGCs attached to the inner part of the tubules. 
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6.6.1 FLOW CYTOMETY RESULTS 
The presence of cells of human origin in the xenotransplanted testes was 
analyzed by flow cytometry using three different markers: an antibody 
against human VASA which is overexpressed in both the i12F- and i6F-iGCs; 
an antibody against V5-peptide in the C-terminal of the transgenes, which is 
included in the lentiviral backbone (Appendix 1); and CellVue far red 
emission resulting from iGC linkage before transplantation. Two well-
differentiated populations of cells double-positive for vasa and CellVue 
were observed only in the transplanted i12F- and i6F-iGCs (Fig. 6.24D-E).  
Therefore, based on the presence of cells positive for V5, VASA, and CellVue 
within the disaggregated tubules in some of the i6F- (5 out of 6) and i12F-
iGCs (4 out of 6) transplanted testis, we concluded that human-origin cells 
were located inside the testis two months after transplantation.  
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FIG. 6. 24. Illustrative flow cytometry histogram plots for the presence of V5 (FITC-A), VASA 
(PE-Texas Red-A), and CellVue (APC-A) positive cells n the transplanted testes in the different 
conditions: MOCK (B), iSYCP3 (C), i12F (D), and i6F (E) transduced hFSKs, and in a busulfan-
treated testis as a negative control (A). Cells positive for CellVue are indicated in red in the 
VASA-positive histogram and Vasa positive cells are indicated in pink in the CellVue-positive 
histogram. 
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Interestingly, a few cells positive for the analyzed markers were also 
observed in MOCK and iSYCP3 transplanted testes (Fig. 6.24B-C), indicating 
that some human-origin cells were also still present in these tissues. In 
these cases, CellVue-positive cells were not positive for VASA. Since CellVue 
is a membrane marker, these CellVue positive cells may have been Sertoli 
cells which had phagocytized non-attached transplanted human cells. 
Nevertheless, this technique only allows cells of human-origin to be 
detected in the testis, so the next step was to detect the presence of these 
cells in the inner part of the seminiferous tubules. 
6.6.2 IMMUNOHISTOLOGICAL ANALYSIS 
Frozen sections were stained for VASA and NuMA antigen detection 
analysis, whilst also searching for co-localization of these markers with a 
CellVue signal. Even though many tubules which had spontaneously 
recovered spermatogenesis were observed in almost every analyzed testis, 
triple positive cells were detected in the basal layer of some germ cell-
depleted tubules only in i6F- and i12F-iGC transplanted testis, indicating 
both their human origin and germ cell identity (Fig. 6.25C).  
Interestingly, VASA was detected in the nucleus, co-localizing with NuMA, 
which correlates with previous reports indicating a nuclear rather than 
cytoplasmic VASA location for human germ cells located in the 16-week old 
human fetal testis (Anderson et al., 2007); this may indicate the possible 
immature state of these transplanted colonizing cells. 
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FIG. 6. 25. Percentage of tubules containing NuMA+/VASA+ cells (A) and efficiency of 
colonization per 105 injected cells (B) in both i12F and i6F transplanted testis. Data is 
presented as the mean ± SEM. Illustrative pictures showing NuMA+/VASA/CellVue+ triple 
positive cells in the basal layer of germ cell depleted seminiferous tubules in both i12F and 
i6F transplanted testis (C). Illustrative pictures of the mouse and human testis tissue as 
negative and positive controls, respectively, for the specificity of the NuMA antibody to mark 
the nucleus of human cells (D). Scale bar represents 10μm.  
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Although there was a high variability in the number of triple positive cells 
observed in each transplanted testis, tubule cross-sections indicated an 
average of around 1.45% triple positive cells located in the basal layer of 
seminiferous tubules for i12F transplanted testis, and 2.1% in i6F 
transplanted testes (Fig. 6.25A) with efficiencies of around 0.2 colonizing 
cells per 105 injected cells for i12F- and 0.3 colonizing cells per 105 injected 
cells for i6F-iGCs (Fig. 6.25B). These percentages showed no statistically 
significant differences between i12F- and i6F-iGCs, suggesting that both 
combinations of factors had a similar capacity to induce cells to colonize the 
SSC niche, demonstrating behavior typical of SSCs.  
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To date several studies have shown that human germ cells can be 
spontaneously derived in vitro either from hESCs (Clark et al., 2004, Kee et 
al., 2009) or hiPSCs (Eguizabal et al., 2011, Medrano et al., 2011, Panula et 
al., 2011, Park et al., 2009). Many groups have also been inspired by 
successes in reprogramming terminally differentiated cells into a 
pluripotent state using defined factors (Takahashi and Yamanaka, 2006), 
thus increasing research aiming to directly reprogram adult cell types into 
other terminally differentiated lineages, bypassing the undifferentiated 
state. Examples in this field include the direct conversion of fibroblasts into 
neurons (Kim et al., 2011, Vierbuchen et al., 2010), blood precursors (Szabo 
et al., 2010), cardiomyocytes and even Sertoli cells (Buganim et al., 2012). 
Based on this background, the possibility of directly reprogramming human 
somatic cells into germ cell-like cells was investigated and the findings are 
presented in this thesis. Following a similar strategy to iPSC reprogramming, 
human primary cells were transduced in order to overexpress different 
germ-line related factors. Germ cells are characterized by a set of specific 
features, the most important of which are their ability to reduce their 
chromosomal charge during meiosis and to erase epigenetic modifications 
so as to subsequently re-establish their sex-specific epigenetic profile 
during germ line epigenetic reprogramming. The results presented 
demonstrate that the overexpression of these germ cell related genes 
induced the formation of a heterogeneous cell population with 
spermatogonial features which is able to progress through and complete 
meiosis, giving rise to a very small fraction of haploid cells. Moreover, some 
of these cells show spermatogonial stem cell-like characteristics, and are 
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able to colonize murine seminiferous ducts in human-to-mouse 
xenotransplant experiments 
- The transcriptomic and epigenomic characteristics of the in vitro human 
induced germ cell-like cell model 
When two non-related types of human primary somatic cell cultures were 
transduced with a combination of 12 germ-line related factors a 
morphological change that resembled a mesenchymal-to-epithelial 
transition was observed which had a similar morphology to that previously 
described in some reports focused on deriving SSCs (Conrad et al., 2008). 
Interestingly, this morphology was only maintained when a specifically 
designed culture media was used, i.e. GC-M (Fig. 6.2) supplemented with 
different factors (i.e. GDNF, bFGF, LIF, SCF, and RA) which are thought to 
promote putative germ cell survival (Guan et al., 2009, Kanatsu-Shinohara 
et al., 2003, Oatley and Brinster, 2006, Kanatsu-Shinohara et al., 2007, 
Kanatsu-Shinohara et al., 2005). Additionally, similar to its use for the 
derivation and maintenance of hESCs (Galan and Simon, 2012) and hiPSCs 
(Takahashi and Yamanaka, 2006, Park et al., 2009 ) GC-M was also 
supplemented with 20% KSR. The use of KSR has recently been described 
for culturing both mouse (Aoshima et al., 2013) and human origin (Riboldi 
et al., 2012) male germ cells, and moreover, it has also been successfully 
used for in vitro testicular organ culture without cytokines (Sato et al., 
2011).  Together this work shows how the use of KSR promotes the 
maintenance of stem cell status and putative SSC survival, supporting its 
use and the results obtained with the specifically designed GC-M. 
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Subsequent expression analysis of these treated cultures showed a 
significant increase in the expression of several pre- and post-meiotic 
markers compared with untreated controls (Fig. 6.4; 6.14; 6.18A-E), 
suggesting the presence of a heterogeneous germ cell-like population at 
different maturation stages. Even though both types of primary cultures 
responded in a similar way, maximum expression of the post-meiotic 
markers TNP2, PRM1 and ACR in hMSCs was reached during the first week 
post-transduction (Fig. 6.18C-E) and not during the third week as occurred 
with hFSK cells (Fig. 6.4C-E), indicating a difference in the timing of the 
reprogramming process between these two somatic cell types. 
Since one of the key features of germ cells is the epigenetic reprogramming 
that they undergo during in vivo development, the methylation levels of the 
imprinted loci promoters widely used in previous reports is a good indicator 
of the epigenetic status of the in vitro derived germ cells (Eguizabal et al., 
2011, Medrano et al., 2011, Panula et al., 2011, Park et al., 2009). Thus, the 
methylation status of the DMRs, of the paternally methylated H19 and of 
the maternally methylated PEG1/MEST loci was determined in the 
reprogrammed cells (Fig. 6.5A-C; 6.15A-C). As expected,  approximately 
50% of CpGs were methylated in MOCK controls in somatic lineages, 
however only the paternally methylated H19 gene showed a hypo-
methylated status in both i12F and i6F-treated cultures, which was 
reconfirmed by analyzing manually selected clumps and putative 1N sorted 
cells (Fig. 6.5A,C; 6.15A,C). However, with the exception of the hyper-
methylation observed in the i6F total population, no substantial changes 
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were observed in the methylation pattern of the maternally methylated 
PEG1/MEST gene (Fig. 6.6B-C; 6.15B-C). 
All the methylation assays performed here are based on the bisulfite-
conversion technique that cannot distinguish between 5mC and 5hmC. 
Immunofluorescence results showed that iGC clumps were enriched in 
5hmC (Fig. 6.5E; 6.15E) and gene expression results showed increased 
expression of the TET1, TET2, and TET3 enzymes (Fig. 6.5D; 6.15D) involved 
in the oxidation pathway of 5mC to 5hmC. Given these results, several 
explanations could be considered. Firstly, it is possible that the methylation 
status of these imprinted genes was biased, and so was overestimated, and 
that the hyper-methylation found in PEG1/MEST actually correlates with 
5hmC enrichment in 5hmC before methylation erasure. Secondly, the clear 
upregulation in the expression of the TET-mediated demethylation pathway 
members TET1, TET2, and TET3 in reprogrammed cells, and especially in the 
case of the i12F and i6F clumps, together with any substantial differences in 
DNA methyl-transferase DNMT1, DNMT3A and DNMT3B expression (Fig. 
6.5F; 6.15F), must be taken in consideration.  
Taking all these results together, it seems that the TET-mediated de-
methylation pathway is active in both i12F and i6F reprogrammed cells, 
inducing a decrease in the methylation pattern of the paternally methylated 
DMRs such as H19, but failing in the case of maternally methylated 
PEG1/MEST. This situation could reflect the fact that most of the 
reprogrammed cells in these cultures were probably at an early maturation 
stage, when methylation erasure is just starting rather than at a stage when 
a sex-specific imprinting pattern is being re-acquired, although it may 
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indicate a failure in the reacquisition of the methylation pattern in these 
cells. Consequently, these observations implicate that reprogrammed cells 
are unable to correctly recapitulate epigenetic reprogramming due to their 
inability to properly erase their methylation marks and the lack of 
expression of the de novo DNA methyltransferases DNMT3A and DNMT3B 
implicated in the reacquisition of the sex-specific methylation marks in 
germ cells in vivo. Therefore further research will be required to find key 
factors that can confer this ability to the iGCs generated in this model. 
- In vitro induced germ cell-like cells show characteristic features of 
spermatogonia-like cells at different maturation stages 
In contrast to somatic tissues the germ line is composed of cells which 
transmit genetic information to the offspring, and so they are characterized 
by a set of specific features, among which the most important is their ability 
to reduce their chromosomal charge during meiosis. When the meiotic 
status of the i12F and i6F-iGCs was studied, a subpopulation of these i12F 
and i6F-iGCs was found to be involved in different stages of Prophase I after 
exposure to RA (Fig. 6.6; 6.16A-D; 6.19A-C). Indeed, most of these meiotic 
cells were able to complete meiosis and form haploid cells (Fig. 6.9; 6.16E-F; 
6.19D-E). According to these results, only 1-2% of haploid cells were 
obtained from reprogrammed cultures. However, after cell sorting for the 
putative 1N population within these reprogrammed cell cultures, the purity 
was increased up to 20% in the case of the i6F-hMSC-iGCs (Fig. 6.19E). The 
higher rate of haploid cell formation in hMSC-iGCs may be explained by the 
different differentiation status of the starting hFSK and hMSC cell cultures 
(Kassem, 2004, Solter, 2006, Takahashi and Yamanaka, 2006). Overall, these 
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data suggest that reprogrammed cell cultures are constituted by a 
heterogeneous population of germ cells in different stages of maturation 
and some of these iGCs may correlate with a spermatogonia-like stage 
because they are capable of going through meiosis after exposure to RA.  
Based on the meiotic progression (Fig. 6.6; 6.16A-D; 6.19A-C) and the 
relative enrichment of post-meiotic marker expression in the iGC clumps 
(Fig. 6.6; 6.12C; 6.18C), the localization of haploid cells within the i12F- and 
i6F-reprogrammed cultures was interrogated. For this purpose, FISH 
analysis was performed on the manually selected iGC clumps, showing that 
haploid cells were relatively enriched compared to the total cell population. 
However, in contrast to the significant enrichment of haploid cells that was 
found when the putative 1N sorted cell populations were analyzed, this 
enrichment was not-significant compared to the percentage of haploid cells 
within the total population of reprogrammed cells (Fig. 6.9D; 6.16F; 6.19F). 
Similarly, results from gDNA bi-seq assays indicated that manually selected 
clumps behave similarly (but not exactly) to the putatively iGC-enriched 1N 
sorted cells (Fig. 6.5A-C; 6.15A-C). This can be explained by contamination 
with cells from outside the iGC clumps at the time the clumps were 
manually collected and therefore it is impossible to specifically pinpoint 
whether these haploid cells are located within iGC clumps or if they are 
homogeneously distributed throughout reprogrammed cell cultures. 
Finally, since iGCs appeared to have a SSC-like phenotype, their ability to 
colonize the spermatogenic niche in vivo was tested. During male germ cell 
maturation only the SSCs, which are spermatogonial precursors, are able to 
colonize and repopulate the SSC niche (i.e. the seminiferous tubules) when 
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transplanted into the germ cell-depleted spermatogenic niche of chemically 
sterilized mice (Geens et al., 2008, Brinster and Avarbock, 1994, Brinster 
and Zimmermann, 1994). Although the efficiency was very poor, i12F- and 
i6F-iGCs were able to colonize this in vivo murine niche in a human-to-mice 
xenotransplant (Fig. 6.25A-C); this low colonization efficiency might be 
explained by the heterogeneous nature of the transplanted cells, which 
were at different stages of maturation due to low reprogramming 
efficiency. However, because of the limitation in cell numbers, the 
xenotransplantation assay was performed with cells from whole i12F- and 
i6F-iGC cultures; similar to previous publications (Geens et al., 2008, 
Goossens et al., 2013, Hermann et al., 2007, Hermann et al., 2012) it can be 
hypothesized that SSC purification prior to xenotransplant might have 
improved colonization efficiency, and so research is this area should be 
continued.. In addition, future research should also address if i12F- and i6F-
iGC xenotransplantation into the spermatogenic niche can help them to 
acquire the correct epigenetic status, a step which they are unable to 
overcome in in vitro culture conditions.  
It should be noted that mouse-to-mouse transplantation assays not only 
evaluate the colonization abilities of transplanted cells but also their 
repopulation capacity, as measured by the formation of spermatozoa and 
thus the recovery of fertility. However, in the case of human-to-mouse 
xenotransplantation human SSCs are able to colonize, but not repopulate, 
the seminiferous tubules due to inter-species barriers (Schlatt et al., 2002, 
Hermann et al., 2007, Hermann et al., 2012). In fact, one recent paper 
attempts to analyze the functionality of human PSC-derived germ cells in 
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vivo in mice (Durruthy Durruthy et al., 2014). Similar to the findings in the 
iGC model presented here, the authors describe seminiferous tubule 
colonization but no repopulation. In summary, these results indicate that 
some iGCs also behave like SSC-like cells demonstrating an ability to 
colonize mouse seminiferous ducts. 
- Proposed model for germ line reprogramming and induction of meiotic 
progression 
Screening the 12 germ cell-related factor pool showed that the combination 
which was the most effective at giving rise to meiotic-like germ cells 
included the two transcription factors PRDM1 and PRDM14 together with 
the RNA-binding proteins LIN28A, DAZL, VASA, and the structural protein 
from the synaptonemal complex SYCP3 (Fig. 6.11; 6.12).  
Among these factors, PRDM1, PRDM14, and LIN28A are implicated in the 
core network that regulates escape from the somatic cell fate during germ 
line specification in E7.5 mouse embryos (Saitou et al., 2002). Classically 
Prdm1 is considered to be the only germ cell specification master regulator, 
although recently the role of Prdm14 has also been shown to be more 
important (Kurimoto et al., 2008). In mouse, overexpression of the Prdm1, 
Prdm14, and Tfap2C genes that act downstream of BMP4, together 
initiating germ cell specification pathway signaling, triggers EpiSCs to form 
germ cells capable of producing live offspring (Nakaki et al., 2013); in this 
same work, the authors also showed that Prdm14 is a prerequisite to 
obtaining this phenotype, which is mainly due to its role in switching on the 
germ line program. 
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Moreover, DAZL and VASA have also been described as essential for germ 
cell survival and meiotic progression in vivo (Tanaka et al., 2000, Ruggiu et 
al., 1997, Gill et al., 2011, Castrillon et al., 2000b) and in vitro (Medrano et 
al., 2011, Kee et al., 2009, Panula et al., 2011). Furthermore, the essential 
role of VASA in priming hiPSCs to form germ cells in vivo has also recently 
been shown by transplanting OSKMV-reprogrammed iPSCs into the testis of 
chemically sterilized mice (Durruthy Durruthy et al., 2014). 
It was, however, surprising to find that SYCP3 is essential for the initiation 
of meiosis in the iGCs (Fig. 6.11). Perhaps this can be explained because 
none of the factors used in this study are implicated in activating 
synaptonemal complex proteins. Even though there was no endogenous 
activation of SYCP3 in response to overexpression of the i12F- and i6F-
reprogramming pools, these factors were essential for correct 
synaptonemal complex assembly because most cells subjected to SYCP3 
overexpression (alone or in combination with factors other than the ones 
included in the i6F- or i12F- cocktail) formed a high percentage of aberrant 
synaptonemal patterns. 
The RNA-binding protein LIN28A mediates Let-7 miRNA repression which in 
turn upregulates the reprogramming transcription factor PRDM1 and 
prevents PRDM1 mRNA degradation. The core transcription factors PRDM1 
and PRDM14 bind to their specific genomic targets to switch on the germ 
line transcription program, in so generating a pool of germ line-related 
mRNA transcripts. Hence, based on the literature and on the results 
presented here, the meiotic phenotype which is observed might be 
explained by the regulatory functions that the RNA-binding proteins DAZL 
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and VASA have on this transcript pool. These regulatory functions are also 
likely to control entry of germ-like reprogrammed cells into meiosis and the 
orchestration of meiotic prophase I (likely in conjunction with other 
downstream translated proteins) by organizing the structural protein SYCP3 
in the synaptonemal complex, thus promoting organization of the proper 
chromosome conformation required for a meiotic-like phenotype (Fig. 7.1). 
- Germ line development and the pluripotency barrier  
Germ line development is associated with pluripotency maintenance: only 
germ cells, classically considered as unipotent, can recover pluripotency by 
 
FIG. 7.1. Proposed model for the germ line reprogramming and induction of meiotic 
progression. The transcription factors PRDM1 and PRDM14 reinforced by LIN28A enhance 
the expression of germ cell-related transcripts (1). The RNA-binding proteins VASA and DAZL 
act over this pool of transcripts (2) allowing the structural protein SCYP3 to mediate the 
proper chromosome conformation required for a meiotic-like phenotype (3). 
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fertilization; hence, germ cells express pluripotency factors in order to 
control a non-restrictive epigenome. In other words, there is a pluripotency 
cycle, which is naïve in early epiblast and latent in germ cells, which is 
maintained only by a pluripotency network common to these cells. 
Therefore the moment of PGC specification in mammals is critical. Firstly, 
since PGC precursors belong to cell population with a somatic fate, they 
must ‘escape’ from that fate and acquire a gametic fate. Secondly, these 
processes are crucial for future oocytes and sperm to be able to generate a 
complete embryo; interestingly, pluripotency markers seem to be lost after 
sexual determination, although SSCs still express some of them (Leitch and 
Smith, 2013).  
It is worth noting that all of our knowledge about germ cell specification is 
based on developmental mouse models. According to this data, BMP signal 
induction is triggered by the extra-embryonic ectoderm (Ohinata et al., 
2005). The exposure of epiblast cells to this signal specifies them to acquire 
a germ cell fate which means that they can overcome the epigenetic 
barriers to reach a naïve pluripotent state. However, although embryonic 
pre-implantation development, including gastrulation, shares some 
characteristics between mouse and humans there are differences that must 
be considered (Fig. 7.2). For example, at week two of human pregnancy, 
(the equivalent of murine E5.5-E6.5) most of the epiblastic cells are 
separated from trophoblast by the amniotic cavity, meaning that there is no 
structure equivalent to me murine ExE (Chuva de Sousa Lopes and 
Mummer, 2009); while in mouse embryos, proximal epiblastic cells remain 
in direct contact with the ExE, from which they receive the BMP signaling 
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FIG. 7.2. Comparison of human and mouse embryonic development. A) Human blastocyst at 
day 13. 1. Secondary yolk sac; 2. Exocoelomic cyst; 3. Amniotic cavity; 4. Extra-embryonic 
coelom; 5. Epiblast; 6. Connecting stalk; 7. Hypoblast; 8. Primary villi; 9. Trophoblastic 
lacunae; 10. Extraembryonic somatic mesoderm; 11. Extraembryonic splanchnic mesoderm; 
B) Midline section of the discoid embryo at day 16. 1. Ectoderm; 2. Primitive pit; 3. 
Endoderm; 4. Neurenteric canal; 5. Notochord; 6. Intra-embryonic mesoderm; 7. Amniotic 
cavity; 8. Yolk sac; 9. Allantois; 10. Cloacal membrane; 11. Prechordal plate; C) Human 
embryo (without extra-embryonic tissues) at day 18. 1. Ectoderm; 2. Mesoderm; 3. 
Notochord; 4. Endoderm; 5. Prechordal plate; 6. Primitive node; 7. Allantois; 8. Primitive 
streak; 9. Caudal mesoderm; 10. Amnion; 11. Yolk sac cavity; D) Mouse egg cylinder at E6.0; 
E) Mouse egg cylinder at E6.5. Onset of gastrulation; F) Mouse embryo at E7.5. Full length 
primitive streak. Images modified from www.embryo.chronolab.com/ and 
www.mun.ca/biology/desmid/brian/BIOL3530. 
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(Saitou and Yamaji, 2010). The way these morphological differences affect 
to human PGC specification and, concomitantly, the cycle of pluripotency, 
are still not understood in great detail and therefore more in depth studies 
should be performed (Saitou and Yamaji, 2010) since the most critical step 
in germ cell development seems to be the epigenetic barriers and the 
underlying reprogramming processes which are initiated during these 
periods of early development (Ng and Surani, 2011). 
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As previously mentioned, germ like-cell derivation from PSCs has already 
been described (Clark et al., 2004, Kee et al., 2009, Eguizabal et al., 2011, 
Medrano et al., 2011, Panula et al., 2011, Park et al., 2009) however, PGCs 
isolated from mice just after their specification can also give rise to another 
type of PSC line, embryonic germ cells (Ng and Surani, 2011), demonstrating 
the reversibility and elasticity of the pluripotent cycle. Interestingly, there 
are other differences between human and mouse related to the core of 
pluripotency and how it is involved in the derivation of ESC lines. Mouse 
ESCs are derived from the inner cell mass of pre-implantation embryos. 
However, EpiSCs are another type of PSC which can be derived from post-
implantation epiblastic cells and which are able to differentiate into several 
cell lineages and form teratomas (although they do not contribute to 
chimera formation as efficiently as ESCs). Under specific culture conditions 
ESCs show features similar to pre-implantation epiblastic cells which can 
then be induced into expressing post-implantation-like characteristics by 
changing the culture conditions, thus becoming EpiSC-like; moreover, 
EpiSCs can be derived in vitro into PGCs, demonstrating the relevance of a 
primed fate towards pluripotency. Interestingly, hESC are derived in a 
similar way from human blastocysts, but there are studies that suggest that 
hESCs are closer to mouse EpiSCs than to mESCs (Tesar et al., 2007, Sato et 
al., 2011).  
This plasticity related to pluripotency networks in PSCs, the strong 
correlation between germ line specification and pluripotency maintenance 
(Aoshima et al., 2013), and paradoxically, the fact that in vivo PGCs must 
overcome epigenetic pluripotency barriers may explain why, to date, 
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gamete derivation in vitro has only been described from a PSC origin.  
In the model of direct conversion of human somatic cells into iGCs 
described in this thesis, initiation of this pluripotency cycle may be induced 
and maintained by the earlier markers (PRDM1, PRDM14, and LIN28A) 
included in the i12F- and i6F-reprogramming cocktail. These three genes 
are described to act in an ‘initiating’ PGC specification network (Fig. 1.4) 
that leads PGCs into a naïve pluripotency state (Nakaki et al., 2013, 
Kurimoto et al., 2008). The overexpression of these early markers seems to 
be necessary for treated cells to achieve a ‘near-to-pluripontency’ state. 
Since iGCs are directly reprogrammed from somatic cells, a proper 
pluripotency state is not reached, as demonstrated by experiments in which 
i12F-iGCs do not express the classical pluripotency markers (i.e. OCT4, 
SOX2) and cannot form teratomas when directly injected in the testes of 
SCID male mice (data not shown).  
In fact, it has been reported that genetic manipulation of PRDM1 
expression in hESCs can drive them to differentiate towards a germ cell fate 
(Lin et al., 2014); indeed, some studies suggest that PRDM14 operates 
together with NANOG, another factor also included in the i12F cocktail (Fig. 
6.1), to maintain pluripotency networks (Ma et al., 2011, Mitsui et al., 
2003). Moreover, LIN28A in conjunction with other reprogramming factors 
(i.e. OCT4, SOX2 and NANOG) is sufficient to reprogram human fibroblasts 
into hiPSCs, suggesting it has an important role in the main core of 
pluripotency factors (Saitou and Yamaji, 2010).  
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According to the literature (Nakaki et al., 2013) this near-pluripotent state 
would allow iGCs to start the epigenetic reprogramming process, and turn 
off expression of the somatic program without reaching full naïve 
pluripotency levels. This may explain why the efficiency of this direct 
conversion model (in terms of gene expression, methylation 
reprogramming and haploid cell formation) is lower than that achieved by 
germ cell derivation from PSCs. 
As mentioned above, overexpression of the RNA-binding proteins DAZL and 
VASA in combination with other early genes might orchestrate the 
formation of a pool of mRNA transcripts in this near-pluripotent state in 
which PRDM1 and PRDM14 transcription factors would promote the 
expression of the germ cell-related program.  It has been proposed that 
RNA-binding proteins involved in germ line development may act as 
chaperones which mediate correct protein folding to enable proper target-
RNA interaction with accessory proteins (Mohr et al., 2002), as well as 
acting as post-transcriptional meiosis-related protein regulators. In fact, 
recent results suggest that DAZL may be an upstream transcriptional 
regulator of Sycp3 and Mvh in mouse (Reynolds et al., 2007, Reynolds et al., 
2005). It has also been proposed that VASA interacts with Nanos2 mRNA, 
thus maintaining mitotic arrest in spermatogonia (Becalska and Gavis, 
2009). In this scenario DAZL and VASA overexpression may control entry 
into meiosis in vitro, as previously described (Medrano et al., 2011, 
Durruthy Durruthy et al., 2014) allowing SYCP3 to find an appropriate 
background in which is can attain the correct conformation.  
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Therefore, studying the overexpression of these reprogramming factors in a 
different system, e.g. in human PSCs, may be very useful to better 
understand how they interact in a proper pluripotent state. Moreover, 
whole genome expression or whole methylome studies (e.g. methylation 
arrays or bisulfite deep sequencing techniques) may also help to elucidate 
how these reprogramming factors (alone or in combinations) act in a 
complete genome context and these experiments may even help us to 
design a more accurate human germ cell development model.  
- Future perspectives and concluding remarks 
Several groups have reported in vitro human germ cell derivation starting 
from a pluripotent state (Clark et al., 2004, Kee et al., 2009, Eguizabal et al., 
2011, Medrano et al., 2011, Panula et al., 2011, Park et al., 2009, Durruthy 
Durruthy et al., 2014). But, to date, this is the first study that has 
interrogated the possibility of directly converting human somatic cells into 
cells with germ cell-like features. From this point of view, the results 
presented here must be considered as a pilot study from which an in vitro 
model can be created to study and gain insights into human germ cell 
development. However, a lot of work is still required to improve this model 
to the point at which it would serve as an effective technology for the 
derivation of clinical-grade gametes in vitro.  
Future work will aim to improve the efficiency of this system, for instance 
by the possible inclusion of other candidate genes to control human germ 
line development. Because some of the genes used in both reprogramming 
i12F- and i6F- cocktails are expressed at different moments of mammalian 
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germ line development, it is possible that some factors, especially the 
earlier markers PRDM1, PRDM14, and LIN28A, must be silenced during the 
later germ cell maturation stages such as in the onset of meiosis. In fact, 
some work has already highlighted that pluripotency core silencing is 
required for proper gamete development not only during germ cell 
migration (Seisenberger et al., 2012) but also for entry into meiosis 
(Anderson et al., 2007). Hence, sequential expression of factors is a 
potential strategy which could be used to better mimic these physiological 
processes. Therefore an inducible model for the activation of each of the 
transduced genes could be used to increase the effectiveness of this iGC 
model. Moreover, changing the reprogramming strategy from a constitutive 
to an inducible system (i.e., doxycycline-inducible lentiviral vectors) would 
be very useful, also helping to avoid variability in the results and 
standardizing the induction response of treated cells. 
Indeed, as mentioned above, some groups have reported how genetic 
manipulation of the expression of some RNA-binding proteins such as the 
DAZ gene family can drive human and mouse pluripotent stem cell germ 
line differentiation and haploid cell formation (Panula et al., 2011, Kee et 
al., 2009, Medrano et al., 2011, Yu et al., 2009). The importance of 
translational control as a germ cell proteome regulating mechanism is also 
noteworthy: transcriptional upregulation of individual RNAs is as relevant as 
an increase in the translation efficiency. Recent studies have shown that,  
there is a higher translational efficiency from the quiescent-gonocyte to 
mitotic-spermatogonium stages in neonatal mice due to a higher ribosomal 
binding rate, including to both germ line specific, housekeeping, and cell 
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cycle gene transcripts, rather than an increase in the abundance of 
transcripts (Chappell et al., 2013), thus highlighting the importance of 
mRNA translational control during germ line development. Hence, more 
research into the role of RNA-binding proteins in germ cell differentiation 
should be undertaken, not only including DAZ-family members, but also 
PIWI proteins.  
It would also be interesting to focus on the methylation regulating 
pathways because the reprogramming process in germ cell development is 
even more extensive than in early embryos, and achieving the proper 
methylation status is one of the main challenges for this model. As 
previously mentioned, it would also be interesting to overexpress the 
factors used in this model in human PSCs to test their efficiency in forming 
haploid cells because their expression and epigenetic profile is much closer 
to that of PGCs than somatic cells.  
Additionally, it would also be of great interest to apply both the i12F- and 
i6F- reprogramming combinations to a female human somatic cell line. 
Results from this approach may help to elucidate the role of the niche in 
the sexual differentiation of gametes and how these genes interplay in a 
female genomic context, focusing on X-chromosome silencing/reactivation 
and the acquisition of the imprinting pattern. As shown here, some of the 
iGCs show some SSC-like characteristics; these could therefore be of great 
help for improving our ability to identify, culture, and mature SSCs in vitro, 
all of which are strategies proposed for preserving and recovering fertility in 
adulthood for oncogenic prepuberal children (Goossens et al., 2013, Baert 
et al., 2013). From a more basic perspective, iGCs could also act as a base to 
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study human spermatogenesis at a molecular level which could be 
compared with other mammalian murine, rabbit or pig models, especially 
given that the latter two  exhibit peri-implantation embryo development 
which is closer to human development (Saitou and Yamaji, 2012).  
Based on these results, this model is still very far away from obtaining 
functional gametes in vitro. Until a method for producing proper 
reprogramming events is reported this technology only serves to model 
germ cell development and perhaps also pathological situations. Because 
iGCs are able to go through and to complete meiosis they could also be 
used to study the causes of meiotic failure from a personalized medicine 
point of view. From a future perspective, this model of direct 
reprogramming human somatic cells into meiotic germ cells could be used 
to help to discover therapies to treat patient-derived fertility problems. 
With this objective, non-viral integration strategies for reprogramming (i.e., 
RNA-reprogramming) should also be tested. 
In conclusion, to date this is the first study that describes the direct 
conversion of human somatic cells into meiotic-like cells in vitro. Therefore 
these results should be considered as proof of concept that iGCs could be 
generated to produce a robust in vitro model for studying human germ cell 
development. Hence, more work must be performed in order to improve 
this in vitro iGC model in both terms of its efficiency and its efficacy. In the 
same sense, further research is required to fully implement this model’s 
potential applications at a translational and clinical level. 
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 Bluebell, White poppy, Sweet Pea 
Grateful, rejoice, goodbye 
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Therefore, the final conclusions of this thesis project are: 
1. By reprogramming two different human primary somatic cells (hFSKs, 
and hMSCs) with key gene regulators a heterogeneous iGC population 
at different stages of maturation was obtained.  
2. iGCs show an transcriptomic expression and methylation profile that 
correlate with that of germ cells at different maturation stages 
3. Some of these iGCs may correlate with a spermatogonia-like stage since 
they are able to go through and complete meiosis after exposure to 
retinoic acid.  
4. The most effective combination of factors used to achieve direct 
reprogramming to a meiotic phenotype included the transcription 
factors PRDM1, PRDM14, the RNA-binding proteins LIN28A, DAZL, and 
VASA, and SYCP3, a structural protein which is part of the 
synaptonemal complex. 
5. Moreover, some of these iGCs demonstrated their in vivo functionality 
by their ability to colonize seminiferous ducts in a murine xenograft 
model. 
6. This work must be considered as a pilot study in which iGCs were 
created in vitro using direct reprogramming to gain insights into human 
germ cell development. 
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APPENDIX 1. PLASIMD MAPS  
- ENTRY VECTOR 
 
Direct reprogramming of human somatic cells to meiotic germ-like cells 
- 166 - 
 
- EXPRESSION VECTOR (plasmid 3 for third generation lentiviral 
transduction) 
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- PLASMIDS 1 AND 2 for third generation lentiviral transduction: 
 
PLASMID 1 
(GAG-pol; Tat, Rev)
PLASMID 2 
(VSV-G)
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- PLASMID FOR Bi-seq sub-cloning 
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APPENDIX 2. PRIMERS SEQUENCES 
GENE Primer sequences for detect ectopic expression Length (bp) 
PRDM1 F: GCCAAGTTCACCCAGTTTGT 183 
R: GATTCGGGTCAGATCTTCCA 
PRDM14 F: TCTCTACGATCTGCCCTGGT 231 
R: CTCAGCCCCTCAGGTAACAG 
LIN28A F: TGCACCAGAGTAAGCTGCAC 189 
R: CTCCTTTTGATCTGGCTTC 
NANOS3 F: GGGAAAGAGGGTCCTGAAAC 221 
R: AGCACGTGGGACTGGTAGAT 
NANOG F: GATTTGTGGGCCTGAAGAAA 155 
R: CAGTCTGGACACTGGCTGAA 
DAZ2 F: GAGATTGGAAGCTGCTTTGG 212 
R: TGCACATGACGAGCACATAA 
DAZL F: CATCCTCCTCCACCACAGTT 202 
R: AACTGTGGTGGAGGAGGATG 
BOULE F:CTAATCCTGTGTCACCTGTGC 205 
R:ACGAAACCATACCCTTTGGA 
VASA F:ATGGATGATGGACCTTCTCG 248 
R:CCTCTGTTCCGTGTTGGATT 
STRA8 F:AATCCCCATGACAGAGCAAC 227 
R:TTATCCAGGGTTTGCTCCAG 
SYCP3 F: AGCCGTCTGTGGAAGATCAG 197 
R: AACTCCAACTCCTTCCAGCA 
DMC1 F: AATCAAATGACTGCCGATCC 166 
R: CAGGCATCTCAGGACTGTCA 
RPL19 F: ACCTGAAGGTGAAGGGGAAT 140 
R: GCGTGCTTCCTTGGTCTTAG 
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GENE Primer sequences for germ cell markers Length (bp) 
GFRA1 F: GCAAGGAGACCAACTTCAGC 190 
R: TCCTCCAGCAGATGATTTCC 
PIWIL2 F: GTTAATGGTGATCGGGATGG 
R: ATGCATGCCATTTATCAGCA 
120 
TNP2 F: CCAACACTAGTCCACCACCA 197 
R: GTTGGATTTCCATCCTGAGC 
PRM1 F: CCGCCAGAGACAAAGAAGTC 200 
R: GGATGGTGGCATTTTCAAGA 
ACRO F: ATTCTGCTGGTCTTGGCAGT 192 
R: TGTGTGGTACCTGTGGCTGT 
DNMT1 F: TACCTGGACGACCCTGACCTC 103 
R: CGTTGGCATCAAAGATGGACA 
DNMT3A F: TATTGATGAGCGCACAAGAGAGC 111 
R: GGGTGTTCCAGGGTAACATTGAG 
DNMT3B F: GGCAAGTTCTCCGAGGTCTCTG 188 
R: TGGTACATGGCTTTTCGATAGGA 
TET1 F: GCTATACACAGAGCTCACAG 139 
R: GCCAAAAGAGAATGAAGCTCC 
TET2 F: CTTTCCTCCCTGGAGAACAGCTC 146 
R: TGCTGGGACTGCTGCATGACT 
TET3 F: ATTCTGCTGGTCTTGGCAGT 93 
R: TGTGTGGTACCTGTGGCTGT 
RPL19 F: GTTCCTGGAGCATGTACTTC 199 
R: CTTCCTCTTTGGGATTGTCC 
 
ICR Primer sequences for bisulfite sequencing  Length (bp) 
hH19 F: TGTATAGTATATGGGTATTTTTGGAGGTTT 231 
R: TCCTATAAATATCCTATTCCCAAATAACC 
hPEG1/MEST1 F: TCGTTGTTGGTTAGTTTTGTACGGTTGC 290 
R: ATAAACTCCTCCCCCACAATAAAAA 
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APPENDIX 3. DERIVED PUBLICATIONS AND SCIENTIFIC COMMUNICATIONS 
Articles 
 
- Martínez-Arroyo, AM.*; Medrano, JV*; Remohí J.; Simón, C. Germ line 
development: lessons learnt from pluripotent stem cells. Current opinion in 
genetics and development. REVIEW. In press. 
* Equally contibuting authors. 
 
- Medrano, JV*; Martínez-Arroyo, AM*; Quiñonero, A; Marqués-Marí, AI; 
Pellicer, A; Remohí, J; Simón C. Direct Conversion of Human Somatic Cells to 
Meiotic Germ-like Cells by Genetic Reprogramming. ORIGINAL ARTICLE. 
Submitted. 
* Equally contibuting authors 
 
- Medrano, JV; Martínez-Arroyo, AM; Sukhwani, M; Noguera, I; Quiñonero, 
A; Martínez-Jabaloyas, JM; Pellicer, A; Remohí, J; Orwig, KE; Simón, C. Germ 
Cell Transplantation Into Mouse Testes Procedure. Fertility and Sterility. 
ORIGINAL ARTICLE. Submitted. 
 
Book chapters 
 
- Medrano, Jose V.; Martínez-Arroyo, Ana M.; Simón, Carlos; Reijo 
Pera, Renee A. Germ Cell Differentiation from Pluripotent Cells. At: 
Stem Cells in Human Reproduction: Basic Science & Therapeutic 
Potential, Third Edition. Cap. 4. Cambridge University Press 
 
Scientific communications: 
 
- Martínez-Arroyo, Ana M.; Medrano, Jose V.; Quiñonero, Alicia; 
Marqués-Marín, Ana I.; Simón C. Direct reprogramming of human 
somatic cells to meiotic germ cells. Conjoint Meeting of the 
International Federation of Fertility Societies and the American 
Society for Reproductive Medicine (IFFS/ASRM). Boston, MA, USA. 
(October 12-17, 2013) ORAL PRESENTATION. 
 
- Medrano, Jose V.; Martínez-Arroyo, Ana M., Quiñonero, Alicia; 
Marqués-Marí, Ana I.; Simón C. Direct conversion of human somatic 
cells to meiotic germ cells by genetic reprogramming. Gordon Reserch 
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Conference on Germinal Stem Cell Biology. Hong-Kong, China. (July 
12-16 2012) POSTER 
 
- Martínez-Arroyo, Ana M.; Medrano, Jose V.; Simón, Carlos. Direct 
reprogramming of human fibroblast to meiotic germ cell-like cells by 
defined factors. Epigenetics and Stem Cells conference. Cambridge, 
UK. (October 16-17 2012). ORAL PRESENTATION 
 
- Medrano, Jose V.; Marqués-Marí, Ana I.; Martínez-Arroyo Ana M.; 
Simón, Carlos. Direct conversion of human adult somatic cells to 
meiotic germ cells by genetic manipulation. International Society for 
Stem Cell Research 10th Annual Meeting. Yokohama, Japan. (June, 
13-16 2012). POSTER 
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